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Abstract 
Accurate empirical modelling of the treatment beam is necessary to ensure accurate delivery of dose 
to the intended target site. Dose calculations within the treatment planning system (TPS) for 
Stereotactic Radiosurgery (SRS) and Stereotactic Radiotherapy (SRT) treatment rely upon accurate 
beam data. Inaccuracies within the empirical measurements will propagate as errors throughout 
calculated patient dose distributions (Tyler, 2013). The necessary empirical measurements for beam 
commissioning include: percentage depth dose (PDD), output factor (OF) and beam profiles. Thus, 
especially for the consideration of the afore mentioned small radiation fields, it is important to 
ensure the most appropriate detector is chosen to conduct measurements of the treatment beams to 
achieve the highest possible accuracy in measurement of beam parameters. 
Stereotactic Body Radiation Therapy (SBRT) requires precise delineation of the target using modern 
imaging modalities (MRI, CT etc.), accurate dosimetry to ensure the planned dose is delivered 
correctly and effective patient immobilisation. For extracranial sites the treatment accuracy is 
affected by tumour delineation which identifies the extent of the tumour volume and tumour motion 
resulting from the physical, biological and physiological processes of the human body. Delivery of 
radiation using highly conformal and small radiation beams presents challenges for dosimetry and 
quality assurance (Heydarian, 1996), (Das, 2008). To correctly measure dose in a small field an 
ideal dosimeter must exhibit properties including: small sensitive volume, near water equivalence, 
minimal beam perturbation and no dose-rate, energy or  directional dependence (Pappas, 2008). 
Also, treatment planning for dose calculation must be conducted using algorithms which can 
account for the impact of the heterogeneities found in the abdomen and thoracic cavities to ensure 
calculation of the dose to tissue in regions with complex scattering conditions is accurate (Rubio, 
2013). 
In charged particle radiation therapy, the deposition of dose by charged particles within a small 
volume at the Bragg peak is uniquely sensitive to the particles penetration range, and it is directly 
dependent upon the incident beam energy and any small variations in material density and stopping 
power along the beam path (Mirandola, 2018). Significant tumour under/over dosage can be the 
result of incorrect estimation of in-patient beam penetration (Paganetti, 2012). The routine 
measurement and verification of percentage depth dose curves of Bragg peaks for charged particle 
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radiotherapy delivery systems is vital to ensure safe provision of radiotherapy treatment (Cantone, 
2013). Unfortunately, devices providing a means of fast verification (for daily measurement) of 
beam energy stability in-phantom with high precision, accuracy and reliability are not readily 
available.  
The Serial Dose Magnifying Glass (sDMG) is a multi-strip silicon detector designed by the Centre 
for Medical Radiation Physics (CMRP) and is comprised of two linear arrays of 128 diodes 
separated with pitch 0.2 mm. A monolithic silicon detector array, referred to and designated as DUO, 
designed by the CMRP is comprised of 505 silicon diodes arranged in two bisecting orthogonal 
linear arrays of 253 diodes, sharing a common central pixel, with pitch 0.2 mm.  
This work examines the properties of the high spatial resolution linear silicon detector array, sDMG, 
for small field dosimetry and quality assurance (QA) of SRS, SBRT and Motion Adaptive Radiation 
Therapy (MART) using photons and the feasibility of the detector for fast, independent energy 
verification in charged particle beam radiation therapy. The 2D monolithic silicon detector array 
DUO was also investigated for dose verification in heterogeneous scattering conditions in MART 
and beam profiling in proton therapy. 
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Radiation therapy is a cancer treatment modality which is both safe and effective for many different 
types of cancers. Treatment by radiotherapy comprises the precise application of radiation to 
abnormal cancerous cells and involves the use of different forms of radiation, such as; high energy 
X-rays, gamma rays, electrons, protons or carbon-ions, to damage and/or kill cancerous cells while 
preserving healthy cells and thus prevent the cancer cells from growing abnormally within the 
human body (What is Radiation Therapy? - Targeting Cancer, 2020). 
Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) require precise 
delineation of the target using modern imaging modalities (MRI, CT etc.), accurate dosimetry to 
ensure the planned dose is delivered correctly and effective patient immobilisation. For extracranial 
sites, in SBRT, the treatment accuracy is affected by tumour delineation which identifies the extent 
of the tumour volume and tumour motion resulting from the physical, biological and physiological 
processes of the human body.  
Delivery of radiation using highly conformal and small radiation beams, of photons or charged 
particles, presents challenges for dosimetry and quality assurance (Heydarian, 1996), (Das, 2008). 
To correctly measure dose in a small field, an ideal dosimeter must exhibit properties including: 
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small sensitive volume, near water equivalence, minimal beam perturbation and no dose-rate, 
energy or  directional dependence (Pappas, 2008). 
In charged particle radiation therapy the deposition of dose by charged particles within a small 
volume at the Bragg peak is uniquely sensitive to the particles penetration range, and it is directly 
dependent upon the incident beam energy and any small variations in material density and stopping 
power along the beam path (Mirandola, 2018). Significant tumour under/over dosage can be the 
result of incorrect estimation of in-patient beam penetration (Paganetti, 2012). The routine 
measurement and verification of percentage depth dose (PDD) curves of Bragg peaks for charged 
particle radiotherapy delivery systems is vital to ensure safe provision of radiotherapy treatment 
(Cantone, 2013). Unfortunately, devices providing a means of fast verification (for daily 
measurement) of beam energy stability in-phantom with high precision, accuracy and reliability are 
not readily available.  
This work investigates the utilisation and accuracy of silicon detector arrays, designed and 
developed at the Centre for Medical and Radiation Physics (CMRP) at the University of 
Wollongong (UOW), for independent dose verification of small photon radiation beams in motion 
adaptive radiation therapy and fast independent energy verification in charged particle radiation 
therapy. 
1.2 Objective of the study 
The objective of this work is to examine the properties of the high spatial resolution linear silicon 
detector array, Serial Dose Magnifying Glass (sDMG), for small field dosimetry and quality 
assurance (QA) of Stereotactic radiosurgery (SRS), Stereotactic Body Radiation Therapy (SBRT) 
and Motion Adaptive Radiation Therapy (MART) using photons and the feasibility of the detector 
for fast, independent energy verification in charged particle beam radiation therapy. The 2D 
monolithic silicon detector array DUO was also investigated for dose verification in heterogeneous 
scattering conditions in MART and beam profiling in proton therapy. 
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1.3 Thesis structure 
This thesis is composed of 7 chapters investigating the use of two silicon detectors as QA devices 
across photon and charged particle beam radiation therapy. This chapter, Chapter 1, provides; a 
short introduction, an overview of the thesis objective and the essential structure of the work.  
Chapter 2 provides a literature review and background to introduce the forms of advanced external 
beam radiotherapy treatment delivery modalities available today, such as; IMRT, SBRT, SRS, 
proton therapy and carbon-ion therapy. The chapter describes the necessity and importance of 
quality assurance processes, discusses and highlights the complexities of small field dosimetry 
relative to available quality assurance devices and summarises the specifications of the 
commercially available systems.  
Chapter 3 characterises the dosimetric properties of the Serial Dose Magnifying Glass (sDMG) 
under photon irradiation, investigating and presenting the results of measurements of radiation 
hardness, dose linearity, dose per pulse dependence, percentage depth dose measurement, beam 
profiling and output factor relative to the gold standard clinical dosimeters, ionisation chambers and 
radiochromic film. This chapter also proposes an investigation into the optimum resolution required 
to reconstruct beam profiles in stereotactic radiation therapy (SRT) modalities based on an analysis 
of high resolution radiochromic film data, conducted to generate recommendations for the pixel 
separation required to accurately measure beam penumbrae and profiles.  
Chapter 4 is centred on the complexities of QA and dose verification of treatments of small volume 
tumours within the lungs which require small conformal radiation beams and real time motion 
adaptation to improve treatment efficiency and reduce normal tissue toxicity. Motion adaption is 
achieved through Multi Leaf Collimator (MLC) tracking, which has been applied clinically to lung 
Stereotactic Ablative Body Radiotherapy (SABR) treatments (Booth et al., 2016). The combination 
of small field dosimetry, target motion and heterogeneous scattering conditions is challenging for 
accurate dose measurement in real-time and thus measurements utilising sDMG and DUO in 
phantoms with various scattering conditions and motion strategies are discussed. The measurements 
undertaken in Chapter 4 investigate the effects of homogenous and heterogeneous scattering 
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conditions upon the delivered dose distribution in the treatment of dynamic targets using small 
photon radiation fields and aims to evaluate the performance of the sDMG and DUO detectors 
compared to the gold standard of high spatial resolution two-dimensional dosimetry, EBT3 film.  
Chapter 5 aims to introduce the use of the sDMG and DUO detectors for lateral beam profile 
measurements in a clinical proton radiation beam with energy 129.46 MeV at the Francis H. Burr 
Proton Therapy Center (FHBPTC) at Massachusetts General Hospital (MGH). The measured results 
from sDMG and DUO for exposure to a proton pencil beam spot, used in proton pencil beam 
scanning, will be compared to a commercially available ionisation chamber array, MatriXX, used 
routinely in the clinic. The experimental results of an investigation will be presented into the efficacy 
and accuracy of the sDMG as a fast, independent proton energy verification system.  
Chapter 6 introduces the use of the sDMG as a fast, independent energy verification system for use 
in charged particle therapy with a heavy-ion carbon beam.  
Chapter 7 concludes the work undertaken to investigate the properties of the high spatial resolution 
silicon detector arrays, sDMG and DUO, for small field dosimetry and QA of SRS, SBRT and 
MART using photons and the feasibility of the sDMG for fast, independent energy verification in 





This chapter aims to introduce some of the forms of advanced external beam radiotherapy treatment 
delivery modalities available today, such as; IMRT, SBRT, SRS, proton therapy and carbon-ion 
therapy. The necessity and importance of quality assurance processes is highlighted and the 
complexities of small field dosimetry are described. Finally, the operation and utility of essential 
dose measurement devices are described and the tools and devices commercially available are 
summarized. 
2.1 Cancer and Radiation Therapy 
Cancer refers to a disease of the cells of the human body in which abnormal cells grow in an 
uncontrolled way into a mass, known as a tumour. These abnormal cells eventually damage or 
invade surrounding healthy tissues and may spread to other parts of the body and cause further harm 
through uncontrolled growth of additional tumours (What is cancer? | Cancer Australia, 2020). This 
invasive action of abnormal cells spreading throughout the body and forming secondary tumours is 
referred to as a process known as metastasizing.  
The World Health Organisation (WHO) describes cancer as the second leading cause of death 
worldwide, being responsible for approximately 9.6 million deaths in 2018 (Cancer, 2018). The 
three leading modalities for the treatment of cancer are surgery, chemotherapy and radiation therapy 
(radiotherapy) (Types of Cancer Treatment - National Cancer Institute, 2020).  
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In 2018, the most common causes of cancer related death worldwide were (Cancer, 2018): 
 Lung – 1,760,000 deaths  
 Colorectal – 862,000 deaths 
 Stomach – 783,000 deaths 
 Liver – 782,000 deaths 
 Breast – 627,000 deaths 
Radiation therapy is a cancer treatment modality which is both safe and effective for many different 
types of cancers. Treatment by radiotherapy comprises the precise application of radiation to 
abnormal cancerous cells and involves the use of different forms of radiation, such as; high energy 
X-rays, gamma rays, electrons, protons or carbon-ions, to damage and/or kill cancerous cells while 
preserving healthy cells and thus prevent the cancer cells from growing abnormally within the 
human body (What is Radiation Therapy? - Targeting Cancer, 2020). The applied radiation 
physically damages the DNA in the abnormal cancerous cells which biologically interrupts the 
cancer cells ability to multiply, this leads to shrinking and eventually destruction of the tumour. 
Unlike the cancer cells, normal healthy cells within the human body can recover from the effects of 
the radiation more easily (What Is Radiotherapy? Benefits & Side Effects - TROG Cancer Research, 
2020). 
The potential benefits of radiotherapy to the patient, in contrast to chemotherapy and surgery, 
include (What Is Radiotherapy? Benefits & Side Effects - TROG Cancer Research, 2020): 
 Patients find that radiotherapy treatments have minimal impact upon their daily schedules, 
 Radiotherapy treatments are generally conducted without requiring prolonged 
hospitalisation, 
 Individual treatment sessions often require less than one hour to be completed, sometimes 
less than thirty minutes. 
Radiation therapy may be prescribed as a definitive treatment modality in some cases, but it is most 
often prescribed in combination with other treatment modalities, such as; chemotherapy and surgery, 
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to achieve the greatest curative benefit to the patient. 
 
2.2 External Beam Radiotherapy 
External Beam Radiotherapy (EBRT) describes the most common method of providing and 
delivering radiotherapy and primarily includes the utilization of a linear accelerator, often referred 
to as a linac. The linac generates high energy photon or electron beams of radiation, outside of the 
patient, which are precisely directed at a target within the patient (Mayles, 2007). 
2.2.1 3D Conformal Radiotherapy (3DCRT) 
The essential form of modern external beam radiotherapy delivered to patients is referred to as 3D 
Conformal Radiotherapy (3DCRT). The goal of conformal radiotherapy is to achieve the delivery 
of a high-dose, which conforms to the targeted volume, whilst ensuring the organs-at-risk (OARs) 
receive a low-dose, so as not to cause any complications (Mayles, 2007). 3DCRT involves the 
utilisation of three primary technological advances (Elith, 2011): 
 Advanced imaging modalities, such as; computed tomography (CT), magnetic resonance 
imaging (MRI) and positron emission tomography (PET), to visualise and provide a 3D 
anatomical model of the target and OARs for accurate identification, 
 Improvements in computational technology enabling the treatment planning system (TPS) 
to incorporate these images and produce dose calculations visualised on the images, 
 Development of the MLC allowing precise shaping of the radiation beam to the shape of 
the target volume in the beams-eye view (BEV). 
The combination of these advances enabled three-dimensional images to guide the treatment 
planning process. This form of EBRT is widely used in the treatment of tumours in; the central 
nervous system, head and neck, thorax, pancreas, prostate and rectum (Purdy, 2008). The most 
significant disadvantage of 3DCRT is the limited ability to generate conformal doses to concave 
targets, this results in higher organs-at-risk doses as the target wraps around critical structures. 
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2.2.2 Intensity Modulated Radiotherapy  
Intensity Modulated Radiotherapy (IMRT) is a form of external beam radiotherapy delivery which 
utilises radiation beams with non-uniform radiation fluence (Webb, 2003). IMRT enables the 
delivery of comparatively improved dose distributions relative to 3DCRT due to the capability to 
sculpt and conform the dose distribution around targets which are composed of complex shapes 
(Elith, 2011).  
The features of IMRT which were not associated with 3DCRT include (Galvin, 2007): 
 Inverse treatment planning methodology, the treatment plan is generated algorithmically 
based on supplied dose and target constraints 
 Large numbers of treatment fields and/or subfields which produce a radiation field with a 
modulated intensity 
Modulation of the radiation field intensity is possible using custom designed beam compensators, 
however the patient specific design and production process would be impractical for modulating 
large numbers of treatment fields across multiple patients. The MLC is key in modulating the beam 
fluence and thus making the delivery of IMRT possible, IMRT is delivered with fixed gantry angles 
with either static MLC dose segments, often referred to as step-and-shoot IMRT (or static MLC), or 
with dynamic MLC dose segments, often referred to as sliding window IMRT (or dynamic MLC or 
DMLC). In sliding window IMRT, the MLC leaf pairs move across the radiation field throughout 
beam delivery to deliver a fluence modulated dose which is conformed to the target shape (Mayles, 
2007). The capability to modulate the radiation fluence within the beam allows for significant 
improvements in the sparing of surrounding critical structures due to the rapid dose falloff (Lee, 
2008). 
IMRT offers significant advantages in generating conformal dose to complex targets in close 
proximity to critical structures (OARs), but there are some disadvantages. A significantly larger 
number of monitor units (MU) are required to deliver a comparable prescription dose to 3DCRT 
due to the increased utilisation of multiple subfields with small MLC apertures (Purdy, 2008). 
Additionally, due to the increased number of radiation beams and beam directions used when 
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delivering IMRT, there is an increase in the volume of normal healthy tissue which is exposed to a 
lower radiation dose, when compared to conventional radiotherapy (Hall, 2003), resulting from the 
increased exposure to head scatter and leakage radiation from the linac.  
2.2.3 Stereotactic Body Radiotherapy & Stereotactic Radiosurgery  
Stereotactic Radiotherapy (SRT) and Stereotactic Radiosurgery (SRS) are a class of radiotherapy 
treatment characterised by the use of highly conformal photon beams to deliver high doses with 
minimal geometric error within a hypofractionated regimen (Charlie Ma, 2019).  
The application of this treatment methodology to tumour sites within the body, known as 
Stereotactic Body Radiation Therapy (SBRT), requires accurate target delineation of the tumour 
volume relative to the surrounding healthy tissue and minimisation of the safety margins resulting 
from the biological and physiological motions of the tumour (Kavanagh, 2006). These goals are 
realised through the implementation of accurate pre-treatment imaging protocols, image guidance 
and motion management strategies. SBRT is generally utilised for the treatment of tumours with 
diameters less than 5 cm (Hanna, 2015). Within the thoracic and abdominal region, possible 
treatment sites may include: lung, liver and kidneys (Kavanagh, 2006),(Rubio, 2013). 
Essentially, SBRT is classified as the treatment of tumours with 1-5 dose fractions which occur 
outside of the brain (extracranial). SRS is generally classified as the treatment of intracranial 
tumours with a single or few fractions. Dose fractions of 5 Gy or more for extracranial treatment 
sites are generally considered stereotactic with fractions of 10 Gy or more for intracranial tumours 
(Brown, 2014). 
SBRT requires precise delineation of the target using modern imaging modalities (MRI, CT etc.), 
accurate dosimetry to ensure the planned dose is delivered correctly and effective patient 
immobilisation. For extracranial sites the treatment accuracy is affected by tumour delineation 
which identifies the extent of the tumour volume and tumour motion resulting from the physical, 
biological and physiological processes of the human body. Delivery of radiation using highly 
conformal and small radiation beams presents challenges for dosimetry and quality assurance 
(Heydarian, 1996), (Das, 2008). To correctly measure dose in a small field an ideal dosimeter must 
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exhibit properties including: small sensitive volume, near water or tissue equivalence, minimal beam 
perturbation and no dose-rate, energy or  directional dependence (Pappas, 2008). Also, treatment 
planning for dose calculation must be conducted using algorithms which can account for the impact 
of the heterogeneities found in the abdomen and thoracic cavities to ensure calculation of the dose 
to tissue in regions with complex scattering conditions is accurate (Rubio, 2013). 
There are a several hypothesised radiobiological effects which describe the greater antitumour 
efficacy exhibited by doses per fraction of 10 Gy and above, these include (Brown, 2014): 
 Damage to endothelial cells may enhance the cytotoxic effect of irradiation of tumour cells 
 Vascular damage which is induced by high doses of radiation lead to indirect tumour cell 
death 
 Irradiation of a tumour at one site, with high doses, induces an antitumour immunological 
rejection of any metastatic lesions present at a distant site 
SBRT can be delivered using any modern linac, provided the appropriate access to image guidance 
and immobilisation devices. Radiosurgery can currently be delivered via a number of contemporary 
systems which include; the Gamma Knife Perfexion (Elekta AB, Stockholm, Sweden), Cyberknife 
(Accuray, Sunnyvale, USA), TrueBeam STx (Varian, Palo Alto, USA) (Sheehan, 2014) and Versa 
HD (Elekta AB, Stockholm, Sweden).  
2.2.4 Motion Adaptive Radiation Therapy  
Modern cancer therapy utilising external beam radiation therapy (EBRT) is becoming increasingly 
complex having progressively introduced radiation beam shaping, intensity modulation and moving 
forward to clinical implementation of radiation therapy treatments which adapt to the changing 
internal anatomy attributable to patient breathing, motion and positioning.  
Real-time adaptive radiation therapy (ART) is an emerging class of highly advanced external beam 
radiotherapy which aims to improve the conformal delivery of radiation dose and minimise the need 
for large treatment margins which are accounting for motion. These effects are achieved by re-
optimising the treatment based upon the patient-specific changes in anatomy which occur during 
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treatment. Within the abdomen and thorax of the patient, periodic changes in anatomy are 
predominantly attributed to the motion resulting from patient breathing; such intrafraction organ 
motions, can adversely impact treatment accuracy (Shirato, 2004).  
Motion management strategies seek to mitigate the effects of target motion, such strategies include: 
gating (Kubo, 1996), breath-hold techniques, compression and tumour tracking (Bertholet, 2019). 
Tumour tracking methodologies re-position the treatment beam and/or patient robotically (Depuydt, 
2011; Lang, 2014) to compensate for tumour motion. In all forms of tracking, the position of the 
tumour site must be localised in real-time. Numerous technologies offer real-time localisation 
capabilities, including; optical imaging of external markers or surrogates (Heinzerling, 2020), 
implanted internal markers (active or passive), fluoroscopic imaging and on-board imaging (such as 
kV or MV imaging) (Ng, 2012), MRI (Green, 2018), (Henke, 2018), (Keall, 2020).  
Multi-Leaf Collimator (MLC) tracking (Booth, 2016), (Keall, 2014) is a motion adaptive strategy 
that applies real-time tumour localisation to modify and re-position the MLC shape during 
treatment. Tumour localisation can be provided using implanted radiofrequency emitters, named 
beacons (Shah, 2011), within the patient. The beacons are positioned within close-proximity to the 
target and deliver surrogate motion data to localize the position of the target during irradiation.  
The Calypso (Varian, Palo Alto, CA) system, Figure 2.1, is the most commonly used means of 
providing non-ionising continuous real-time 3D localization of implanted transponders. For clinical 
use of localisation and monitoring of an internal target, three transponders are implanted in or near 
to the target. Each transponder is an electromagnetic resonance circuit with a different resonance 
frequency (300-500 kHz), sealed in a glass capsule for tissue compatibility and protection. A panel 
positioned above the patient contains an array of excitation coils and a second array of receiver coils. 
Each transponder is excited in series and the signal localised by triangulation to provide a 3D spatial 
coordinate of the centroid of the transponder with a frequency of 10-25 Hz relative to the position 
of the panel. The position of the transponders is then determined relative to the linac isocentre based 
on the calibration of three in-room cameras detecting infrared (IR) markers on the panel (Bertholet, 
2019). The panel is present in the path of the treatment beam throughout delivery with the influence 







Figure 2.1 (a) The Calypso panel and intrafraction motion monitoring system, the panel is 
extended and positioned over the patient during treatment (Calypso | Varian, 2020). (b) The 17G 
transponder beacon can be implanted in any soft tissue for localisation using Calypso (Bertholet, 
2019).  
 
2.3 Charged Particle Beam Radiotherapy 
Charged particle beam radiotherapy, also referred to as ion or hadron therapy, utilises beams of 
charged particles, such as protons or heavier ions, like carbon, instead of photons, to deliver dose to 
the target (Mayles, 2007).  
Particle beams exhibit an increase in energy deposition, and physical absorbed dose, with increasing 
penetration depth, reaching a sharp maximum value of energy deposition which occurs at the end 
of the particles range in the material through which it traverses. For a mono-energetic beam of 
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particles this is referred to as the pristine Bragg peak (Schulz-Ertner, 2007). This behaviour of 
particles is in direct contrast to the initial maximum intensity deposited by photons upon reaching 
charged particle equilibrium in the medium followed by decay in intensity due to attenuation. A 
percentage depth dose (PDD) comparison between photons, protons and carbon ions is shown in 
Figure 2.2. 
 
Figure 2.2 PDD profile comparison between 21 MeV photons, 148 MeV protons and 270 MeV/U 
12C ions (Schulz-Ertner, 2007). Figure reproduced with permission from ASCO Publications. 
 
The range of the particle in the medium is directly determined by the energy of the incident particles. 
Particle beams also demonstrate steep dose fall-off at the field edges, this effect combined with the 
Bragg peak means that particle beams can localise dose to the target with greater precision than 
photons (Trikalinos, 2009).  
2.3.1 Proton Therapy 
The pristine Bragg peak of a mono-energetic proton beam is too narrow and sharp to be used directly 
to treat tumours of the various shapes and sizes necessary for cancer treatment. Thus, it is necessary 
to broaden the peak of the beam to conform to the shape of the tumour, the spread-out Bragg peak 
(SOBP). This is generally achieved using one of two methods, either; passive scattering or pencil 




Figure 2.3 Diagram of the relative dose distributions from the surface of the skin for protons, 
carbon ions and X-rays. The SOBP of the proton and carbon-ion beams are generated by the 
summation of contributions from pristine Bragg peaks to cover the tumour target volume 
(Ishikawa, 2019). Figure reproduced with permission from Wiley. 
 
Passive scattering utilises a ridge filter to generate a spread-out Bragg peak which corresponds to 
the necessary size to cover the targeted volume. Pencil beam scanning dynamically alters the path 
of the particle beam using powerful scanning magnets, allowing generation of the SOBP by the 
deposition of dose as individual spots within the target volume. This is often termed dose painting 
and in proton therapy can be most commonly achieved by one of two methods; slice-by slice where 
dose is delivered from the most distal to proximal layer of the target sequentially (Saini, 2016) or 
volumetrically where repeated scans through the target volume are delivered in depth (Zenklusen, 
2010). The clearest advantages of pencil beam scanning relative to passive scattering result from 
the capability to optimise dose delivery, in terms of absorbed dose conformality, at both the distal 
and proximal extents of a target. Additionally, availability of inverse planning methods allows for 




Figure 2.4 Schematic illustration of the two primary methods of particle beam delivery, specific 
to proton therapy. (a) Passive scattering method – a broad particle beam is generated by scatterers, 
the SOBP is generated by a ridge filter, a binary range shifter alters the beam energy, and patient 
specific compensation bolus and collimator is used to conform the distal edge of the SOBP to the 
target in the patient. (b) Pencil beam scanning – a collimator defines the field size and scanning 
magnets are utilised to scan the pencil beam in three dimensions through the target (Ishikawa, 
2019). Figure reproduced with permission from Wiley. 
 
Proton beams deposit very little physical dose within the medium beyond the depth of the Bragg 
peak, shown in Figure 2.2. Thus, the physical radiation dose delivered to normal tissues at the 
entrance of the radiation field and beyond the targeted area is less for protons when compared to 
photons (Trikalinos, 2009). 
In terms of the biological advantages of protons in comparison to photons, protons exhibit a higher 
linear energy transfer (LET) than photons, however, the radiobiological properties of protons are 
not that substantially different to photons (Morimoto, 2014). LET is the rate at which a particle 
beam loses energy when penetrating into tissue. Photons, electrons and protons are considered to be 
sparsely ionizing radiations and often referred to as low-LET radiations (Tsujii, 2012).  
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2.3.2 Carbon-ion Therapy 
Important differences exist between carbon ions and protons. The foremost physical difference 
between carbon ions and protons is that the peak-to-plateau ratio in the PDD profile (Figure 2.2) is 
greater in carbon ion beams than it is in proton beams (Shioyama, 2015). Additionally, the beam 
penumbra is smaller in carbon ion beams compared to protons beams as a result of the reduced 
influence of Coulomb scattering for particles with a larger mass. Carbon ion beams also exhibit an 
energy spread and range straggling that is smaller than proton beams thus carbon ion beams possess 
an improved lateral dose fall-off at the field edges. Carbon ion beams demonstrate a higher physical 
dose at the distal end beyond the Bragg peak compared to protons, this is caused by the primary 
carbon ions undergoing nuclear interactions and fragmenting into lower atomic number particles, 
referred to as a fragmentation tail (Tsujii, 2012).  
In contrast to the biological comparison of protons and photons, heavy ions, such as carbon, exhibit 
the similarly favourable physical properties of protons, in addition to superior biological advantage 
over protons, in comparison to photons (Morimoto, 2014). Carbon-ions are densely ionising 
particles and are thus considered to be a high-LET radiation type. The LET of a particle is an 
important parameter to consider to evaluate biological effect as the relative biological effectiveness 
(RBE) of a radiation type increases with increasing LET. The RBE is defined as the delivered dose 
of radiation under investigation which is required to produce the same biological effect as a 
delivered dose of reference radiation (assumed to be a Co-60 source) (Mayles, 2007).  In terms of 
different common radiotherapy particle types; the RBE of photons is assumed to be 1.0, for protons 
an RBE of 1.1 is generally clinically used and for carbon-ions the RBE is assumed by most 
institutions to be 3.0 (Lühr, 2018). These assumptions introduce uncertainties in establishing the 
radiobiological dose to targets and thus more sophisticated methods of modelling RBE are in 
constant active development. Carbon ions exhibit an advantageous radiobiological property 
whereby the LET of carbon ions increases with increasing depth, reaching a maximum in the Bragg 
peak where the targeted tumour will be located (Tsujii, 2012).  
The tumour sites generally targeted for treatment using carbon ions include; non-small cell lung 
cancer, malignant tumours in the head, neck and spine, ocular melanoma, prostate cancer, uterine 
cancer and bone and soft tissue sarcomas (Trikalinos, 2009). 
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2.4 Quality Assurance in Radiation Therapy 
The processes of quality assurance (QA) in radiation therapy involve the ongoing evaluation of 
functional performance characteristics of the treatment machine (Low, 2011). Assessment and 
routine validation of the stability and consistency of such performance characteristics is vital for 
ensuring safe patient treatment as the functional performance of a radiotherapy machine directly 
influences the geometrical and dosimetric accuracy of the delivered treatment. Evaluation of 
functional performance characteristics are conducted with high accuracy and precision during the 
commissioning of a radiotherapy treatment delivery system. From these initial measurements 
routine QA check methods utilizing the most appropriate tool or detector are established to ensure 
functional performance characteristics are accurately and efficiently monitored for fluctuation or 
fault. The development of new QA tools and devices which offer measurements with high spatial 
resolution without requiring laborious clinical time on the machine are important for improving 
treatment delivery outcomes throughout radiotherapy. 
It is important and necessary to establish a distinction between routine quality assurance checks of 
machine performance characteristics and patient specific quality assurance to measure the 
magnitude and distribution of dose intended to be delivered to a patient. 
For complex external beam radiotherapy treatment modalities (i.e. VMAT or IMRT; step and shoot 
or sliding window) it is important to conduct patient specific quality assurance (QA) involving 
physical measurements (i.e. in-phantom). This practice encompasses the investigation and 
evaluation of the dose distribution delivered by the treatment machine compared to the predicted 
dose distribution calculated by the treatment planning system (TPS) (Miften, 2018).  
The most appropriate dosimeter and phantom for measurement-based patient specific verification 
practices is dependent upon a number of factors: 
 Detector-related performance characteristics, such as; effective point of measurement, 
tissue-equivalency, energy dependence, resolution, volume averaging, sensitivity, active 
area, angular dependence, dose-rate dependence, output information 
31 
 
 Delivery technique-related characteristics, such as; beam energy, flattening filter free, 
dose-rate, field sizes, dose distribution gradients, gantry rotation 
Dose verification can be conducted as spatial analysis in one-dimension (a single point or line), two-
dimensions (a plane) or three-dimensions (a volume). The method of assessment of delivered dose 
must be carefully chosen considering the strengths, weaknesses, available equipment, intended 
treatment technique and time (Miften, 2018): 
 1D measurements - provide accurate absolute dose measurement at a single point or along 
a line-profile in a phantom 
 2D measurement methods - must be calibrated (to yield absolute dose) and provide more 
comprehensive information for plan analysis, but only in a single predetermined plane of 
interest within the phantom 
 3D methods - can be either; true 3D measurements or calculated from 2D projections based 
on reconstruction algorithms. They must also be calibrated and offer three-dimensional 
assessment of the delivered dose throughout a representative volume, but are increasingly 
complex and to provide accurate QA results (i.e. tolerance and action limits) must be 
carefully commissioned assessing the error detection capability 
2.4.1 Small Field Dosimetry 
The physics of small radiation fields is an important area of investigation due to the increasing 
utilization of SBRT and SRS worldwide in the treatment of cancer. Accurate and precise 
measurement of absorbed dose in small radiation fields is vital to ensure radiation therapy is safely 
provided to patients who will be able to directly benefit from the improvements in local control and 
overall survival demonstrated by SBRT and SRS in the treatment of some cancers.  
The characteristics of the ideal dosimeter for use in small field dosimetry, and consequently SBRT, 
may be summarised to include the properties: near water equivalence, minimal beam perturbation 
and high spatial resolution due to  small sensitive volume and minimal extra cameral material,  as 
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well as dose-rate, energy and directional independence (Pappas, 2008). Several detectors and 
dosimetry systems possess a number of these properties.  
The treatment of small volume cancers often requires small area radiation beams to minimise effects 
on healthy tissue. Measuring the physical effects of small radiation fields requires specialised 
detectors. The challenges of small photon field dosimetry include: steep dose gradients, partial 
occlusion of the beam source and lateral electron disequilibrium, as well as considerations related 
to beam perturbation effects, detector size and detector packaging composition (Heydarian, 1996; 
Das, 2008; Bouchard, 2015, 2015). The implications of the three main physical small field 
conditions will be summarized. 
2.4.1.1 Lateral Charged Particle Equilibrium 
A loss of lateral charged particle equilibrium (LCPE, often referred to as lateral electron 
disequilibrium) is found to occur if the maximum range of secondary electrons is larger than the 
half width (or radius) of the photon beam (Aspradakis, 2010). A parameter is determined which 
describes the minimum radius of a circular photon field for which at the centre of the field, the 
absorbed dose to water and the collision kerma in water are equal, equation (2.1) (Palmans, 2017). 
 𝑟𝐿𝐶𝑃𝐸 = 8.369 × 𝑇𝑃𝑅20,10(10) − 4.382 (2.1) 
 
The rLCPE establishes the relationship between the minimum detector size, for which the conditions 
of LCPE exist, and the photon beam field size. This parameter is dependent upon the ratio of the 
measured tissue-phantom ratio (TPR) at 20cm depth in water to 10cm depth in water, this is a 
common energy specifier in MV radiotherapy (Andreo, 2006).  In a region in which the LCPE 
condition does not exist; absorbed dose is not equal to the collision kerma in water and thus a 
detector (or cavity) is unable to accurately measure absorbed dose. 
2.4.1.2 Partial Source Occlusion 
The focal spot of the X-ray beam is not a point but can be represented by the full-width at half 
maximum (FWHM) of the bremsstrahlung photon fluence distribution that is exiting the X-ray 
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target, which can be termed the direct beam source.  This distribution is typically represented by a 
Gaussian distribution and is the result of blurring of the finite-size electron pencil beam striking the 
X-ray target caused by bremsstrahlung production and electron scattering (Aspradakis, 2010).  
From the point of measurement, less of the direct beam source is visible as the collimator setting is 
decreased, Figure 2.5. Thus, the indirect and extra-focal scatter becomes less important to the 
measurement of dose at the point of measurement. That is, for small collimator settings, such as 
those for small radiation beams, the direct beam source is obstructed (or shielded) from the view of 
the point of measurement. Thus, the number of primary photons reaching the isocentre, and the point 
of measurement, is reduced, this phenomenon is referred to as partial source occlusion (Aspradakis, 
2010). 
 
Figure 2.5 Schematic diagram illustrating the phenomenon of partial source occlusion (Palmans, 
2018). Figure reproduced with permission from Wiley. 
 
2.4.1.3 Volume Averaging 
The size of the detector relative to the size of the radiation field is an important feature of the physics 
of small field dosimetry. The signal produced within a detector (measuring absorbed dose), in 
response to a radiation field, is proportional to the mean absorbed dose over its sensitive volume. 
This signal is also influenced by the homogeneity of the absorbed dose over the volume of detection 
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and this effect results in volume averaging. Figure 2.6 is an illustrative depiction of the 
consequences, in one-dimensional (1D) space, of volume averaging upon a physical measurement 
of a small radiation beam, which exhibits Gaussian curvature, by a detector which is 5 mm wide. 
The dimensions of the ideal and circular detector, relative to the ideal and circular radiation beam, 
are depicted in Figure 2.6 as two black dots, upon the plot. This is a theoretical depiction of the 
consequences of attempting to measure the Gaussian curve (black solid line) of a small radiation 
beam with a detector with volume averaging over a dimension of 5 millimetres (black dotted line) 
(Wuerfel, 2013). The result measured by the detector (black dotted line) is shown to not perfectly 
record the intensity of the small radiation beam, exhibiting underestimation of the radiation peak 
and overestimation of the beam penumbra. Additionally, the presence of the detector within the 
radiation field results in a perturbation of the charged particle fluence, this perturbation effect is 
entangled with volume averaging (Palmans, 2018). 
 
Figure 2.6 A Gaussian (solid black) curve approximates a small radiation field in one dimension, 
the dotted black curve demonstrates the measurement of a detector with a volume effect (5 mm 
wide), the deviation between the curves is displayed as a dot-dashed black line (Palmans, 2018). 





2.4.2 Current QA tools 
2.4.2.1 Ionisation Chamber 
The ionisation chamber is the simplest form of a gas-filled detector and consists of a receptacle 
filled with gas and two opposing electrodes. A voltage is applied between the electrodes and as the 
gas is (theoretically) a perfect insulator, no electric current flows between the two electrodes. 
Incident radiation traversing the gas will interact with and ionise the gas, the electric field present 
between the electrodes causes the diffusion of the ions produced by the radiation in the gas towards 
the electrodes. This produces a current which can be measured using an electrometer (Mayles, 
2007). 
Cavity ionisation chambers encompass two basic geometries of ionisation chamber: cylindrical (or 
thimble) chambers and parallel-plate (or plane-parallel) chambers. Both of these geometries of 
ionisation chamber are designed to perform as Bragg-Gray cavities in megavoltage photon qualities.  
The Bragg-Gray cavity theory establishes a link between the absorbed dose in a medium and the 
absorbed dose measured in a detectors sensitive volume (often referred to as a cavity). If the cavity 
is small and doesn’t perturb the fluence of charged particles in the medium and if the absorbed dose 
in the cavity is solely deposited by particles crossing it then the cavity is said to be obey the Bragg-
Gray conditions. Under the conditions of Bragg-Gray cavity theory the dose in the medium, Dmed 
can be related to the absorbed dose in the cavity, Dcav through the ratio of the average unrestricted 
mass stopping powers of the medium and the cavity. 
 









For the chamber to behave as a good approximation of a perfect Bragg-Gray cavity it should possess 
the following features (Mayles, 2007): 
 The air cavity should be small such that the sensitive volume is well-defined.  
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 The central electrode and wall should be constructed from materials which are as 
homogenous and water-equivalent as possible. 
 The chamber walls should be as thin as possible. 
The Spencer-Attix cavity theory is an extension of the Bragg-Gray cavity theory which accounts for 
the production of secondary electrons resulting from the hard collisions of primary electrons that 
are slowing down while traversing the cavity. These secondary electrons may possess enough 
kinetic energy, above a cut-off value (often denoted Δ), to either escape the sensitive volume or 
produce further ionisations, thus they must be considered a part of the electron spectrum traversing 
the cavity. To account for this phenomenon modification is required to the stopping power 
calculated within the cavity to include this additional particle fluence (Mayles, 2007).  Thus, the 
absorbed dose in the medium can be related to the absorbed dose in the cavity through the mean 
restricted mass collision stopping power ratio of the medium to the cavity. 
In the case of small field dosimetry and small sensitive volumes it is necessary to utilise Monte 
Carlo simulation to accurately model and determine the electron fluences. The accurate 
determination of the particle fluence allows the use of the Spencer-Attix cavity theory for the 
determination of the necessary stopping powers for calculation of dose within the medium 
(Bouchard, 2015). 
Deviations of the design and construction of ionisation chambers away from being perfect Bragg-
Gray and Spencer-Attix cavities necessitates the use of perturbation correction factors to ensure 
accurate measurement of absolute dose to the medium. These correction factors include (Andreo, 
2006): 
 Chamber cavity - The presence of an air-filled ionisation chamber introduces a low-density 
heterogeneity into the medium. 
 Chamber wall - The electron fluence within the air cavity of an ionisation chamber consists 
partly of electrons generated in the uniform medium surrounding the chamber which 




 Central electrode material - The cylindrical ionisation chamber has a central electrode 
which is generally composed of either aluminium or graphite. 
 Replacement of medium by chamber - A certain volume of the medium is displaced by the 
presence of the detector when a measurement with an ionisation chamber is performed. 
Furthermore, the charge collected within an ionisation chamber can be different from the charge 
produced by the complete interactions of radiation within the chamber gas. This difference arises 
from the practicalities of electrical design and the physics of ion transport. The phenomena which 
affect the charge collected include; air density correction at time of measurements, ion 
recombination, polarity effects and stem (and leakage) effects. The mechanism of influence for each 
phenomena must be understood and the appropriate means of correction or mitigation (or 
minimisation of effect) applied. 
2.4.2.2 Diamond Detector 
Diamond detectors operate as a form of solid-state ionisation chamber (Laub, 2014). Ionising 
radiation incident upon the diamond crystal produces electron-hole pairs which move freely through 
the crystal lattice altering the electrical conductivity of the diamond. With the application of an 
external bias voltage the current generated by ionising radiation is proportional to the incident 
radiations dose-rate.  
As diamond is composed almost entirely of carbon (except for some necessary impurities), diamond 
detectors exhibit near tissue equivalent properties as the ratio of the mass attenuation coefficients of 
water to carbon are nearly constant for all photon energies (X-ray Mass Attenuation Coefficients | 
NIST, 2020). Diamond detectors are well suited for dosimetry in stereotactic radiosurgery and high 
dose gradient regions due to their high resistance to radiation damage (Planskoy, 1980), negligible 
directional dependence (Veselsky, 2018), high sensitivity (Vatnitsky, 1993), stability in prolonged 
response (Hoban, 1994), small physical size (high spatial resolution) and near energy independence. 
Synthetic single crystal diamond detectors with sensitive volumes of about 0.0038 mm3 have been 
fabricated for relative dosimetry in small photon and electron beams. The investigated small volume 
synthetic diamond dosimeter demonstrated good linearity, dose rate independence, energy 
independence and minimal angular and temperature dependences (Ciancaglioni, 2012). 
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To achieve accurate and reproducible dose measurements with diamond detectors it is necessary to 
stabilize their dose response with pre-irradiation prior to use (Veselsky, 2018). The irradiation prior 
to use reduces the impact of the polarization effect where the electric field generated by the external 
bias is reduced by electrons captured in ionized traps. Diamond detector exhibit very small 
temperature dependence (Veselsky, 2018) which is easily corrected and dose-rate dependence which 
must be appropriately corrected to yield accurate results (Hoban, 1994).  
2.4.2.3 Thermoluminescent Detectors (TLD) 
The thermoluminescent dosimeter (TLD) is an ionising radiation detector which operates using the 
principle of thermoluminescence (TL) (Kron, 1994, 1995). TLDs are composed of specific types of 
crystal which upon exposure to ionising radiation absorb and store the delivered energy within their 
crystal lattice structure, when heated the crystals re-emit that energy as light (Mayles, 2007). TL 
materials are generally produced by doping phosphors with activators as with lithium fluoride doped 
with magnesium and titanium (LiF:Mg-Ti) and lithium borate doped with copper (Li2B4O7:Cu) 
(Sadeghi, 2015). Detection and measurement of the light output (generally using a photomultiplier 
tube, PMT) upon heating can be used to identify the magnitude of dose previously delivered to the 
crystal (Kry, 2020). 
The processes of TL within a crystal can be explained using band theory. When the crystal is 
irradiated, holes and free electrons are produced within the lattice. The free electrons may travel 
within the conduction band for a short time until they are either (Mayles, 2007): 
 Trapped at defects within the crystal lattice, recombining with holes either radiatively (e.g. 
fluorescence) or non-radiatively within the valence band or,  
 Captured at activated luminescence centres, and thus deactivating the centre by emission 
of light. 
When the crystal is heated after irradiation the electrons which were trapped within the defects in 
the lattice are provided with sufficient thermal energy to escape into the conduction band. Once in 
the conduction band the free electrons will again travel freely until they are either: 
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 Trapped at defects, 
 Recombine with holes within the valence band (either radiatively or non-radiatively) or, 
 Captured and recombine at the luminescence centres which are activated by holes 
(thermoluminescence). 
The final of the three processes mentioned above is responsible for the capability to accurately 
measure the magnitude of dose to which the crystal was exposed by measurement of the 
luminescence. The light output from the crystal is measured during the readout heating cycle using 
a photomultiplier tube (PMT), converting the luminescence or light output into a current. Different 
temperatures are required to readout the intensity of light emitted from different trapping centres 
which possess different depths within the crystals bandgap structure. The temperature of the TLD 
is increased while monitoring the light output forming a glow curve graph of signal vs temperature. 
The thermoluminescence signal over a region of interest or the maximum intensity of a 
thermoluminescence peak defines the measured signal from the crystal (Kry, 2020). Following the 
heating and readout cycles the crystal will either return to its natural state or may require additional 
heating, known as annealing, to restore it to its natural state. 
The appropriate and accurate clinical utilisation of TLD’s in radiotherapy requires consideration of 
the detectors clinical advantages and disadvantages. TLD’s exhibit near tissue equivalence as a 
result of the chosen crystal composition. Appropriate clinically acceptable TLD materials must be 
chosen to appropriately minimise the dosimetric performance related to energy dependence for the 
radiation quality being measured. The limitations in use of TLD’s in a radiotherapy clinic are related 
directly to the functional physical size, temperature dependence, thermal and optical fading, dose 
dependence (supralinearity) and accuracy and the significant read-out and handling requirements. 
Optically stimulated luminescent dosimeters (OSLD) function similarly to TLD’s except are read-
out using optical stimulation rather than heat. The properties of these dosimeters are similar to 




Figure 2.7 An example of a thermoluminescent glow curve for LiF:Mg,Ti (TLD-100) material, 
which is readout following different pre-irradiation annealing processes. The peaks 1-5 identify 
the trapping centres (Kry, 2020). Figure reproduced with permission from Wiley. 
 
2.4.2.4 Radiochromic (EBT3) Film 
Radiochromic (often referred to as Gafchromic) film is a transparent and colourless film medium 
which responds to ionising radiation and ultraviolet light by turning deep blue, exhibiting two 
nominal absorption bands at 636 nm and 582 nm (León-Marroquín, 2016). The colour change 
induced by the ionising radiation traversing the film material is proportional to radiation dose and 
formed by a process of solid-state polymerisation within the sensitive layer. The radiation-induced 
molecular process produces conjugated double bonds between the ends of neighbouring polymer 
chains, combining to form longer structures which absorb light. This polymerisation process is 
responsible for the characteristic darkening of the film and occurs over time without the need for 
additional thermal, optical or chemical processing (Mayles, 2007).  
The polymer chains produced within the sensitive layer upon exposure to ionising radiation absorb 
light. The transmission of light through the film and thus the image present within the film can be 
read out by a standard flat-bed transmission scanner (or other densitometer). The attenuation of light 
traversing the film medium is described by the Beer-Lambert law relating the properties of the film 
to the absorption of light. The blue image generated within film is stable up to temperatures of 60°C, 
above these temperatures the image changes from blue to red. 
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Radiochromic (radiotherapy) films are manufactured and sold in a number of standard 
configurations designed for different purposes i.e. EBT3, EBT-XD, RTQA2, MD-V3, HD-V2. In 
general these film configurations are intended for different dose ranges and are composed of 
different active and base layer thicknesses (Radiotherapy Films - GAFchromicTM, 2020). EBT3 film 
is the standard radiochromic film for patient dosimetry and IMRT verification and is designed for 
the dose range 0.2-10 Gy. The structure of EBT3 film is symmetrical, consisting of a single active 
layer (~28 um of active component, marker dye and stabilisers) between two clear polyester base 
substrate laminates (~125 um) (Niroomand-Rad, 1998). The active component of radiochromic 
EBT3 film is lithium-10, 12-pentacosadiyonate (LiPCDA) in crystalline form (Lewis, 2016).  The 
surface of the polyester substrates is treated to contain microscopic silica spheres which prevent the 
formation of Newton’s Rings interference patterns when scanning using a flatbed scanner 
(Marroquin, 2016). Other configurations (e.g. asymmetrical layer geometries) of radiochromic film 
are available, optimised for different intended purposes. 
The photon mass energy absorption coefficient (μen/ρ) and electron mass collision stopping power 
for radiochromic film are very similar to those for skeletal muscle and water. This can be attributed 
to the near tissue equivalent composition of radiochromic films (9.0% hydrogen, 60.6% carbon, 
11.2% nitrogen, 19.2% oxygen) (Avevor, 2017). Thus, radiochromic films (EBT3) may be 
considered near tissue equivalent in response, exhibiting minimal energy dependence over the 
therapeutic (MV & kV) photon energy ranges (Ataei, 2019).  
 
Figure 2.8 Schematic drawing identifying the thickness and structure of EBT3 Gafchromic film 
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(Devic, 2016). Figure reproduced with permission from Elsevier. 
 
After irradiation the degree to which the radiochromic film darkens in response to the delivered dose 
to the sensitive layer can be quantified by measuring how much light is attenuated as it passes 
through the film. The darkening is measured in terms of net optical density (OD) which is defined 
as the log10 of the ratio of the intensity of light transmitted through the film prior to irradiation (I0) 
to the intensity of light transmitted through the film after exposure to radiation (I) (Butson, 2003). 
This quantity is proportional to dose (within certain limiting conditions): 
 






For the purposes of radiotherapy dosimetry, film is generally scanned in 48-bit RGB (Red Green 
Blue) colour mode at a nominal spatial resolution with the results saved in .TIFF file format. The 
intensity across the film is digitised over a grid determined by the selected spatial resolution and 
quantified in terms of a 16-bit pixel value describing the magnitude of red, green and blue colour at 
each pixel location.  
To derive dose from the intensity quantified as a 16-bit pixel value (in one of the three colour 
channels), a calibration curve is necessary to relate the net optical density to dose. Ideally the 
relationship between these two quantities should be linear, however in reality it is not and is only 
linear over a short range, and may differ based on film batch number. Thus, the characteristic or 
dose calibration curve should be established for each film batch by exposing a set number of film 
pieces to known dose quantities, measuring the resultant film darkening after a standardised period 
of time. Fitting the data of the calibration curve (dose as a function of net optical density) with a 
polynomial (or other interpolant method) enables determination of dose values from measured net 
optical densities. Further film pieces may now be irradiated with complex dose deliveries, the 
delivered dose distribution along the plane of the films’ sensitive layer will be recorded and may be 
read out and converted to dose values for interrogation of the delivery quality. 
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In practice, for dosimetry in radiotherapy applications the red colour channel is most often used as 
it provides the best sensitivity up to doses of 8-10 Gy. The green channel is used to measure higher 
dose values (Papaconstadopoulos, 2014) while the blue channel offers homogeneity correction 
(Chen, 2016).  
Radiochromic film represents an effective solution for dosimetry in SBRT as it is high spatial 
resolution, near water equivalent in response (Huet, 2014) and does not require chemical processing 
to develop (Low, 2011).  Film dosimetry offers a planar two dimensional measurement of dose 
distributions and has been used extensively within intensity modulated radiation therapy (IMRT) 
quality assurance. However, dosimetry with radiochromic film possesses significant limitations, 
particularly in adaptive radiotherapy, as it is not a real-time dose measurement tool and demands a 
strict calibration and handling protocol to achieve an acceptable accuracy (Tyler, 2013). 
2.4.2.5 Semiconductor (silicon) detectors 
Diodes are generally composed of crystals of semiconductor (i.e. silicon, germanium etc.) where 
the energy of electrons within the crystal (or amorphous solid) are described by electronic band 
structure theory. Band structure theory describes the ranges of energy an electron may possess 
(known as bands, a continuum of acceptable energy levels) and may not possess (known as band 
gaps, ranges of forbidden energies) as a part of the crystal lattice structure of the solid, a result of 
obeying the Pauli Exclusion Principle (Mayles, 2007). 
The controlled introduction of impurities (known as doping) alters the electronic characteristics (i.e. 
electrical conductivity) of the crystal. Impurities refer to the additional ions of alternate elements to 
the main constituents of the crystal which when introduced may act as either an electron donor or 
electron acceptor within the crystal. Doping with electron donor elements causes an excess of 
electrons (negative charge carriers) and produces an n-type semiconductor whereas doping with 
electron acceptor elements creates a deficit of electrons (or excess of electron holes, positive charge 
carriers) and produces a p-type semiconductor (Rosenfeld, 2020).  
The most common form of diode for radiation dosimetry is the p-n diode which is composed of the 
junction of a p-type (positive majority charge carrier, excess of electron holes) semiconductor with 
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an n-type (negative majority charge carrier, excess of electrons) semiconductor. At the junction of 
the two semiconductors the confluence between the excess electrons and excess holes produces a 
region devoid of charge carriers (known as the depletion region). The terminals of the p-n diode are 
attached to the n-type region (the cathode) and the p-type region (the anode). When a sufficiently 
high voltage (of the correct polarity) is applied to the cathode the width of the depletion region is 
narrowed until forward conduction of the majority charge carriers is allowed. The nature of the p-n 
junction prevents the movement of electrons in the opposite direction.  
 
Figure 2.9 Schematic diagram of a silicon p-n junction as a radiation detector. The incident 
radiation generates excess electron (●) and hole pairs (○) which diffuse, over one diffusion length 
Lp, to the p-n junction and are subsequently swept across by the built-in potential and collected 
by the electrometer (Shi, 2003). Figure reproduced with permission from Wiley. 
 
Ionising radiation traversing the semiconductor junction (which forms the sensitive detection 
volume of the diode) generates electron-hole pairs by collision processes (either directly or 
indirectly) along its track through the crystal lattice, Figure 2.9. For dosimetry, the quantity of 
practical interest is the average energy lost by the primary ionising particle which is necessary to 
produce an electron-hole pair within the crystal, known as the ionization energy. This quantity is 
independent of incident radiation type and energy and provided the particle is fully stopped within 
the sensitive volume of the detector, allows interpretation of the number of electron-hole pairs 
generated as an indicator of the energy absorbed within the diode as a result of irradiation. The 
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production of the majority and minority charge carriers in the form of electron-hole pairs and their 
consequent movement within the semiconductor junction forms an electrical current within the 
diode which is collected and measured. The magnitude of the collected current within the junction 
under irradiation may be related to the delivered radiation dose under known conditions. 
For reliable dosimetry using semiconductor detectors the correction factors and dependencies which 
need to be considered include: 
 Diode Calibration –  
o For single point diodes it is necessary to calibrate the response of the diode to a 
known radiation dose to convert charge collected to dose (Gy). 
o For arrays consisting of multiple diodes it is also necessary to expose the diodes 
to a uniform stimulus to identify the independent intrinsic gains and sensitivities 
(resulting from manufacturing tolerances in diode doping and pre-amplifier gain) 
in each channel and correct for the discrepancies. 
 Temperature Dependence – diode response is expected to increase with ambient 
temperature (Welsh, 2001). This effect may be attributed to the increasing thermal energy 
of the charge carrying electrons. 
 Directional Dependence – the geometrical construction and packaging of diodes is 
commonly asymmetrical, i.e. the shape, composition and relation of components 
(terminals, etc.) to one another is different for different orientations. This asymmetry can 
affect the response of the detector to irradiation as the beam traverses the diode at different 
angles of incidence (Jursinic, 2009). Correcting for directional dependence is vital for 
reliable dosimetry with semiconductor detectors in rotational treatment modalities. 
Semiconductor diodes exist which exhibit minimal directional dependence as a result of 
improved fabrication technology and packaging design (Petasecca, 2015). 
 Dose Dependence – semiconductors suffer ongoing radiation damage affects with 
increasing accumulated dose as atoms within the crystalline lattice are displaced forming 
recombination centres which capture charge carriers. This effect reduces sensitivity as it 
limits charge carrier collection. The effects of dose dependence in diodes are reduced by 
pre-irradiation (American Association of Physicists in Medicine Radiation Therapy Task 
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Group 62, 2005). 
 Energy Dependence – diodes are composed of high effective atomic number materials (i.e. 
silicon doped with phosphorous or boron) and thus are not directly tissue equivalent for all 
photon energies (especially low energies) (Mayles, 2007). 
Silicon diodes are commonly used in small field dosimetry (Tyler, 2013) and the quality assurance 
of complex radiotherapy modalities as both point detectors and arrays. Diodes may be designed and 
fabricated with a small sensitive area and size, and arrays of diodes can possess submillimeter spatial 
resolution, especially in the case of a monolithic diode array topology (Wong, 2010). Silicon diodes 
are not tissue equivalent but dependencies upon energy, dose-rate, temperature and angle of 
radiation incidence can be corrected. 
The metal oxide field effect transistor (MOSFET) dosimeter is technologically similar to a 
semiconductor diode but is composed of semiconductor silicon substrate, a layer of insulating oxide 
and a metal gate. The MOSFET as a dosimeter shares similar advantages and disadvantages with a 
diode such as; small sensitive volume, temperature dependence, directional dependence and energy 
dependence. Due to the increased complexity of the MOSFET junction they are not as readily 
available in the form of pixelated arrays. 
2.4.2.6 (Pixelated) Array Detectors 
Pixelated detectors or array detectors are a composite dosimeter in which numerous individual 
detectors are combined together in a structured geometric pattern to form an array for simultaneous 
measurement across a plane or volume in a radiation field.  These detector arrays are generally 
composed of a series of semiconductor dosimeters or ionisation chambers forming the individual 
pixels. The following table summarises the available commercial pixelated array detector systems 
for radiation dose measurements and patient specific QA in EBRT, Table 2.1. 
Table 2.1 Currently available commercial detector array systems, summarizing properties of both 
2D and 3D dose acquisition systems (OCTAVIUS 4D - PTW Freiburg GmbH, 2020; ArcCHECK® 
- Sun Nuclear, 2020; Products, 2020; MapCHECK® 3 - Sun Nuclear, 2020; OCTAVIUS Detector 











Company: Sun Nuclear PTW Sun Nuclear 
Detector 
Type: 









1013 1521 1527 
Detector 
Spacing: 
2.47 mm                   
(centre-to centre), 
Checkerboard pattern: 
X & Y – 3.5 mm 
2.5 mm in centre area 
(6.5 x 6.5 cm2), 
5.0 mm in outer area (15 
x 15 cm2) 
7.07 mm               
(centre-to-centre), 
checkerboard pattern; 
X & Y – 10 mm 
Detector 
Size: 
0.48 x 0.48 mm 
(0.007 mm3) 
2.3 x 2.3 x 0.5 mm3 
0.003 cm3 
(3 mm3) 












(using Octavius 4D 
phantom) 
2D 




























7.1 mm                     
(centre-to-centre), 
checkerboard pattern; 




7.07 mm               
(centre-to-centre), 
Checkerboard pattern: 
X & Y – 10 mm 
Detector 
Size: 
4.4 x 4.4 x 3 mm3 
(60 mm3) 
4.5 (Φ) x 5 
(h) mm3 
(80 mm3) 













(i.e. 2D or 
3D) 
3D 
(using Octavius 4D 
phantom) 
2D 2D 




Detector: Delta4+ ArcCHECK® OCTAVIUS® 1000 SRS 












(distributed on coronal 





(central 6x6 cm2 area), 
10 mm                                  
(outer area) 
10 mm                     
Helical Grid (HeliGrid) 
2.5 mm                    
(centre-to-centre) in 
centre (5.5 x 5.5 cm2), 
5 mm                                 
(centre-to-centre) in 
outer area (11 x 11 cm2) 
Detector 
Size: 









Max. field size: 200 x 
200 mm2 (200 x 380 
mm2 with merging) 
210 x 210                   
(Array diameter x length) 








(using Octavius 4D 
phantom) 
Weight 27 kg 15.4 kg 5.4 kg 
 
2.4.3 Gamma Analysis 
The measurement of an absorbed dose distribution by a detector system in two dimensions or three 
dimensions necessitates a method for quantifiable evaluation of the measured distribution compared 
to an expected (or reference) dose distribution. Quantifying the agreement between a measured and 
expected dose distribution is uniquely important for commissioning of a TPS, commissioning a new 
treatment technique and patient specific QA, the complexity of these tasks is compounded by the 
presence of small area radiation beams and steep dose gradients. One methodology for evaluation 
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of two and three dimensional distributions is through the use of gamma analysis. 
Gamma analysis (Low, 1998) combines a distance to agreement criterion with a dose-difference 
criterion. It compares the dose difference at various points of interest in a measured and comparison 
dose distribution and evaluates the distance between points with the same magnitude of dose.  The 
distance to agreement component is particularly important for measurements within high dose 
gradient regions. This method of gamma analysis can be summarised by defining two acceptance 
parameters; ΔDM and ΔdM as the dose-difference criterion and distance-to-agreement criterion 
respectively.  
The one-dimensional representation of the application of the dose and distance difference criterion 
for evaluation, gamma analysis, between two dose measurements, with one spatial dimension, is 
shown in Figure 2.10, the (measured) point of interest to be evaluated is at the origin, Dm(xm), xm. 
 
Figure 2.10 One-dimensional representation of dose-difference and distance to agreement 
evaluation between dose values which possess one spatial dimensions (Low, 1998). Figure 
reproduced with permission from Wiley. 
 
The abscissa represents the spatial location of the points; measurement (xm) and comparison (xc), 
and the difference in spatial location is evaluated between them, i.e xc-xm. The ordinate represents 
the magnitude of dose of the points; measurement (Dm(xm)) and comparison (Dc(xc)), and the 
difference in dose magnitude is evaluated between the points, δ.  
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The two-dimensional representation of gamma analysis, utilizes an ellipsoidal surface to evaluate 
the dose-difference and distance to agreement simultaneously between points, shown in Figure 2.11. 
In this two-dimensional example the spatial notation is extended to be a vector of the two-
dimensional location of each of the dose points. The evaluation of the gamma value between points 
can be further extended to a three-dimensional analysis. 
 
Figure 2.11 Two dimensional representation of gamma analysis using the ellipsoid dose 
difference and distance to agreement evaluation method (Low, 1998). Figure reproduced with 
permission from Wiley. 
 
The surface of the ellipsoid, shown in Figure 2.11, describes the limits of acceptance and is defined 














 𝑟(𝑟𝑚 , 𝑟) = |𝑟𝑚 − 𝑟| (2.5) 
 




If any portion of the compared point Dc(rc) in Figure 2.11 intersects with the defined ellipsoids 
surface, the calculation is said to have passed at 𝑟𝑚. A generalized acceptance criteria calculation 
can be defined using the right hand side of equation (2.3), Γ.  
 











Points lying inside (and including) the surface of the ellipse, with axes having the criteria values, 
have a gamma value equal or smaller than one and therefore pass. That is, if γ ≤ 1, pass or if γ > 1, 
fail. This evaluation method allows for a quantitative evaluation of the agreement between two-
dimensional and three-dimensional dose distributions. 
2.4.4 Charged Particle Range Verification 
Verification of the constancy of radiation beam performance characteristics is a vital component of 
a routine QA program for the delivery of radiotherapy (Arjomandy, 2019). However, extensive or 
time consuming QA measurements and processes limit the time a machine is available for patient 
treatment.  
The deposition of dose by charged particles within a small volume at the Bragg peak is uniquely 
sensitive to the particles penetration range, and it is directly dependent upon the incident beam 
energy and any small variations in material density and stopping power along the beam path 
(Mirandola, 2018). Significant tumour under/over dosage can be the result of incorrect estimation 
of in-patient beam penetration (Paganetti, 2012). The routine measurement and verification of PDD 
curves of Bragg peaks for charged particle radiotherapy delivery systems is vital to ensure safe 
provision of radiotherapy treatment (Cantone, 2013). Unfortunately, devices providing a means of 
fast verification (for daily measurement) of beam energy stability in-phantom with high precision, 
accuracy and reliability are not readily available.  
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In charged particle radiotherapy, measurements of the PDD distribution are routinely performed, 
commonly measured using an ionization chamber and a computerized scanning water tank 
dosimetry system. The measurement of the PDD distribution along the central axis of the charged 
particle radiation beam is time-consuming with a scanning water tank due to the prolonged and 
complex setup. Other dosimetry systems are available for verification of charged particle 
range/energy in-phantom. 
Multi-layer ionization chamber (MLIC) systems are devices which are composed of a stack of 
numerous parallel plate ionization chambers sharing a single central axis of measurement (Yajima, 
2009). These systems can be aligned to the central axis of the incident charged particle radiation 
beam for fast measurement of charged particle depth dose distributions. The Zebra (IBA dosimetry, 
Schwarzenbruck, Germany) is an MLIC consisting of 180 independent 2.5 cm diameter circular 
vented plane parallel ionization chambers with a 2 mm native resolution (Dhanesar, 2013), Figure 
2.12. The Zebra system is a bulky device with a mass of 10 kg and measuring 43.9 cm x 19.5 cm x 
17.5 cm (Zebra - Scan monolayer & SOBP measurements | IBA Dosimetry, 2020). 
 
Figure 2.12 The Zebra multi-layer ionization chamber device (Zebra - Scan monolayer & SOBP 
measurements | IBA Dosimetry, 2020). 
 
Radiochromic films in solid slab phantoms provide another means of charged particle range 
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verification in-phantom. Film dosimetry provides significant advantages in high spatial resolution, 
however also significant disadvantages in the time-consuming film processing requirements, and 
for charged particles specifically, significant energy dependence in the region of the Bragg peak 
(Castriconi, 2017). 
Prompt Gamma Emission (PGE) and Positron Emission Tomography (PET) are potential imaging 
modalities which offer potential for accurate proton range verification.  
Positron Emission Tomography for range verification utilises coincident gammas which result from 
the annihilation of emitted positrons with electrons, as a small fraction of protons traversing the 
medium will produce positron emitting isotopes (Rutherford, 2020). A PET camera can be used to 
observe the recombination of emitted positrons with an electron in the surrounding material. This 
method can be performed either ‘off-line’, after treatment or ‘on-line’, during treatment (Knopf, 
2013). The beam range is able to be verified by PET imaging, in clinical head-and-neck patients to 
well-co-registered bony structures, to an accuracy of 1-2 mm (Parodi, 2007). 
Prompt Gamma Emission is an indirect method which measures the emission of single photons 
(prompt gammas) which follow the inelastic collisions (and excitations) between the nuclei of the 
target and the incident protons. A direct correlation exists between the point of emission of the 
prompt gamma photons in the material and the range of the incident protons upon the material 
(Zarifi, 2017). This method is useful for online in-vivo verification as the time between 
excitation/de-excitation of the target nuclei and detection of the prompt gamma photon is of the 
order of nanoseconds (Knopf, 2013). This method has reported position verification accuracy of 1 
to 2 mm at the Bragg peak of 100 MeV proton beam in a phantom (Min, 2006).  
2.5  Devices designed by Centre for Medical Radiation Physics  
2.5.1 Serial Dose Magnifying Glass (sDMG) 
The Serial Dose Magnifying Glass (sDMG) is a multi-strip silicon detector designed by the Centre 
for Medical Radiation Physics (CMRP) and is comprised of two linear arrays arranged in sequence 
with each individual array consisting of 128 diodes, with physical thickness 0.04 mm, separated 
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with pitch 0.2 mm and each diode presenting a sensitive strip area of 0.02 x 2 mm2. The sDMG 
consists of n+ silicon strips implanted upon a thin p-type silicon substrate and is operated in passive 
mode (without an external bias voltage applied). This linear array is based upon the technology of 
the Dose Magnifying Glass (DMG), which has been investigated for use in radiotherapy QA (Wong, 
2011), IMRT QA (Wong, 2010) and helical tomotherapy QA (Wong, 2011). The density of silicon 
is 2.33 g/cm3 thus the water equivalent thickness of each individual diode along the axis of the linear 
array is approximately 0.466 mm and perpendicular to the axis of the linear array is 0.0186 μm. 
The sDMG is composed of two linear arrays with a physical gap separating the linear arrays of 0.6 
mm. The arrays are wire bonded end-to-end, to a flexible printed circuit board (PCB) which is 
0.5mm thick, providing the connections to the readout electronics and data acquisition (DAQ) 
system. The single axis of detection of the sDMG measures a length of 50.8 mm. The detector and 
PCB are enclosed within a rigid holder composed of two slabs of recessed Solid Water (GAMMEX, 
WI, USA) material, 5 mm thickness each, to provide protection, rigidity and appropriate scattering 
conditions around the detector. The upper Solid Water slab which encompasses the detector is 
machined with a 2mm recess into the Solid Water larger than the dimensions of the detector, in 
which the detector sits, this leaves a 1.6mm air gap above the detector and a 1mm air gap 




Figure 2.13 The Serial Dose Magnifying Glass (sDMG). (a) Schematic diagram of silicon strip 
detector, DMG (Debrot, 2018). (b) sDMG mounted and wired bonded to a thin printed circuit 





Figure 2.14 sDMG enclosed within Solid Water phantom and connected to data acquisition 
system. 
 
2.5.2 Monolithic silicon detector array (DUO) 
DUO is a monolithic silicon detector array designed by the CMRP and comprised of 505 silicon 
diodes arranged in two bisecting orthogonal linear arrays of 253 diodes, sharing a common central 
pixel. This form of the DUO detector array investigated was fabricated on a bulk p-type silicon 
substrate with thickness of 470 µm and with a total area of 52 x 52 mm2. The individual diodes 
present a sensitive volume of 0.04 x 0.8 mm2 with diode pitch of 0.2 mm. The array is wire bonded 
to a 50 µm thick printed circuit board which provides the connections to the data acquisition (DAQ) 
system for readout.  
 




The central pixel of the DUO array is 0.18 x 0.18 mm2, the four pixels which directly surround the 
central pixel are 0.16 x 0.2 mm2, and the subsequent pixels which compose the orthogonal arms of 
the array are 0.04 x 0.8 mm2. The separation between each detector pixel in the DUO array is 0.2 
mm. The monolithic silicon array and the PCB are enclosed between two recessed slabs of PMMA, 
each 5 mm thick, to provide protection, rigidity and scattering to the detector. 
DUO is operated without an external bias applied to the p-n junctions. The performance of DUO for 
small field dosimetry has previously been reported including a detector characterization for dose-
per-pulse dependence, dose-rate response, radiation damage, output factor, PDD and beam profiling 
(Al Shukaili, 2017). 
2.5.3 Data Acquisition System 
The data acquisition (DAQ) system utilised to readout the sDMG detector and DUO was designed 
and developed by CMRP and is based upon a custom-design multi-channel electrometer with Field 
Programmable Gate Array (FPGA) interface.  
2.5.3.1 AFE 
The electrometer, AFE0064 (Texas Instruments, Dallas, USA), is a current integrator and possesses 
64 parallel input channels and two differential outputs. The current is measured individually from 
each detector channel and integrated over a capacitor for a user defined time-interval, the resulting 
output charge is normalised to the nominated dynamic scale, from 0.13 to 9.6 pC.  
The DAQ system utilised in conjunction with the sDMG is comprised of four AFE0064 chips 
serving 256 individual channels and readout by two analogue to digital converters (ADC), with a 
resolution of 16 bit. The system utilised in conjunction with the DUO detector is comprised of eight 
AFE0064 chips serving 512 individual channels for readout by four ADC’s with a resolution of 16 
bit.  
Synchronisation of the electronics is managed by the FPGA; enabling measurement, acquisition and 
transfer of data from the electrometers to the host computer via a USB2.0 communication protocol. 
Acquisition of data from the AFE0064 chips is triggered and synchronised by the FPGA to the 
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electron gun trigger pulses of the linac by a coaxial connection between the FPGA and the linacs 
sync pulse (Varian). An internal trigger generator can also be used to acquire signal from the 
detector, up to a frequency of 10 kHz, in case of irradiation by a continuous radiation source. For 
further information about the performance and design details of the AFE DAQ please refer to Fuduli 
et al. (Fuduli, 2014). 
For the experiments described in Chapter 3, Chapter 4 and Chapter 5, the detectors used, were 
readout using the AFE DAQ technology. 
 
Figure 2.16 The sDMG detector connected to the AFE DAQ system with FPGA. 
 
2.5.3.2 TERA 
The TERA06 is a readout electrometer consisting of 64 channels per chip. The TERA06 chip is 
based on a charge to frequency converter and digital 16-bit counter, referred to as an application 
specific integration circuit (ASIC). The TERA06 DAQ system reads out the 256 detector channels 
of the sDMG with zero dead time and provides a large dynamic range and high temporal resolution 
(Fuduli, 2014). The sDMG is readout by four TERA06 chips synchronized and managed by the 
FPGA, connected to a personal computer by USB 2.0 interface.  
2.5.4 Graphical User Interface 
The graphical user interfaces (GUIs) which are used for; connection to the DAQ, acquisition of data 
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from the detector, visualisation and analysis, are designed by CMRP. The sDMG and DUO detectors 
utilise GUIs with different visualisations configurations, Figure 2.17 for sDMG and Figure 2.18 for 
DUO respectively, but the underlying architecture, programming and communication of the 
software with the DAQ is identical. The GUI is compiled in the C++ programming language and 
designed and developed using the Qt cross-platform software development toolkit. The USB 
connection between the dynamic language libraries and the DAQ is managed by the GUI, which 
initializes the USB connection and sends the necessary firmware to the FPGA. From the GUI the 
user is able to alter the data acquisition settings, which include (but are not limited to); integration 
time, acquisition time, acquisition frequency, gain, buffer size and external or internal generated 
trigger. Data acquired from the detector is displayed to the user in real time with both instantaneous 
response and integral response displayed in a logical representation of the geometry of the detector. 
Once acquisition is complete the user can save the file in an encoded file format, which can be 
decoded and visualised at any time for post-acquisition analysis.  
 
Figure 2.17 The AFE-Histogram graphical user interface (GUI) for acquisition, visualisation and 





Figure 2.18 The AFE-DUO graphical user interface (GUI) for acquisition, visualisation and 






Device characterisation of Serial Dose 
Magnifying Glass (sDMG) 
3.1 Introduction 
To independently assure the quality of planned treatments that use small radiation fields requires a 
unique instrument which combines high spatial and high temporal resolution. The sDMG is a multi-
strip 1D silicon detector array to realize the requirements for an independent dosimetry tool for 
patient specific quality assurance and pre-treatment verification in real-time adaptive radiotherapy 
using small radiation fields matching, within the technological limitations of the number of channels 
able to be readout simultaneously for this project, the resolution required for an optimal dose profile 
reconstruction. This chapter first evaluates an optimum spatial resolution which would be necessary 
to reconstruct quantifiable detail in measured beam profiles and then presents the results obtained 
from the sDMG detector, with AFE readout, which will be compared to the gold standard detectors 
adopted clinically: the ionisation chamber and radiochromic film, under identical experimental 
conditions within each investigation. 
3.2 Materials and Methods 
3.2.1 Evaluation of the spatial resolution required by a pixelated detector 
The optimum resolution required to reconstruct beam profiles in SRT modalities has never been 
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assessed using discrete-time Fourier analysis of measured high resolution EBT3 film beam profiles. 
This work presents an analysis of high resolution radiochromic film data conducted to generate 
recommendations for the pixel separation required to accurately measure the beam penumbra and 
profile.  
Gafchromic EBT3 film (Ashland Advanced Materials, NJ, USA) represents the best option for high 
spatial resolution measurement of radiotherapy small field beams. In applications where real-time 
dosimetry is crucial, they must be substituted with a pixelated detector which should have 
comparable performance. A method has been established to evaluate the minimum spatial resolution 
required by a strip detector to measure the dose profile of jaw-defined square fields with the same 
accuracy of an EBT3 film readout at high resolution. The method has been applied to various beam 
sizes delivered by a 6MV Varian Clinac iX (Varian Medical Systems, Palo Alto, USA) medical 
linear accelerator (linac) at depths of 5 cm and 10 cm in a Solid Water (Standard Imaging, Madison, 
USA) block phantom. The EBT3 film pieces were scanned six times each using a MicroTek scanner 
(MicroTek, Hsinchu, Taiwan) before and 72 hours after irradiation in 48 bit RGB colour mode with 
a scanning resolution of 300 dpi (corresponding to 84.7 µm pixel size) and saved in .TIFF format. 
The images were analysed using ImageJ 1.47v where a second-order polynomial generated from an 
associated calibration curve was used upon the red colour channel to convert from pixel value to 
dose via a net optical density protocol. Line profiles were extracted along the central axis of the 
EBT3 film pieces for comparison. The dose profiles were normalised to the central axis (CAX) 
response of the 10 x 10 cm2 field for the corresponding depth. Figure 3.1 illustrates the results of 
the line profiles extracted from the high resolution film scans for the various field sizes and depths 







Figure 3.1. Dose profiles for various field sizes measured in a Solid Water block phantom using 
EBT3 film. (a) At depth 5 cm in Solid Water field sizes 0.5x0.5 cm2 to 10x10 cm2. (b) At depth 
10 cm in Solid Water field sizes 0.5x0.5 cm2 to 10x10 cm2. 
 
In this initial study, the penumbral width (PW) was defined as the distance between either the 3% 
and 97% (PW3-97%) response values or the 20% and 80% response values (PW20-80%) and was 
measured on the left hand side (LHS) of the normalised dose profiles for all field sizes investigated. 
The full-width at half-maximum (FWHM) was also determined.  
63 
 
Within the scope of modern radiotherapy treatment modalities steep dose penumbrae are necessary 
to achieve highly conformal treatments. Accurate reconstruction of the penumbral features is 
necessary as treatment margins are reduced and the steep dose gradients generated by sharp field 
penumbrae approach critical organ boundaries. 
Further investigation into the resolution required by a detector to reconstruct the penumbra in small 
field applications was conducted using discrete-time Fourier analysis to identify the frequency 
composition of the penumbral structures for different field sizes. For a discrete signal xn with a 
finite-duration, sampled at N points with frequency k, the Fourier series representation of the 
sequence is: 
 
xn =  
1
N
∑ Xk ∙ [cos (
2π
N









The discrete Fourier Transform (DFT) (Oppenheim, 1999) is: 
 















The bandwidths (BW90%) of the Fourier spectra generated in this work are defined as the width of 
the frequency band that contains 90% of the total area under the amplitude spectrum. The Nyquist-
Shannon sampling theorem was applied to the identified frequency bandwidths for each field size’s 











3.2.2 Radiation Hardness Characterisation 
The response of the sDMG detector was measured under irradiation by a photon beam from a 6 MV 
linac (Varian Medical Systems, Palo Alto, USA). The detector was positioned at 1.5 cm depth (dmax 
for 6 MV photons) in a phantom composed of Solid Water. The detector was then irradiated up to 
40 kGy using a Co-60 gamma emission source in steps of 20 kGy without a bias applied to the 
detector during irradiation to mirror the standard operation procedure of the detector during clinical 
use. The response of the detector was then measured and recorded under 6 MV photon irradiation 
at 0, 20 and 40 kGy absorbed doses to evaluate the effect of radiation damage upon the detector 
response. 
3.2.3 Dose Linearity 
The linearity of the detector’s response was examined and verified. The detector was positioned 
within a Solid Water phantom at a depth of 1.5 cm and irradiated using a 6 MV photon beam from 
a linac with a field size of 10 x 10 cm2 and source to surface distance (SSD) of 100 cm. The delivery 
ranged from 50 MU to 500 MU at 600 MUmin-1, corresponding to a dose range of 50 cGy to 500 
cGy at these conditions in 50 cGy dose increments. 
3.2.4 Dose per Pulse Dependence 
An investigation into the dose per pulse dependence (DPP) of the sDMG detector was carried out 
within the range of 2.1x10-5 Gy pulse-1 to 2.78x10-4 Gy pulse-1. This was undertaken utilising a 6 
MV linac beam with dose-rate 600 MU min-1 and field size 10 x 10 cm2. The detector was positioned 
at a depth of 1.5 cm (dmax for 6 MV photons) with 10 cm of backscattering material in a water 
equivalent phantom, the source to surface distance (SSD) was varied sequentially from 100 cm to 
366 cm and the detector response tested by irradiating the detector with a 10 x 10 cm2 field size (at 
100 cm SSD). The detectors depth in the phantom remained constant for all measurements to 
minimise variation in the detectors response, which may be attributed to changes in the energy 
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spectrum of the incident radiation beam. A reference data set was collected through the repetition 
of the experiment utilising a CC13 (IBA Dosimetry, Schwarzenbruck, Germany) ionisation chamber 
in place of the sDMG detector. The response of the sDMG was normalised to the response of the 
ionisation chamber for each measurement point to quantify the detectors dependence upon dose per 
pulse values compared to the ionisation chamber. 
3.2.5 Percentage Depth Dose Measurements 
The detector is secured and encapsulated within a protective holder composed of two 5 mm pieces 
of Solid Water. The sDMG detector and holder was positioned between 30 x 30 cm2 sections of 
Solid Water material to form a volume surrounding the detector possessing water-equivalent 
scattering conditions. A series of 30 x 30 cm2 Solid Water slabs are placed beneath the detector, 
totalling 10 cm for backscattering and the amount of Solid Water above the detector is varied from 
0.5 cm to 25 cm. The system is irradiated by a 6 MV linac photon beam with field size 10 x 10 cm2 
at a constant source to surface distance (SSD) of 100 cm, delivering 100 MU for each depth. The 
response of the sDMG detector is compared to the response of a Markus ionisation chamber (PTW-
Freiburg, Freiburg, Germany) irradiated in Solid Water utilising the same procedure. 
3.2.6 Beam Profile Measurements 
The clinical megavoltage photon beam possesses an axial profile composed of inter-umbral, 
penumbral and out of field regions. Linacs which utilise flattening filters exhibit inter-umbral 
regions of dose uniformity, whereas the penumbral region of a beam profile describes the rapid 
dose-falloff at the radiation field edges. For small field dosimetry and stereotactic treatments, the 
penumbral width measured between the 20% and 80% points of the maximum dose intensity is an 
important metric. The beam profiles of small fields of 0.5 x 0.5 cm2, 1 x 1 cm2, 1.5 x 1.5 cm2, 2 x 2 
cm2, 3 x 3 cm2, 4 x 4 cm2 and 5 x 5 cm2 defined by the collimation jaws, with the MLC retracted, 
were measured. The sDMG was positioned at a depth of 10 cm in a Solid Water phantom with 10 
cm of backscattering material. The system was irradiated at 90 cm SSD using a 6 MV linac for 200 
MU at 600 MU min-1 for each of the field sizes investigated. The detector was aligned to the central 
axis of 0.5 x 0.5 cm2 field such that the axis of detection of the sDMG bisected the square field.  
The measurements were repeated using Gafchromic EBT3 film. The film was cut into 4 x 4 cm2 
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pieces for field sizes 3 x 3 cm2 and below and 6 x 6 cm2 pieces for the larger field sizes. The film 
was aligned and irradiated with each of the square fields investigated by the sDMG detector. Prior 
to exposure to the radiation fields, each film piece was scanned using a MicroTek scanner, in 48-bit 
RGB colour mode. The film pieces were positioned in the centre of the scanner field of view and 
scanned at 72 dpi (corresponding to a 0.353 mm pixel size). Six scans were conducted for each 
individual film piece, the results saved in .TIFF format, with the first three scans for each film piece 
discarded. This procedure was repeated 72 hours after radiation exposure with care taken to maintain 
the orientation of the film pieces before, during and after irradiation. A further set of films from the 
same batch were prepared and irradiated following the outlined protocol to produce a dose 
calibration curve. Analysis was conducted using ImageJ 1.47v where the red channel was used for 
the pixel value to net optical density to dose conversion based upon a second-order polynomial 
derived from the associated film calibration curve. Line profiles were extracted along the same axis 
of measurement as the sDMG from the dose converted images for comparison and quantitative 
analysis. The full-width at half-maximum (FWHM) and penumbral widths of the profiles were 
measured for both the EBT3 film and sDMG detector and subsequently compared.   
3.2.7 Output Factor Measurements 
The output factor is defined, within this study, as the ratio of the dose per monitor unit measured at 
the centre of the radiation field size under investigation relative to dose per monitor unit measured 
at the centre of a specific reference radiation field. The reference field size considered was 10 x 10 
cm2 with all measurements conducted at 10 cm depth and 90 cm SSD (isocentre) with 6 MV photon 
beams. 
The square radiation fields under investigation were aligned with the detector to ensure that the 
centre of the radiation field coincided with the centre of the sDMG detector, the response within 
these channels was utilised to calculate the output factor values. Radiation fields ranging in size 
from 0.5 x 0.5 cm2 up to 10 x 10 cm2 were investigated. The measurements were repeated using 
EBT3 film for direct comparison between sDMG and EBT3 film under identical conditions. The 
film was scanned with resolution 72 dpi, the acquisition and analysis of the EBT3 film followed the 




3.3.1 Evaluation of the spatial resolution required by a pixelated detector 
The results of the measurements of FWHM and PW are presented in Table 3.1. It is evident that 
across the field sizes and depths investigated the PW20-80% is shown to range between 2-3 mm. The 
PW3-97% value ranges from 4-18 mm across the field sizes investigated as this metric incorporates 
both shoulders of the field penumbra. The distance over which the dose falls-off to zero is of the 
order of a few millimetres (PW20-80%) thus it is clear the penumbra of a jaw-defined square field 
contains steep dose gradients, Figure 3.1(a) and (b). 
Table 3.1 Penumbral width (PW) and Full-Width at Half-Maximum (FWHM) measurements for 

















100 15.79 3.12 103.84 18.65 3.20 105.47 
50 12.19 3.28 51.50 12.51 3.22 52.41 
30 10.57 2.97 30.01 10.97 3.04 31.35 
20 9.69 2.92 20.34 9.96 2.94 20.13 
10 6.64 2.55 9.88 7.30 2.57 10.57 
5 4.16 1.98 4.88 4.87 2.05 5.07 
 
Figure 3.2 illustrates the amplitude spectra generated from the calculation of the discrete Fourier 
transform of the 3–97% penumbral region response for the LHS of each field size investigated. 
Figure 3.2(a) presents the spectrums for the penumbrae of profiles acquired at 5 cm deep in a Solid 








Figure 3.2 One-sided Fourier amplitude spectra for the penumbral regions (3-97%) of various 
field sizes. (a) Fourier spectrums of profiles acquired at depth 5 cm in a Solid Water phantom. (b) 
Fourier spectrums of profiles acquired at depth 10 cm in a Solid Water phantom. 
 
The bandwidths and Nyquist resolutions calculated for each field size and depth in Solid Water 
investigated are presented in Table 3.2. The analysis has identified a suggested resolution for the 
sampling of radiation field profiles to be of the order of 100-200 µm to effectively resolve the 
complex features of these profiles. 
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Table 3.2 90% bandwidth measurements and corresponding Nyquist resolutions for various field 
sizes. 
Square Field Size 
(mm) 









100 35.91 139.23 34.61 144.45 
50 36.91 135.48 36.44 137.23 
30 37.98 131.65 37.67 132.75 
20 38.96 128.34 37.89 131.95 
10 39.93 125.21 39.27 127.33 
5 40.72 122.78 39.57 126.35 
 
3.3.2 Radiation Hardness Characterisation 
Figure 3.3 shows the response of five pixels of the sDMG detector normalised to the response 
attributed to the pre-irradiation condition of the detector. The normalised response is presented for 
five independent channels across the array as a function of accumulated dose delivered to the 
detector. These five pixels were chosen as exhibiting the maximum and minimum deviations in 
individual response from the mean normalised response of the array for each accumulated dose. The 
response is measured with the detector operated in passive mode and demonstrates the increase and 
stabilisation of the charge collection efficiency to within +/-5% for the whole detector array after 40 
kGy of delivered dose. The error bars indicate an uncertainty corresponding to two standard 




Figure 3.3 Experimental result for the measurement of the response of five pixels normalised to 
the pre-irradiation condition of the sDMG detector as a function of accumulated dose. Each pixel 
in the legend is denoted as a ‘Ch’, this is an abbreviation for channel, which relates to the 
chronological number of the individual pixel in the linear array. 
 
3.3.3 Dose Linearity 
Figure 3.4 illustrates the measured dose linearity for the sDMG detector within the dose range of 50 
cGy to 500 cGy. The measurements were taken in increments of 50 cGy over the range investigated 
and the resulting accumulated charge measured within the central channel of the sDMG fitted with 
a linear function. The conversion factor determined from the linear fitting function is 105 pC/cGy. 
The error bars indicate an uncertainty corresponding to two standard deviations in the fluctuation of 




Figure 3.4 The accumulated charge measured within the central channel of the sDMG detector 
as a function of applied photon radiation dose. 
 
3.3.4 Dose per Pulse Dependence  
Figure 3.5 presents the dose per pulse dependence of the sDMG detector. The response of the sDMG 
is normalised to the response of a CC13 ionisation chamber (IBA dosimetry, Schwarzenbruck, 
Germany), at a depth of 1.5 cm (dmax) in a 10 x 10 cm2 6 MV photon beam. The value of 2.78 x 10-
4 Gy/pulse corresponds to the dose per pulse experienced by the CC13 ionisation chamber under 
these conditions at 100cm SSD.  
The results presented in Figure 3.5 illustrate that the sDMG possesses a maximum dose per pulse 
dependence of approximately -40 % across the range investigated. This significant dependence in 
the response of the sDMG detector, relative to the CC13 ionisation chamber, must be accounted for 
utilising correction factors. The methodology undertaken within this portion of the study assumes 




Figure 3.5 The dose per pulse response for the sDMG detector normalized to the estimated dose 
per pulse delivered at 1.5cm depth in water and 100cm SSD of 2.78x10-4 Gy/pulse. 
 
3.3.5 Percentage Depth Dose Measurements 
Figure 3.6 illustrates the PDD response of the sDMG detector measured under irradiation by a 6 
MV photon beam with field size of 10 x 10 cm2 at 100cm SSD, compared to response of a Markus 
Ionisation chamber under the same conditions. The PDD was investigated within the range of 5 mm 
to 250 mm depth in Solid Water for both detectors. Figure 3.6(a) shows the sDMG detectors initial 
PDD behaviour, the exhibited agreement is within +/-8% for depths less than 5 cm in Solid Water, 
at greater depths the percentage difference between the sDMG and Markus chamber increases to a 
maximum of 20%.  
This discrepancy at depths greater than 5 cm in Solid Water is the result of the intrinsic dose per 
pulse dependence of the sDMG detector. Following the characterisation of the dose per pulse 
dependence of the detector, this behaviour is able to be corrected. Correction factors are generated 
for the range of dose per pulse values experienced by the detector within the experiment by fitting 
a polynomial to the relationship shown in Figure 3.5. The dose per pulse experienced by the detector 
at each depth is calculated and the necessary correction factor is determined from the polynomial 
73 
 
equation. The dose per pulse correction factors are in turn applied to the sDMG results at each depth. 
The result of the application of the calculated correction factors is shown in Figure 3.6(b). The 
observed maximum difference is reduced from −20% (Figure 3.6(a)) to maintaining an overall 





Figure 3.6 PDD response measured with the sDMG detector and Markus ionisation chamber for 
a 6MV photon beam with 10 x 10 cm2 field size at 100cm SSD and percentage difference. (a) 
Uncorrected PDD response of sDMG detector. (b) PDD response of sDMG detector corrected for 




3.3.6 Beam Profile Measurements 
Figure 3.7 presents the results measured from the sDMG detector for 6 MV photon beam field sizes 
ranging from 0.5 x 0.5 cm2 to 5 x 5 cm2 at 10cm in Solid Water and 90 cm SSD. The sDMG profiles 
are compared to those measured under identical conditions using Gafchromic EBT3 film. The 
sDMG profiles are normalised to the response of the central axis (CAX) pixel within the detector 
and are aligned to the left hand side spatial coordinate of the 50% response of the CAX pixel value. 
Profiles measured using the EBT3 film are normalised to the average pixel value within a 1 mm 
window surrounding the CAX of the film profile. A quantitative analysis of the agreement between 
the datasets was undertaken using MATLAB (R2013a MathWorks) and the Curve Fitting Toolbox. 
The individual datasets were fitted with a ‘Piecewise Cubic Hermite Interpolating Polynomial’, the 
data was interpolated to calculate the spatial coordinates of the 20%, 80% and 50% responses 
relative to the CAX within each profile. The left-hand side (LHS) penumbral width (20%-80%) and 
full width at half maximum, FWHM (50%-50%), were determined and compared between the 
detectors. The average uncertainty calculated across all measurements for the EBT3 film is ±1.9% 
(Aldosari, 2014) and for the sDMG detector is ±1 %. The results are summarised, including 










Figure 3.7 sDMG and EBT3 film measured beam profiles for 6MV photon beam at 10cm deep 
and 90cm SSD for small radiation fields. (a) Field size 0.5 x 0.5 cm2. (b) Field size 1 x 1 cm2. 
(c) Field size 1.5 x 1.5 cm2. (d) Field size 2 x 2 cm2. (e) Field size 4 x 4 cm2. (f) Field size 5 x 
5 cm2. 
 
The sDMG detector demonstrates an agreement with EBT3 film measurements within 0.90% for 
the determination of the FWHM of the radiation field sizes for all measured beams. The penumbral 
width exhibits an agreement within at most 60 µm that confirms that the spatial resolution of sDMG 
of 0.2 mm enables accurate reconstruction of the penumbral region in 6 MV photon fields for sizes 
below 5 x 5 cm2.  
Table 3.3 sDMG and EBT3 film measurement FWHM and penumbral width (20%-80%) 


























3.3.7 Output Factor Measurements 
Figure 3.8 illustrates the results of the experimental measurement of output factor utilising the 
sDMG detector and EBT3 film. The response of the pixels closest to the CAX of each field for 
sDMG and the pixel region surrounding the CAX for the EBT3 film for each field size is normalised 
to the response under irradiation by a 10 x 10 cm2 field size. The results are investigated as a function 
of radiation field size, delivered at a depth of 10 cm at isocentre for a 6 MV photon beam. Figure 
3.8(a) presents the uncorrected output factor results acquired with the sDMG. Based on the 
calculated output factor result of the EBT3 film for each field size investigated a dose per pulse 
correction factor is calculated and applied, as in 3.3.5, to the sDMG results for each field size, Figure 
3.8(b). The sDMG is shown to under-respond relative to the EBT3 film for field sizes smaller than 
1.5 x 1.5 cm2 up to a maximum of 3.1% for the field size of 0.5 x 0.5 cm2. For radiation field sizes 
greater than 1.5 x 1.5 cm2 the sDMG detector is observed to over-respond relative to EBT3 film 
with the agreement remaining within 2%. 
5 5.04 2.11 5.0 2.1 40 10 
10 10.03 2.62 10.0 2.6 30 20 
15 15.14 2.71 15.1 2.7 40 10 
20 19.92 2.88 20.0 2.9 -80 -20 
30 29.84 3.46 29.9 3.4 -60 60 
40 40.00 3.85 39.8 3.8 160 50 







Figure 3.8. Response of sDMG detector and EBT3 film to varying field size of a 6 MV photon 
beam normalised to response of detector to 10 x 10cm2 field size. Percentage difference between 
sDMG and EBT3 film presented as a function of radiation field size. (a) Uncorrected OF response 




The results of Table 3.2 identify a series of recommended sampling resolutions to accurately 
78 
 
reconstruct 90% of the features present in the radiation field penumbra for different field sizes and 
depths in Solid Water. The penumbral width of a radiation field decreases for smaller field sizes and 
shallower depths in phantom material, as shown in Table 3.1. It is evident from Table 3.2 that as the 
field size decreases the Nyquist resolution decreases, identifying a need for higher resolution 
sampling to resolve the sharper features of smaller field sizes. Also, as depth in phantom material 
decreases the penumbral width is shown to decrease, thus, penumbral features become sharper closer 
to the material surface.  
The Serial Dose Magnifying Glass (sDMG), Figure 2.13, is a multi-strip silicon detector comprised 
of two linear arrays of 128 diodes with pitch 200 µm. The response of the detector operated in 
passive mode was measured under irradiation by a Co-60 gamma emission source. The radiation 
damage study illustrates the detectors response increase and stabilisation of the charge collection 
efficiency across the detector to within +/-5% for the array after 40 kGy of delivered dose. sDMG 
shows a variation of the response versus accumulated dose opposite to the expected trend from a 
silicon diode array. This behaviour has been extensively investigated and an explanation provided 
by means of Technology CAD simulations in Aldosari et al. (Aldosari, 2013) where a pad detector 
fabricated by the same p-type substrate manufacturing technology has been characterised. 
Additionally, it has been demonstrated previously that the charge collection efficiency of this 
detector technology remains stable up to 120 kGy of lifetime accumulated dose (Aldosari, 2013), 
assuming a conservative delivery of 200 Gy per week for quality assurance of stereotactic 
treatments, this would result in a minimum lifetime of  approximately 7.7 years.  
Normalised beam profile measurements were conducted for field sizes between 0.5 x 0.5 cm2 and 4 
x 4 cm2 and compared between the sDMG and EBT3 film.  The sDMG detector exhibited agreement 
to within 0.90 % for the determination of the FWHM of the radiation field sizes when compared 
with EBT3 film measurements. The disagreement in penumbral width measurements between 
sDMG and EBT3 film was found to be at most 60 µm difference for static 6 MV photon beam 
delivery. This disagreement between the detectors is restricted to the submillimeter scale and is at 
most 0.45 mm in the case of FWHM comparison. From Figure 3.1 and Table 3.1 it is evident that 
the penumbral gradient is similar for all field sizes when the beam profile is presented as an absolute 
dose distribution. As the penumbra is mostly determined by the scattering power of photons i.e. 
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their energy spectra and therefore should not be dependent on the field size. Based on this it is clear 
that the sDMG is applicable for penumbra measurements for field sizes both smaller and larger than 
5 x 5 cm2, up to 10 x 10 cm2. These results confirm the requirement estimated by the discrete Fourier 
transform method for the minimum spatial resolution (Table 3.2) required for a pixelated detector 
to reconstruct dose measured by the EBT3 film. 
Extensive characterisation of the DUO detector for 6 MV photons was conducted by Al Shukaili et 
al. (Al Shukaili, 2017). This characterisation followed the methodology outlined in this work and 
included investigation into dependence and response of DUO for dose rate (dose per pulse), PDD, 
beam profiles and output factors. The dose per pulse corrected PDD was demonstrated to agree 
within 1.5% of a Markus ionisation chamber for depths up to 25 cm in Solid Water. FWHM 
agreement was found to be within 1% and within 0.5 mm for penumbral width (20%-80%) 
measurements. These results compare favourably to the sDMG with similar beam profile accuracy 
and magnitude of dose per pulse corrected PDD agreement. 
3.5 Conclusion 
The Discrete Fourier Transform was used to generate Fourier spectrums for the 3-97% penumbral 
regions of response normalised, high spatial resolution radiochromic EBT3 film beam profiles of 
radiation fields with field sizes ranging from 0.5 x 0.5 cm2 up to 10x 10 cm2. The bandwidth of the 
Fourier amplitude spectrum was defined to be the frequency band containing 90% of the total area 
under the curve. The Nyquist-Shannon sampling theorem was applied to the bandwidth 
measurements to calculate a recommended sampling spatial resolution for the field sizes 
investigated of the order of 130 - 200 µm. 
The sDMG exhibits a maximum dose per pulse dependence of approximately 40% across the range 
of 2.1 x 10-5 Gy pulse-1 to 2.78 x 10-4 Gy pulse-1 investigated. The response of the detector was 
normalised to the response of the CC13 ionisation chamber irradiated under identical conditions. 
The results were used to generate a series of correction factors to account for the dose per pulse 
dependence within the sDMG detector. Based on the obtained results a recommendation is made to 
fabricate new generations of DMG on low resistivity bulk Si and later on epitaxial p-Si to improve 
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DPP dependence while providing the same spatial resolution. 
PDD measurements for the sDMG were compared to a Markus ionisation chamber over the range 
0.5 cm to 25 cm depth in Solid Water. Initially the exhibited agreement between the Markus IC and 
sDMG is within +/-8% for depths less than 5 cm in Solid Water, at greater depths the percentage 
difference between the sDMG and Markus chamber increases to a maximum of 20%. The 
discrepancy between the response of sDMG and the Markus IC is attributed to the intrinsic dose per 
pulse dependence of the sDMG. Utilising the calculated correction factors the observed maximum 
difference is reduced from ±20% to ±4% with the sDMG response maintaining agreement within 
±1.27% for depths greater than 1.5cm in Solid Water. 
The output factor for the sDMG was measured and compared to EBT3 film for field sizes ranging 
from 0.5 x 0.5 cm2 up to 10 x 10 cm2. For field sizes less than 1.5 x 1.5 cm2 the sDMG is observed 
to under-respond up to a maximum of 3.3% for the field size of 0.5 x 0.5cm2 relative to EBT3 film. 
For field sizes greater than 1.5 x 1.5 cm2 the sDMG detector is observed to over-respond relative to 
EBT3 film with the agreement remaining within ±2%. The disagreement between the EBT3 film 
and sDMG without dose rate dependence correction is within 8%, with dose rate dependence 
correction agreement is within 3.1%.  
Dose linearity, dose per pulse dependence, PDD, beam profile and output factor measurements were 
conducted for the sDMG detector on a 6 MV linac. The results of these measurements demonstrate 
the applicability of the sDMG detector for use as an accurate tool for commissioning and QA of 






Quality Assurance of stereotactic 
radiotherapy combined with electromagnetic 
MLC tracking using silicon detectors 
4.1 Introduction 
The treatment of small volume tumours within the lungs requires small conformal radiation beams 
and real time motion adaptation to improve treatment efficiency and reduce normal tissue toxicity. 
MLC tracking has been applied clinically to lung SABR treatments, providing reduced target 
volumes whilst delivering the planned target dose in the presence of respiratory motion (Booth, 
2016). The combination of small field dosimetry, target motion and heterogeneous scattering 
conditions is challenging for accurate dose measurement in real-time and necessitates a specialised 
tool for quality assurance (QA) and treatment verification. 
This chapter investigates the effects of homogenous and heterogeneous scattering conditions upon 
the delivered dose distribution in the treatment of dynamic targets using small radiation fields and 
aims to evaluate the performance of the sDMG and DUO detectors with AFE readouts compared to 
the gold standard of high spatial resolution two-dimensional dosimetry, EBT3 film. 
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4.2 Materials and Methods 
4.2.1 DUO and sDMG 
DUO and sDMG are both pre-irradiated to stabilize the response of the detectors, DUO is pre-
irradiated to 120 kGy (Al Shukaili, 2017) and sDMG is pre-irradiated to 40 kGy for uniform 
stabilisation of CCE across the array, as per results of 3.3.2. A uniformity equalization is applied 
prior to irradiation to correct the response of each pixel for intrinsic sensitivities and gain variations 
attributed to the individual preamplifier channels. The correction factor is generated under 
stimulation from a 20 x 20 cm2 6MV photon beam from a linac equipped with a flattening filter at 
10 cm depth in Solid Water and 100cm SSD. In comparison to a 20 x 20 cm2 radiation field the 
DUO is 5.2 x 5.2 cm2 and the sDMG is 0.2 x 5.08 cm2 with each detector aligned to the central axis 
of the radiation beam. The profile of the beam across the detectors at this depth is considered flat, 
with a clinically stated flatness (IEC 60976) measure in this region of 100.3, thus the stimulation of 
each pixel is assumed to be uniform. An array of correction factors is generated based upon the 
individual response of the pixels and the combined average response (Aldosari, 2014). 
4.2.1.1 Dosimetric Validation 
The results of profiling on a 6 MV linac photon beam in Solid Water using DUO has been 
investigated and reported previously (Al Shukaili, 2017). To ensure the dosimetric accuracy of the 
DUO detector is valid for a low-density medium, the detector was encapsulated within the 
homogenous timber phantom (Figure 4.1 (b)) and irradiated with the planned 3DCRT treatment. 
The irradiation was repeated with EBT3 Film within the homogeneous timber phantom and the 
results of the axial beam profiles from the two detectors compared. 
4.2.2 Phantom Scattering Conditions 
The DUO detector was encapsulated in three different phantoms to simulate various scattering 
conditions. Figure 4.1 illustrates the materials of the various phantoms in cross-section, with silicon 
representing the detector. The first scattering condition, Figure 4.1(a), consists of homogenous Solid 
Water (GAMMEX, WI, USA) surrounding the detector, the second scattering condition is 
composed of homogenous timber as an analogue for lung material with a density of approximately 
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0.4 g/cm3, Figure 4.1(b). Figure 4.1(c) represents the phantom designed to mimic the heterogeneous 
conditions of a tumour within the lung, consisting of a Solid Water spherical target with diameter 
of 1 cm within timber.  
 
Figure 4.1 Cross-sections illustrating the material composition of the three scattering conditions 
investigated and dimension of air gap. (a) Homogenous Solid Water phantom. (b) Homogenous 
timber phantom. (c) Heterogeneous timber phantom with Solid Water target. 
  
4.2.3 Film Dosimetry 
Gafchromic EBT3 film (Ashland Inc., Wayne, NJ, USA) was used as the benchmark for the profile 
measurements due to its high spatial resolution, dosimetric accuracy (Sorriaux, 2013) and energy 
independence in the MV photon energy range (Borca, 2013). EBT3 film is a self-developing 
dosimetry film offering symmetrical layer configuration. A single active radiochromic layer of 
30µm nominal thickness is laminated between two transparent polyester layers of 125µm nominal 
thickness (Huet, 2014).  
The EBT3 film was scanned before and 72 hours after irradiation, maintaining identical orientation 
in transmission mode using a MicroTek scanner without image corrections. Six scans were taken of 
each film piece in 48-bit RGB colour mode with a resolution of 72 dpi. The images were saved in 
84 
 
the .TIFF file format and were analysed and converted to optical density (OD) using ImageJ 1.47v. 
A second-order polynomial was generated from an associated calibration curve acquired from the 
same film batch. Using a net optical density protocol, the red colour channel information was 
converted from pixel value to OD to dose (Butson, 2006). Line profiles along the central axis of the 
EBT3 film pieces were examined for comparison to profiles acquired with DUO. 
4.2.4 Dynamic treatment plan delivery  
4.2.4.1sDMG linear detector array 
The sDMG detector was placed upon a HexaMotion 6D Motion platform manufactured by 
Scandidos (Sweden). The HexaMotion platform is capable of replication of motion along 6 axis of 
freedom and is designed as accessory for the Delta4 dosimetry phantom. The prototype of 
HexaMotion adopted in this work has been adapted for use with other detectors and dosimetry 
systems via the addition of a rigid timber platform between the pedestals. The detectors are 
positioned upon the timber platform above 6 cm of Solid Water backscattering, at a depth of 1.5cm 
in Solid Water (water equivalent depth) and 100 cm source to axis distance (SAD) (isocentre). The 
Calypso motion tracking array is placed above the system, consisting of a panel composed of a series 
of coils able to detect the electromagnetic signal from a set of three inductors (transponder beacons) 
positioned above the detector upon HexaMotion. The position of the Calypso EM tracking panel is 
registered by three infrared cameras to the room coordinate reference system (Shah, 2011) and the 
tracking information recorded by Calypso drives the algorithms which modify the position of the 
MLC leaves to compensate for motion of the target (Keall, 2014). Within this investigation the 
motion of the detector is limited to the ‘x’ and ‘y’ directions only. Figure 4.2(a) illustrates the 
direction of the spatial vectors relative to the physical experimental setup, Figure 4.2(b) shows the 
quantitative magnitudes of the spatial displacement expected along both spatial axis as a function 
of time. The temporal pattern shown in Figure 4.2(b) is indicative of real patient lung motion, the 
coordinates are supplied to the HexaMotion via a formatted text file as absolute ‘x’ and ‘y’ spatial 





(a)  (b) 
Figure 4.2 (a) The sDMG detector positioned upon the HexaMotion platform above 6cm of Solid 
Water for backscatter and beneath 1.5cm of Solid Water. The Calypso motion tracking array is 
suspended above the detector, beneath the linac head, with the transponders suspended upon a 
foam insert above the detector to enable tracking. (b) The temporal pattern supplied to the 
HexaMotion phantom to mimic the motion of a lung in x and y direction during irradiation of the 
detector, x direction is into the image. 
 
Square MLC fields of sizes 1x1cm2 and 3x3cm2 are delivered from gantry angle of 0 degrees, to 
both the sDMG detector and Gafchromic EBT3 film independently within the experimental setup. 
The sDMG is first aligned along the ‘y’ direction of motion (Figure 4.2(a)), acquiring a complete 
data set and then rotated 90 degrees to be aligned along the ‘x’ direction to repeat acquisition of the 
dataset. The jaws within the linac head are retracted a further 1 cm in each direction from the MLC 
leaf end positions to minimise leaf-leakage out of field, without restricting the complete range of 
motion necessary for the MLC leaves. From Figure 4.2(b) the maximum displacement is +8mm in 
the ‘y’ direction and +2 mm in the ‘x’ direction for this temporal pattern.  
The silicon detector, sDMG and the EBT3 film are irradiated with 1000 MU at 600 MUmin-1 with 
a 6MV photon beam for three cases; static platform (HexaMotion), dynamic platform without 
motion tracking and dynamic platform with motion tracking (MLC tracking enabled). Under the 
static platform conditions, the detector is positioned upon the platform, which remains stationary 
throughout the treatment time. The first dynamic case consists of the HexaMotion platform 
providing the temporal lung motion during the treatment time without motion tracking engaged. 
Lastly, the HexaMotion provides the dynamic lung motion during the treatment delivery while the 





MLC to compensate for this motion by re-positioning the beam aperture.  
4.2.4.2DUO monolithic detector array 
The detector was irradiated using a 6MV Varian 21EX linac (Varian Medical Systems, Palo Alto, 
USA) photon beam to assess the performance of the detector and investigate the impact of motion 
and scattering conditions upon the delivered dose distribution. DUO placed in each of the phantoms 
(Figure 4.1) was placed upon the HexaMotion 6D motion platform. The HexaMotion platform is 
capable of replicating motion with 5 degrees of freedom. 
The detector and HexaMotion platform were positioned at 100 cm source to axis distance (SAD) 
with the gantry at 0 degrees throughout delivery. A series of spatial coordinates in the form of 
absolute displacements from origin in the ‘X’ (Left-Right) and ‘Y’ (Superior-Inferior, ‘Sup-Inf’) 
directions are supplied to the platform. The platform drives to the coordinates in series, altering the 
position of the detector throughout treatment. The motion pattern supplied is a real patient’s lung 
motion (Figure 4.2(a)) restricted to two-dimensional motion in the ‘X’ and ‘Y’ axis only, Figure 4.2 
(b).  
A planning CT was acquired with the detector encapsulated in the heterogeneous phantom (Figure 
4.1(c)), positioned upon HexaMotion. From this image dataset, the Solid Water target was 
delineated as Gross Tumour Volume (GTV) and a +5 mm margin was applied to the GTV to form 
the Planning Target Volume (PTV). A 3-D Conformal Radiotherapy (3DCRT) plan and an Intensity 
Modulated Radiotherapy (IMRT) were generated with the Eclipse treatment planning system to 
deliver a mean dose of 500 cGy to the PTV for the 3DCRT plan and 540 cGy to the PTV for the 
IMRT plan. The 3DCRT plan consisted of a single beam conforming to the PTV using the MLC. 
The IMRT plan consisted of a single beam with MLC leaves beginning in a closed position and 
sweeping across the field while conforming to the shape of the PTV. The plans were exported to the 
linac and delivered to the detector for all experimental configurations (i.e. motion and scattering 
conditions). 
4.2.4.3Scattering conditions 
For dynamic treatment plan delivery to DUO in each scattering condition, the Calypso panel (Varian 
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Medical Systems, Palo Alto, USA) was positioned above the moving platform. The location of the 
panel within the room coordinate system is determined by three fixed infrared cameras (Shah, 2011).  
The position of transponder beacons placed on the platform is recorded. The spatial localization 
information provided by Calypso is used to modify the position of the MLC aperture (Keall, 2014). 
The linac collimator is rotated such that the driven direction of the leaves is aligned with the Sup-
Inf direction (‘Y’ direction, Figure 4.2(b)). A predictive algorithm is applied during MLC tracking 
to extrapolate the trends in the targets motion and predict the necessary position of the MLC aperture 
to mitigate motion effects and account for the expected time delay between motion detection and 
MLC re-positioning (Ruan, 2010). 
The generated 3DCRT and IMRT plans are delivered for a series of motion cases: (i) ‘no motion’ 
(NM) which represents the ideal case where the platform remains stationary at its home position 
throughout delivery, (ii) ‘motion’ (M) where the platform is provided with the motion and moves 
during delivery with the MLC remaining static and not adapting, (iii) ‘motion+tracking’ (MT), the 
platform moves and the MLC tracking system is engaged to track and compensate for identified 
motion by adapting the MLC during delivery. The three motion management schemes were repeated 
for each of the three phantom scattering conditions. 
4.3 Results 
4.3.1 DUO Dosimetric Validation 
The axial profiles for each motion case are aligned at 50% on the left-hand side penumbra. The 50% 
response coordinate is determined relative to the response of the pixel positioned along the central 
axis (CAX) of the beam. The charge to dose conversion factor for the DUO is (56.34±0.04) 
pC/cGy/pixel. The conversion factor is used to transform the response of the detector from charge 
in pC to dose in cGy. Figure 4.3 demonstrates the direct comparison of the dose profiles measured 




Table 4.1 summarises the measurements of Full-Width at Half Maximum (FWHM) and left-hand 
side (LHS) penumbral width (PW) between the 20% and 80% response values for the EBT3 film 
and DUO. 
Table 4.1 Comparison of Full-width at Half Maximum (FWHM) and Penumbral Width (PW) 
measurements for EBT3 Film and DUO in Superior-Inferior (Sup-Inf) and Left-Right directions. 
Profile 
Direction 
















Sup-Inf 2.48 0.44 2.46 0.51 0.012 -0.065 
Left-
Right 
3.04 0.80 3.05 0.77 -0.015 0.030 
 
4.3.2 Dynamic treatment plan delivery with varying scattering conditions 
4.3.2.1sDMG linear detector array 
The diagrams in Figure 4.4 present a sample of the measurements of beam profiles along the ‘y’ and 
‘x’ direction for the irradiation of the sDMG and EBT3 film by square MLC-defined fields under 
static and dynamic platform conditions. The one-dimensional beam profiles reconstructed from the 
sDMG detector are compared with profiles extracted under identical conditions from the 
 
Figure 4.3 Comparison of EBT3 film and DUO beam profiles for 6 MV linac in homogenous 
timber phantom. (a) Superior-Inferior direction. (b) Left-Right direction. 
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Gafchromic EBT3 film measurements. The beam profiles presented include those of 1 x 1 cm2 in 
the ‘y’ and ‘x’ directions and 3 x 3 cm2 in the ‘y’ direction. For the irradiation of the sDMG by the 
3 x 3 cm2 field size, the beam is centred on the physical gap between the sequential linear arrays. 
The radiation beam profile is reconstructed based on the accurately known distance separating the 
ends of the two linear arrays. The response of each channel within the sDMG detector is normalised 
to the response of the central axis (CAX) pixel within the profile. The EBT3 film response is 
normalised to the response of the pixels occupying a 1 mm window surrounding the CAX of the 
beam profile. The beam profiles acquired from both detectors are aligned such that origin lies at the 
coordinate corresponding to 50% response of the CAX beam profile pixel for sDMG and CAX beam 
axis pixels for the EBT3 film. 
   
(a) (b) (c) 
   
(d) (e) (f) 
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(g) (h) (i) 
No Motion Motion Motion and Tracking 
Figure 4.4 6 MV Photon beam profiles measured with sDMG detector and EBT3 film at 1.5 cm deep 
and 100 cm SAD (isocentre) for characterisation of high resolution dynamic quality assurance 
capabilities with different field sizes. (a) No motion, 1 x 1 cm2, along y-direction. (b) Motion, 1 x 1cm2, 
along y-direction. (c) Motion and Tracking, 1 x 1 cm2, along y-direction. (d) No motion, 1 x 1 cm2, along 
x-direction. (e) Motion, 1 x 1 cm2, along x-direction. (f) Motion and Tracking, 1 x 1cm2, along x-
direction. (g) No motion, 3 x 3 cm2, along y-direction. (h) Motion, 3 x 3 cm2, along y-direction. (i) 
Motion and Tracking, 3 x 3 cm2, along y-direction. 
 
An investigation was conducted to evaluate the quantitative agreement between the EBT3 film and 
sDMG datasets using MATLAB (R2013a MathWorks) as in 3.2.6. The right-hand side (RHS) PW 
(20%-80%) and FWHM (50%-50%) were calculated and compared between the detectors. The 
average uncertainty across all measurements with the sDMG detector is ±1.5 %, induced by the RF 
generated by Calypso, which effects the SNR of the DAQ system. The results are summarised, 
including the associated percentage difference between the datasets, in Table 4.2. 
Table 4.2 sDMG and EBT3 film measurement FWHM and penumbral width (20%-80%) 




























No Motion 11.39 2.94 11.4 2.6 -0.09 11.56 
Motion 11.99 4.94 11.9 4.6 0.75 6.88 
Motion&Tracking 11.20 3.98 11.1 3.4 0.90 14.57 
30 
No Motion 31.00 3.67 30.6 3.1 1.3 15.53 
Motion 30.53 5.43 31.0 5.4 -1.54 0.55 




The motion supplied to the HexaMotion platform, experienced by the detectors, demonstrates a clear 
baseline shift along the ‘y’ axis of motion, Figure 3.1(b). This baseline shift is approximately +4 
mm in magnitude from the platform origin and effectively distorts the dose profile along the ‘y’ axis 
in the positive ‘y’ direction.  
Table 4.2 summarises the quantitative analysis of the independent detectors datasets and highlights 
the agreement between the devices. The agreement observed between the measurements of FWHM 
of the static and dynamic radiation field sizes was within 1.73 %. The most significant disagreement 
between the detectors was observed in the penumbral width measurements with a maximum spatial 
difference of 0.82 mm for the 3x3cm2 static radiation field. Both datasets from the independent 
detectors confirm the effectiveness of MLC tracking to reduce the impact of dose smearing 
attributed to the supplied lung motion. 
Figure 4.4 (d), (e) and (f) present the results of measurements taken along the ‘x’ direction of motion, 
evident in Figure 4.2(a). The ‘x’ motion supplied to the motion platform possesses an absolute 
spatial displacement in the ‘x’ direction of maximum 2 mm. This limits the effective distortion 
occurring to the reconstructed profile along this direction of motion. The beam profiles are still 
distorted by the ‘y’ component which is evident in Figure 4.4(e) and partially compensated in Figure 
4.4(f). The distal penumbral regions of the profiles illustrate the effect of MLC inter-leaf leakage, 
radiation escapes along the edges of the MLC leaves until the retracted jaws shield the out of field 
regions.  
4.3.2.2 DUO monolithic detector array 
Axial profiles of a 6MV linac photon beam for the three separate motion cases with three different 
scattering conditions and two different treatment modalities were acquired, Figure 4.5 and Figure 
4.6. The three motion cases are compared for each of the scattering conditions investigated. The 
average uncertainty calculated for the DUO is ±1.5%, induced by fluctuations in the response 
baseline by the radiofrequency field generated by Calypso. The measured profiles of the dose 
distributions in the Left-Right and Sup-Inf directions are compared using a point-to-point validation 
to assess the similarity of the profiles to the ‘no motion’ case. Figure 4.5 illustrates the results and 



















Figure 4.5 3DCRT 6MV linac beam profiles for the three different scattering conditions and three 
different motion cases (No Motion, Motion and Motion+Tracking) using DUO and the 
corresponding point-to-point profile comparison. (a) Sup-Inf direction with homogenous Solid 




Figure 4.5(a) illustrates the beam profile comparison in the Sup-Inf direction for the homogenous 
Solid Water phantom. The impact of the applied motion during treatment is evident because the 
central axis of the beam is displaced 0.5 cm and the penumbrae are smeared out with a difference 
between the ‘no motion’ and ‘motion’ profiles in the penumbral region at most 340 cGy 
(approximately 80%). The deformation or skewing of the profile is attributed to the slow periodicity 
of the applied motion pattern. The impact of motion produces a systematic under and overdosing 
outside the intended target volume. Implementation of MLC tracking returns the features of the 
delivered dose distribution to the ‘no motion’ case, with only small discrepancies in the penumbral 
regions at most 85 cGy (approximately 15%). The activation of the predictive algorithm with MLC 
tracking results in additional improvements within the penumbral region with the discrepancy 
reduced to at most 80 cGy difference. Figure 4.5(b) presents the results of the axial profiles in Solid 
Water for the Left-Right direction which is perpendicular to the direction of MLC leaf travel and 
shows the interleaf leakage out of field. The impact of the applied motion in this direction is minimal 
because the motion has a dynamic magnitude of approximately ± 0.5 mm (X axis in Figure 4.2(a)) 
and results in minor differences between the profiles. 
Figure 4.5(c) and (d) show the axial beam profiles for the homogenous timber phantom. These 
profiles exhibit similar features to the Solid Water case. Relative to the homogenous Solid Water 
phantom the beam profiles within the lower density homogenous timber phantom show a less flat 
in-field dose deposition with broader penumbrae, as expected due to the larger lateral scattering 
range of the electrons [22]. Despite the broadening effect of the low-density material, the application 
of motion has a significant impact upon the total dose delivered in the Left-Right direction as shown 
in Figure 4.5 (d). The motion in the Sup-Inf direction displaces the beam from the central axis of 
the detector and the Left-Right profile measures across the beam penumbra where the field has 
narrowed leading to under-dosing of at most 150 cGy (Figure 4.5(d)), in direct contrast to Figure 
4.5(b) where the effect from motion is almost absent. Introduction of MLC tracking is shown to 
direction with homogenous timber phantom. (d) Left-Right direction with homogenous timber 
phantom. (e) Sup-Inf direction with heterogeneous timber and Solid Water target phantom. (f) 
Left-Right direction with heterogeneous timber and Solid Water target phantom. 
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mitigate the effects of the applied motion upon the beam profiles and recovers the characteristics of 
the ‘no motion’ profile with minor discrepancies. 
The results of axial beam profiles in the heterogeneous timber phantom with hidden Solid Water 
target are shown in Figure 4.5(e) and (f). Dose enhancement surrounding the higher density Solid 
Water hidden target is evident in the profiles. The effects of the applied motion and implementation 
of MLC tracking are similar to the observed effects in the homogeneous timber phantom where the 
magnitude of motion and the lateral range of the scattering electrons in the low-density medium 
interplay to cause greater discrepancy in the Left-Right direction. 
To further investigate the impact of scattering conditions upon MLC tracking a 1D pass/fail gamma 
analysis (Low, 1998) was conducted on the 3DCRT results. Determination of the global 
normalisation gamma index in absolute dose was achieved with a 2%/2mm (Low, 2003) criterion 
and 0% dose threshold for each motion case beam profile compared with the ‘no motion’ case for 




Table 4.3 shows the global gamma analysis and the effectiveness of MLC tracking to mitigate the 
impact of motion. In the Solid Water scattering condition the percentage agreement between ‘no 
motion’ and ‘motion’ is 27.2% for the Superior-Inferior direction, with the implementation of MLC 
tracking the agreement between the axial profiles becomes 99.6%. For the homogeneous timber 
phantom, the motion is shown to have a greater effect as the initial agreement is 19.3%. Motion has 
Table 4.3 Percentage agreement from global gamma analysis for 2%/2mm criterion for Superior-
Inferior and Left-Right directions between ‘no motion’ (NM) and ‘motion’ (M) or 
‘motion+tracking’ (MT) for 3DCRT plan delivery with DUO. 
Motion 
Cases 













NM-M 27.2 19.3 17.7 76.4 4.7 16.1 
NM- MT 99.6 100.0 100.0 91.7 86.2 79.5 
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greater impact in the inhomogeneous timber phantom with the agreement reduced to 17.7%. With 
tracking the agreement between the beam profiles is found to be 100% for homogeneous and 
inhomogeneous scattering conditions in the Sup-Inf direction. For the Left-Right motion MLC 
tracking is shown to improve results for all scattering conditions and thus minimise the effects of 
motion upon the delivered dose distribution. It is shown to be less effective in the Left—Right 
direction in the inhomogeneous phantom than in the Solid Water phantom, this result may be 
attributed to the significant effect of the Sup-Inf motion to displace the central axis of the radiation 
beam from central axis of the detector. 
The central pixel of the DUO detector was aligned to the linac treatment isocentre by the external 
room lasers, this point coincides with the centre of the hidden target and thus the PTV. A region of 
interest (ROI) was selected on each of the axial profiles to encompass the exact spatial location of 
the PTV (20 mm) and the mean absorbed dose calculated in this ROI and compared across the 
motion and scattering conditions investigated. The results of this analysis for the 3DCRT delivery 
are shown in Table 4.4 and Table 4.5. 
Table 4.4 Mean absorbed dose in PTV for Superior-Inferior axial profiles of 3DCRT delivery. 


















NM 507.2 2.6% 458.6 4.5% 452.8 6.2% 
M 430.0 30.0% 390.8 29.0% 392.8 28.7% 
MT 504.7 4.3% 452.5 6.3% 448.6 7.5% 
 
Table 4.5 Mean absorbed dose in PTV for Left-Right axial profiles of 3DCRT delivery. 


















NM 510.4 1.4% 468.6 2.3% 463.8 3.9% 
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M 509.7 1.1% 428.7 6.3% 436.0 7.6% 
MT 509.8 1.4% 467.0 2.5% 462.4 4.5% 
 
The mean absorbed dose in the no motion case with Solid Water scattering achieves the prescription 
with 507.2 cGy delivered to the PTV. The introduction of the motion significantly affects the dose 
delivered to the PTV in the sup-inf direction, reducing the mean absorbed dose to 430 cGy. The 
introduction of the MLC tracking improves the delivery of dose to the PTV, achieving the 
prescription with 504.7 cGy mean dose. The introduction of the timber in the homogenous and 
inhomogeneous timber scattering conditions significantly affects the mean absorbed dose to the 
PTV as the dose in the PTV region decreases due to the significant change in density of the phantom 
material. In each case of scattering condition the MLC tracking system works effectively to 
compensate for the physical motion of the phantom and detector and achieve a dose delivered to the 
target similar to the case without motion. 
Figure 4.6 illustrates the results and direct comparison of the three motion cases for each scattering 



















Figure 4.6 IMRT 6MV linac beam profiles for the three different scattering conditions and 
three different motion cases (No Motion, Motion and Motion+Tracking) using DUO and the 
corresponding point-to-point profile comparison. (a) Sup-Inf direction with homogenous 




Table 4.6 and Table 4.7 present the mean dose results for the ROI analysis over the PTV for the 
IMRT delivery. The mean absorbed dose in the Solid Water scattering conditions without motion 
achieves the planned dose prescription to the PTV, 540 cGy. Introduction of the clinical patient 
motion significantly reduces the dose delivered to the PTV, the application of MLC tracking 
mitigates this influence and restores the dose to the PTV. As in the 3DCRT case, the motion is most 
influential in the superior-inferior direction. The reduced scattering conditions with the 
measurements in timber and inhomogeneous timber results in a reduction of the measured absorbed 
dose in the PTV and lessens the overall influential effect of the motion upon the delivered dose. The 
measured results, with sliding window IMRT delivery, agree with the 3DCRT results, 
demonstrating the efficacy of the MLC tracking system to mitigate the influences of the applied 
motion trace upon the delivered dose based upon a representative measurement in the PTV. 
Table 4.6 Mean absorbed dose in PTV for Superior-Inferior axial profiles of IMRT delivery. 


















NM 539.9 2.3% 491.6 1.6% 487.2 3.0% 
M 484.7 18.3% 445.7 17.7% 456.5 14.9% 
MT 535.4 1.4% 497.3 3.3% 485.2 3.6% 
 
Table 4.7 Mean absorbed dose in PTV for Left-Right axial profiles of IMRT delivery. 


















Sup-Inf direction with homogenous timber phantom. (d) Left-Right direction with 
homogenous timber phantom. (e) Sup-Inf direction with heterogeneous timber and Solid 




NM 533.1 3.1% 491.2 2.8% 485.2 4.1% 
M 529.0 5.7% 479.7 6.4% 475.2 6.1% 
MT 532.1 4.5% 494.2 4.5% 486.9 4.3% 
 
4.4 Discussion  
Adaptive radiotherapy (ART) aims to improve the outcome of radiation treatment through re-
optimisation of patient treatments based on patient-specific changes in anatomy and biology during 
delivery.  MLC tracking is one real-time motion adaptive strategy that applies real-time tumour 
localisation and tracking to modify and re-position the MLC shape during patient treatment. Patient 
specific quality assurance of MLC tracking treatments is complex due to the daily variations in a 
patients’ tumour motion track, creating new adaptations each day. The use of the sDMG and DUO 
detectors for high spatial resolution beam profiling in motion adaptive radiotherapy lung treatments 
with MLC tracking has been investigated through the use of the detectors upon a HexaMotion 
motion platform to recreate patient-specific lung motion during irradiation.  
Shown in Figure 4.3 are the axial profiles for the Superior-Inferior and Left-Right directions 
measured with DUO within the static homogenous timber phantom under exposure by a 6 MV linac 
compared with EBT3 film. The shape and features of the profiles are consistent between the 
detectors. From Table 4.1, DUO can reconstruct the FWHM of the delivered beam in a low-density 
medium with equivalent accuracy to EBT3 film, with at most an absolute difference of 0.015 mm 
between the two detectors. For the LHS PW the greatest difference between DUO and EBT3 film 
was 0.065 mm, demonstrating the agreement between the detectors.  
In all scattering condition cases, and both 3DCRT and IMRT delivery techniques, the introduction 
of MLC tracking compensates for the effects of motion upon the dose distribution delivered, 
reducing the discrepancy for a motion scenario. MLC Tracking is shown to effectively mitigate the 






Small MLC defined square fields were delivered to both the sDMG and EBT3 film for three motion 
cases to investigate the detectors dosimetric performance in adaptive deliveries. The cases 
investigated include: static platform (no motion), dynamic platform without motion tracking 
(motion) and dynamic platform with motion tracking (motion+tracking). The quantitative 
agreement between the sDMG and EBT3 film was established through measurement and 
comparison of the FWHM and penumbra widths for each beam profile. The agreement between the 
sDMG and EBT3 film for measurements of the FWHM of the static and dynamic radiation field 
deliveries was within 1.31%. The most significant disagreement between the detectors was observed 
in the measurements of the profiles penumbral width, with a maximum spatial difference of 0.58 
mm between the individual detectors measurements for the 1 x 1 cm2 dynamic radiation field with 
tracking. 
It is observed that motion distorts the planned dose profile in the homogenous Solid Water, 
homogenous timber and heterogeneous timber phantoms. MLC tracking reduces the dose smearing 
significantly as demonstrated by the ‘no-motion’ and ‘motion+tracking’ results. The global gamma 
analysis of the axial beam profiles highlights the effectiveness of the MLC tracking system to 
compensate for the effects of motion upon delivered dose yielding excellent agreement between 
‘motion+tracking’ beam profiles and ‘no-motion’ beam profiles in  the 3DCRT delivery. The DUO 
and sDMG detectors have proven to be effective tools for pre-treatment verification of real-time 






Quality Assurance in Proton spot scanning 
radiation therapy 
5.1 Introduction 
This chapter aims to introduce the use of the sDMG and DUO detectors for lateral beam profile 
measurements in a clinical proton radiation beam, with energy 129.46 MeV, at the Francis H. Burr 
Proton Therapy Center (FHBPTC) at Massachusetts General Hospital (MGH). The measured results 
from sDMG and DUO for exposure to a proton pencil beam spot, used in proton pencil beam 
scanning, will be compared to measurements using a commercially available ion chamber array, 
MatriXX, used routinely in the clinic. The experimental results of an investigation will be presented 
into the efficacy and accuracy of the sDMG as a fast, independent proton energy verification system. 
A published manuscript, of which I am the second author, uses the same experimental data presented 
here to compare with Monte Carlo simulations. 
Merchant, A. H., Newall, M., Guatelli, S., Petasecca, M., Lerch, M., Perevertaylo, V., Milluzzo, G., 
Petringa, G., Romano, F., Cirrone, G. A. P., Cuttone, G., Jackson, M. and Rosenfeld, A. B. (2017) 
‘Feasibility study of a novel multi-strip silicon detector for use in proton therapy range verification 




The first page of this manuscript is included in Appendix B. 
5.2 Materials and Methods 
The following experimental results were acquired at the Francis H. Burr Proton Therapy Center 
(FHBPTC) at Massachusetts General Hospital (MGH). The facility consists of a 235 MeV cyclotron 
(IBA dosimetry, Schwarzenbruck, Germany) providing a proton beam that is degraded and 
transported to one room with two fixed horizontal beams and two gantry equipped rooms (Tran, 
2017), (DeLaney, 2007). The proton therapy system is capable of delivering a pencil beam spot with 
a range of 7 to 32 g/cm2 and a full-width at half maximum (FWHM) of 20 to 35 mm. For a Gaussian 
distribution the FWHM is related to the standard deviation, σ, by: 
 𝐹𝑊𝐻𝑀 = 2√2 ∙ ln 2 𝜎 (5.1) 
 
The experimental measurements were acquired in a clinical therapy room with a rotating gantry for 
acquisition of data by the detector arrays with their measurement axes orientated either 
perpendicular for lateral profiles or parallel for edge-on acquisitions, to the proton pencil beam 
incidence. A pristine Bragg peak (PBP) proton pencil beam spot was used for irradiation of the 
detector systems with a spot size (σ) of 11 mm and energy 129.46 MeV at the treatment isocentre, 
which corresponds to a FWHM of 25.9 mm in air at isocentre and a range of 12.64 g/cm2 to the 
distal 90% of the pristine Bragg peak in the PDD (R90).  
5.2.1 Equalisation of detector 
The equalisation of the individual sensitivities and gain of each channel in the arrays of the sDMG 
and DUO detectors was carried out using a 6 MV linac, as described in 4.2.1. In summary, the 
detectors were exposed to the uniform intensity of a 20 x 20 cm2 field size 6 MV photon beam at 10 
cm depth in Solid Water with 10 cm of Solid Water backscattering material. The equalisation 
correction factor for each channel (CFi) is calculated from the ratio of the individual response of 










The calculated correction factor per channel is uniquely applied to the measured response from each 








5.2.2 Lateral profiles 
For the measurement and acquisition of lateral profiles of the PBP proton pencil beam spot, the 
detectors arrays; sDMG, DUO and the MatriXX ionization chamber array (IBA dosimetry, 
Schwarzenbruck, Germany) were placed upon the patient treatment couch and aligned at the 
treatment isocentre using the in-room lasers. The central axis of the detectors were aligned to the 
central axis of the proton pencil beam spot, such that the axis of measurement of the detector systems 
bisected the beam spot. Various depths of Solid Water were placed on top of the detectors for each 
measurement of the proton beam spot lateral profile, with 10 cm of polystyrene material beneath for 
backscattering. The following water equivalent depths were investigated; 13.8, 54.5, 105.1 and 
125.9 mm with each depth repeated and measured using the sDMG, DUO and MatriXX. In this 
experiment the sDMG and DUO detectors are both enclosed within rigid PMMA holders which are 
recessed around the detectors at a water equivalent depth of 3.9 mm. The lateral profiles only of the 
proton pencil beam spot were analysed and quantitatively compared between the three detector 




Figure 5.1 Schematic diagram (not to scale) of the experimental setup of DUO detector in proton 
pencil beam delivery for lateral profile measurements. Detector is positioned beneath increasing 
depths of Solid Water material and aligned with the central axis of the pencil beam and the 
treatment isocentre, setup is repeated for sDMG and MatriXX. 
 
5.2.3 Edge-on acquisition 
The edge-on acquisition of the proton pencil beam at MGH was conducted with the sDMG detector 
aligned using the in-room lasers to the treatment isocentre, with measurement axis of the detector 
parallel to the beam incidence. The gantry of the proton therapy delivery system was rotated to 270° 
to simplify setup of the system, Figure 5.2. Various depths of a polystyrene phantom material are 
placed in front of the linear array detector, manually degrading the energy of beam exiting the snout, 
until the pristine Bragg peak occurs within the sDMG and thus within the silicon sensitive volumes. 
Additional polystyrene phantom material is placed above and below the detector to improve 
scattering conditions. The depth of the sDMG detector in polystyrene is varied with depths 







Figure 5.2 Schematic diagram (not to scale) of the experimental setup of edge-on acquisition of 
proton pencil beam spot delivery for pristine Bragg peak energy reconstruction with sDMG. (a) 
Schematic of experimental setup, various depths of polystyrene are placed in front of the detector. 
(b) Delivery of proton pencil beam spot to sDMG detector, the treatment isocentre is identified 
by the green lasers, aligned to the front of the sDMG. 
  
5.2.4 Energy Reconstruction 
Energy reconstruction of the incident proton pencil beam spot is achieved through accurate 
measurement of the location of the pristine Bragg peak in silicon within the sDMG linear detector 
array. The proton pencil beam to which the sDMG is exposed is mono-energetic, with energy of 
129.46 MeV at the treatment isocentre, which corresponds to a range of 12.64 g/cm2 to the distal 
90% of the pristine Bragg peak in the PDD (R90). Polystyrene phantom material of varying 
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thicknesses are placed in front of the sDMG detector to degrade the energy of the beam and vary 
the position at which the pristine Bragg peak occurs within the silicon detector array. The physical 
measurement of the spatial coordinate of the initial Bragg peak, with depth in silicon, provides an 
effective means of determining the incident energy of the proton beam upon the detector based on 
the known geometry and materials of the phantom surrounding the detector. 
The sDMG detector is encapsulated in a complex environment of varying materials which provide 
protection, provision of scattering material and a reduction of air surrounding the sensitive volumes 
of the detector array. The materials surrounding the silicon detector include; Solid Water and the 
printed circuit board (PCB) carrier. Due to the volume of Solid Water surrounding the detector, 
upon which the proton beam is incident, a broader scattered Bragg peak from the interaction of 
protons in the Solid Water material surrounding the detector is expected beyond the location of the 
initial Bragg peak in silicon. This is a result of the difference in the effective mass density of Solid 
Water Zeff = 1.032 g/cm3 (Solid Water® HE (GammexTM Technology) - Sun Nuclear, 2020) and the 
mass density of silicon, ZSi = 2.33 g/cm3.  
The energy of the incident proton beam is determined from the measurement of the Bragg peak in 
silicon utilising the assumptions and predictions of Continuous Slowing Down Approximation 
(CSDA). The CSDA range approximation assumes that the rate of energy loss of a charged particle 
along it’s track while traversing a medium is equal to the total stopping power within that medium, 
thus fluctuations in the rate of energy loss are neglected. 
Determination of the initial energy of the proton beam upon the phantom surface from the 
measurement of the initial Bragg peak position in silicon requires determination of the predicted 
energy of the proton beam, which produces the peak in silicon, using the CSDA ranges of protons 
in silicon calculated by National Institute of Standards and Technology (NIST). The energy of the 
proton beam is thus determined, using the CSDA ranges of protons (Berger, 2017) in the preceding 
known thickness of phantom materials, for the various depths, the energy of the proton beam at the 
phantom surface can be reconstructed. The CSDA ranges for proton beams with energies from 1 to 
235 MeV in silicon, polystyrene and water from NIST are shown in Figure 5.3.  Fifth order 
polynomials are fitted to the data for each material across the proton energy range and using the 
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Figure 5.3 NIST calculated CSDA range for protons with energy from 1 to 235 MeV for silicon, 
polystyrene and water (Berger, 2017). (a) Visualised with Proton Energy as the ordinate and 
Projected Range the abscissa. (b) Visualised with Projected Range as the ordinate and Proton 




5.3.1 Lateral Profiles 
Figure 5.4 presents the results measured from the sDMG detector for 129.46 MeV proton pencil 
beam spot at various depths in Solid Water. The lateral profile of the beam spot measured by the 
sDMG is compared directly to the clinically measured profiles using the MatriXX ionisation 
chamber array under identical setup conditions. The response of the detectors are normalised to the 
maximum response at central axis, corresponding to the centre of the beam spot. The lateral profiles 





Figure 5.4 Lateral profiles of the proton pencil beam spot for varying depths in Solid Water 
compared between the sDMG and MatriXX. (a) 1.38 cm water equivalent depth. (b) 5.45 cm 




Agreement between the quantitative measurements of the beam spots’ FWHM and penumbral width 
for sDMG and MatriXX are presented in Table 5.1. These results were determined by fitting a sixth 
order polynomial to the response values on each side of CAX of the detectors in each array, to 
calculate the spatial coordinates of the 20%, 80% and 50% responses relative to the CAX, within 
each profile. For the sDMG detector the RHS penumbral width and FWHM are calculated and 
compared to the values determined by the MatriXX. The LHS penumbral width is not calculated 
due to the size of the pencil beam spot being greater than the length of the sDMG detector. 
 
Figure 5.5 presents the results acquired from the DUO detector for the 129.46 MeV proton pencil 
beam spot, at the various depths in Solid Water investigated. The lateral profiles of the beam spot 
measured by DUO are compared directly to the clinically measured profiles using the MatriXX 
ionisation chamber array, which was exposed under identical experimental setup conditions. The 
response of the detectors are normalised to the maximum response at central axis, corresponding to 
the centre of the beam spot. The lateral profiles are aligned to the centre of the beam spot.  
 Table 5.1 sDMG and MatriXX measurements of FWHM and penumbral width for left hand side 




















13.8 24.99 13.15 27.0 13.3 -2.01 -0.15 
54.5 25.02 13.41 27.3 13.4 -2.28 0.01 
105.1 26.34 14.06 27.8 13.6 -1.46 0.46 







Figure 5.5 Lateral profiles of the proton pencil beam spot for varying depths in Solid Water 
compared between DUO and MatriXX. (a) 1.38 cm water equivalent depth. (b) 5.45 cm water 
equivalent depth. (c) 10.51 cm water equivalent depth. (d) 12.59 cm water equivalent depth. 
 
Quantitative agreement between the measurements of the beam spot FWHM and penumbral width 
determined by DUO and MatriXX are presented in Table 5.2. These results were determined by 
fitting a sixth order polynomial to response values each side of CAX of the detectors, in each array, 
to calculate the spatial coordinates of the 20%, 80% and 50% responses relative to the CAX within 
each profile. The LHS and RHS penumbral widths and FWHM are calculated for DUO and 
compared to the values determined by the MatriXX. 





The results summarised in Table 5.2 demonstrate agreement between DUO and MatriXX in 
measurement of the FWHM to within 1 mm over the range of water equivalent depths investigated.  
5.3.2 Edge-on acquisition 
The sDMG is exposed to a mono-energetic proton beam, with energy of 129.46 MeV at the 
treatment isocentre, which corresponds to a range of 12.64 g/cm2 to the distal 90% of the pristine 
Bragg peak in the PDD (R90). Polystyrene phantom material is placed in front of the detector in a 
series of thicknesses including; 60, 70, 80 and 90 mm. A coordinate system considering only depth 
in silicon is used for analysis of the measured results and determination of the spatial coordinate of 
the initial Bragg peak in silicon. 












(mm)  FWHM 
(mm)  





LHS  RHS LHS  RHS LHS  RHS 
13.8 26.24 12.34 12.55 27.0 13.7 13.3 -0.76 -1.36 -0.75 
54.5 27.48 12.82 13.04 27.3 13.9 13.4 0.18 -1.08 -0.36 
105.1 28.39 13.26 13.47 27.8 14.2 13.6 0.59 -0.94 -0.13 




Figure 5.6 Schematic diagram (not to scale) of the experimental setup of the sDMG in edge-on 
acquisition with “Depth in Silicon” coordinate system described. 
 
Figure 5.7 shows the measured results of the edge-on acquisition of the proton pencil beam spot for 
varying thickness of polystyrene phantom material in front of the detector. The response of the 
detector is normalised to the peak position of the Bragg peak for each individual depth investigated 












Figure 5.7 Results of the edge-on acquisition with sDMG in a proton pencil beam spot with 
varying thickness of polystyrene phantom material in front of the detector, with measured initial 
Bragg peak position highlighted in each callout box. (a) 60 mm polystyrene. (b) 70 mm 




Table 5.3 summarises the results of the measured Bragg peak positions in silicon and the 
subsequently reconstructed proton beam energy at the phantom surface based on the CSDA range 
approximation for the varying thickness of polystyrene phantom material investigated. Based on the 
results of the experiment, the energy determined for the proton pencil beam incident upon the sDMG 
detector was calculated to be 129.2 ± 0.49 MeV (this uncertainty is quoted with a coverage factor 
of k = 2). The measurement agrees with the delivered energy of 129.46 MeV at isocentre, within 
the statistical uncertainty quoted of the measurement of the energy of the incident proton pencil 
beam using the sDMG. 
Table 5.3 Results of the measured Bragg peak in silicon using the sDMG in edge on acquisition 
Polystyrene phantom material 
preceding sDMG  
(mm) 
(± 0.5 mm) 
Measured Bragg peak 
position in silicon  
(mm)  
(± 0.2 mm) 
Predicted proton energy at 
phantom surface, E  
(MeV) 
(± 0.2 MeV) 
60 24.4 129.5 
70 18.8 129.4 
80 13.0 129.1 
90 7.0 128.9 
 
5.4 Discussion 
With the advent of proton pencil beam scanning systems, accurate beam data commissioning and 
beam modelling measurements are vital for the treatment delivery commissioning process. 
Establishing effective, independent and accurate means of conducting routine QA including 
identifying tools for routine quality assurance checks is necessary for efficient and safe delivery of 
advanced radiotherapy.  
The sDMG and DUO detector systems were investigated for their capabilities to provide rapid, 
accurate and high spatial resolution measurements of a proton pencil beam spot and compared to 
the measured results of the MatriXX ionisation chamber array. The centre-to-centre distance 
between the ionization chambers of the MatriXX ionization chamber array is 7.62 mm (MatriXX - 
Universal Detector Array | IBA Dosimetry, 2020), compared to the silicon pixel spacing of 0.2 mm 
for both the sDMG and DUO detector arrays. In the results presented in Table 5.1 the significantly 
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higher spatial resolution of the sDMG detector compared to the MatriXX should result in a more 
accurate evaluation of FWHM, however the polynomial interpolation of the RHS spatial coordinate 
of the 50% response, in the space between the two silicon chips which compose the linear detector 
array of the sDMG, introduces uncertainty in the quantitative evaluation when compared to the 
MatriXX. This effect is also influential in the determination of the penumbral width using the 
sDMG. As such the agreement between the sDMG and the MatriXX for penumbral width 
measurements to within ± 0.5 mm is acceptable for the water equivalent depths 1.38, 5.45 and 10.51 
cm. The measurement of the penumbral width at 12.59 cm water equivalent depth for the MatriXX 
of 13.5 mm should be greater in magnitude than the measurement at 10.51 cm water equivalent 
depth, this outlier generates an increased difference in measurement between the two systems. For 
FWHM, the results of Table 5.1 identify a systematic determination of the FWHM quantity to be 
less than measured by the MatriXX, this result is produced in part by the smaller volume of each 
pixel of the sDMG compared to the volume of the MatriXX ionisation chambers over which the 
signal is averaged. 
It is evident that the physical dimensions and arrangement of DUO provides distinct advantages in 
enabling complete simultaneous two-dimensional acquisition of the proton pencil beam spot, such 
that the penumbral width of both LHS and RHS of the lateral profiles are measured simultaneously 
and quantified for comparison to the MatriXX, Figure 5.5. Table 5.2 demonstrates that the measured 
spot penumbrae are calculated to be sharper with the DUO evaluation than either the MatriXX or 
sDMG determinations. However, the sDMG evaluation may be influenced by the increased 
uncertainty due to the discontinuity in the profile measurement between the two linear arrays. 
A Monte Carlo feasibility study was conducted for the sDMG detector and was related to its use in 
proton therapy range verification. The results of this study, which involved Monte Carlo simulation 
of the practical experimental measurements conducted in this chapter, demonstrated an excellent 
overall agreement between the experimental measurements and the simulation of the Bragg peak 
position in silicon, as measured in the sDMG detector (Merchant, 2017). The practical measured 
results for proton range verification using the sDMG, which are presented in Figure 5.7, demonstrate 
a series of detector pixels which return a measurement of zero. These pixels were found to be non-





Pencil beam spot profiles are an important characterization parameter of proton radiotherapy 
delivery in pencil beam scanning delivery systems. Quantitative measurement of spot profile 
characteristics with high spatial resolution detectors provides valuable information to the clinical 
department. Using the sDMG and DUO detectors the FWHM and penumbral width (80%-20%) 
were quantitatively measured for a proton pencil beam spot at water equivalent depths of 13.8, 54.5, 
105.1 and 125.9 mm, with each depth repeated for measurement using the sDMG (Table 5.1), DUO 
(Table 5.2) and MatriXX detector systems for comparison. The sDMG and DUO calculated sharper 
FWHM and penumbral widths than the MatriXX ionization chamber array.  
The sDMG detector was irradiated by the proton pencil beam spot in an edge-on acquisition mode 
to investigate a means of fast and independent method of proton beam energy verification. The 
reconstructed entrance energy at the phantom surface was calculated to be 129.5 ± 0.2 MeV, 129.4 
± 0.2 MeV, 129.1 ± 0.2 MeV and 128.9 ± 0.2 MeV for the thickness of 60, 70, 80 and 90 mm of 
polystyrene phantom material respectively, Table 5.3. This results in a mean energy determination 
of 129.2 ± 0.49 MeV, which compares accurately with the delivered proton beam energy of 129.46 
MeV at the treatment isocentre. 
The feasibility of using the high spatial resolution pixelated silicon detector arrays, sDMG and 
DUO, for quantitative measurements in proton pencil beam spot scanning systems has been 
demonstrated. DUO provides significant advantages in terms of simultaneous and spatially 
continuous acquisitions of high resolution dose profiles for accurate penumbral and FWHM 
measurements. Both sDMG and DUO demonstrate limitations in terms of capability to measure 






Energy Verification in heavy-ion radiation 
therapy 
6.1 Introduction 
The previous chapter described the results of independent energy verification measurements using 
the sDMG linear detector array in a proton pencil beam with energy 129.46 MeV.  This chapter 
aims to introduce the use of the sDMG and TERA data acquisition system as a fast, independent 
energy verification system for use in charged particle therapy with a heavy ion carbon beam. 
A published manuscript, of which I am the second author, uses the same experimental data to 
compare with Monte Carlo simulations. 
Debrot, E., Newall, M., Guatelli, S., Petasecca, M., Matsufuji, N. and Rosenfeld, A. B. (2018) ‘A 
silicon strip detector array for energy verification and quality assurance in heavy ion therapy’, 
Medical Physics, 45(2), pp. 953–962. doi: 10.1002/mp.12736. 




6.2 Materials and Methods 
The experimental results presented here were conducted at the Heavy Ion Medical Accelerator in 
Chiba (HIMAC) with the National Institute of Radiological Sciences (NIRS), Japan.  
The sDMG detector was irradiated in a research bunker with a fixed horizontal beamline using a 
mono-energetic 12C ion beam with energy 290 MeV/U. The 12C ion beam exits the vacuum beam 
port, within the bunker, and traverses an aluminium scattering filter and approximately 10 m of air 
before it is defined by a brass collimator with 10 x 10 cm2 square field opening.  
The measurement axis of the sDMG was orientated parallel to the direction of the 12C ion beam for 
edge-on acquisitions of the pristine Bragg peak (PBP). The sDMG was carefully aligned to the 
central axis of the defined field by measurement and an independent external laser assembly. Known 
thicknesses of PMMA phantom material were placed directly in front of the sDMG detector to 
degrade the energy of the incident 12C ion beam.  
Various thicknesses were investigated to examine the deposition of the pristine Bragg peak within 
the sDMG detector. Figure 6.1(a) is a schematic representation (not to scale) of the exposure of the 
sDMG in the PMMA phantom to the incident mono-energetic 12C ion beam orientated for edge-on 
acquisition. Figure 6.1(b) depicts the real experimental setup of the sDMG detector in edge-on 
acquisition mode to the 12C ion beam at HIMAC. 
The response of the sDMG detector was equalised for the individual sensitivities and gain of each 
channel in the array using a 6 MV linac. This exposure consisted of irradiation of the detector the 
uniform intensity of a 20 x 20 cm2 field size 6 MV photon beam at 10 cm depth in Solid Water with 
10 cm of Solid Water backscattering material. The equalisation correction factors were calculated 







Figure 6.1 Setup of edge-on acquisition of sDMG detector in 12C ion beam. (a) Schematic 
representation (not to scale) of the exposure of the linear detector array to the mono-energetic 
carbon ion beam for varying depths in PMMA phantom material. (b) Setup of experimental 
measurements at the carbon ion beam facility. 
 
6.2.1 Energy Reconstruction 
Energy reconstruction of the incident 12C ion beam is achieved through accurate measurement of 
the location of the pristine Bragg peak in silicon within the sDMG linear detector array. 
The 12C ion beam is incident upon the surface of the PMMA phantom with energy 290 MeV/U (E0 
in Figure 6.1(a)). The energy of the mono-energetic 12C ion beam degrades as it traverses the PMMA 
phantom, with the 12C ion’s reaching maximum range in the sDMG detector, producing a pristine 
Bragg peak in the detector. The depth of the pristine Bragg peak in silicon, measured within the 
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sDMG detector, is used to reconstruct the residual energy of the 12C ion beam upon incidence on 
the silicon of the sDMG detector (E1 in Figure 6.1(a)).  
The energy of the incident 12C ion beam is determined from the measurement of the Bragg peak in 
silicon utilising the calculations of the projected range in matter of 12C ions of the SRIM-2013 
software package (Ziegler, 2013), (Ziegler, 2010). SRIM (The Stopping and Range of Ions in 
Matter) is Monte Carlo simulation software package which calculates the range and stopping power 
of ions traversing different materials using a quantum mechanical treatment of ion-atom collisions. 
The software requires input of the type of ion, energy and target material and is able to calculate 
(but not limited to) the ion-penetration depth and energy deposition in target material. Using SRIM-
2013 the projected range of 12C ions was calculated between 100 MeV/U and 400 MeV/U for 
PMMA and silicon. The results were then plotted and fit with third order polynomials for the 
calculation and interpolation of; the residual energy (E1) of 12C ions at the entrance to silicon from 
Bragg peak measurement in silicon (Figure 6.2(a)), the projected range of 12C ions in PMMA 
without silicon present (Figure 6.2(b)), and the energy of 12C ions (E0) at the PMMA phantom 









Figure 6.2 The calculated projected ranges from SRIM-2013 (Ziegler, 2013). (a) Determination 
of residual energy of 12C ions at the entrance to silicon from Bragg peak measurement in depth 
of silicon. (b) Determination of the projected range of 12C ions in PMMA without silicon present. 
(c) Determination of the energy of 12C ions at the PMMA phantom surface from measurement of 




The energy of the 12C ion beam is reconstructed from the measurement of the pristine Bragg peak 
location in the silicon sDMG detector array using the calculation method described above for 
various depth of PMMA phantom material. 
The sDMG detector is encapsulated in a complex environment of varying materials which provides 
protection, provision of scattering material and a reduction of air surrounding the sensitive volumes 
of the detector array. The materials surrounding the silicon detector include; Solid Water and the 
printed circuit board (PCB) carrier. Due to the energy and nature of the 12C ions in the beam incident 
upon the PMMA phantom, unlike in the proton beam irradiation, a secondary phantom scatter peak 
is not expected. 
6.3 Results 
The sDMG is exposed to a mono-energetic 12C ion beam, with energy of 290 MeV/U exiting the 
vacuum port. PMMA phantom material is placed in front of the detector in a series of thicknesses 
including; 54, 64, 89 and 102 mm. A coordinate system considering only depth in silicon is used for 
first visualisation of the measured results with equalisation factor applied, Figure 6.3(a).  
The overall shape of the pristine Bragg peak measured by the sDMG detector clearly demonstrates 
the peak of maximum dose deposition, which is defined and can be accurately localised in the linear 
array. Figure 6.3(b) illustrates the measured results aligned in depth in PMMA, which is used for 
localisation of the pristine Bragg peak. The pristine Bragg peak measured by the sDMG detector in 
silicon in the 12C ion beam is more defined than compared to the measurements in the proton pencil 







Figure 6.3 Combined measurements results of sDMG detector exposed to 12C ion beam in edge-
on acquisition mode with varying depths of PMMA phantom material preceding detector. (a) 
Results presented with abscissa describing the depth of the pristine Bragg peak delivered in depth 
in Silicon of linear sDMG array. (b) Results presented with abscissa describing the depth of PBP 
delivered in depth in PMMA phantom. 
 
The measurement of the location of the pristine Bragg peak within the silicon detector (at a known 
depth in the PMMA phantom) is completed after each acquisition. The energy of the beam (E1) at 
entrance to the silicon detector is calculated from the experimental measurement of the location of 
the pristine Bragg peak within the detector. The measured location of the pristine Bragg peak in 
PMMA (projected range without silicon + build-up PMMA) is determined from this calculated 
energy (E1). The energy (E0) at the entrance to the PMMA phantom is calculated from the measured 
128 
 
location of the pristine Bragg peak in PMMA (without silicon) following the energy reconstruction 











Figure 6.4 Individual measurements results of sDMG detector exposed to 12C ion beam in edge-
on acquisition mode with varying depths of PMMA phantom material preceding detector. (a) 54 
mm PMMA. (b) 64 mm PMMA. (c) 89 mm PMMA. (d) 102 mm PMMA. 
 
The results of the measurement of the pristine Bragg peak position for a 12C ion beam incident upon 
a PMMA phantom of various thicknesses and the subsequent calculation of the energy of the 12C 





Table 6.1 Results of the measurement of the pristine Bragg peak location in the sDMG detector 
for various depths of PMMA phantom material and the calculation of the incident 12C ion beam 














(± 0.7 MeV/U) 
Projected range in 
PMMA without 
silicon from 
phantom surface  
(mm) 




(± 0.5 MeV/U) 
54 48.8 119.5 132.4 278.8 
64 42.2 143.7 131.2 277.8 
89 27.2 186.3 130.3 278.8 
102 19.5 203.4 131.1 280.4 
 
Based on the results of the experiment, the energy determined for the 12C ion beam incident upon 
the sDMG detector was calculated to be 278.9 ± 2.1 MeV (this uncertainty is quoted with a coverage 
factor of k = 2).  
6.4 Discussion 
A Monte Carlo simulation of the experimental setup was conducted by Debrot et al. (Debrot, 2018) 
with the simulated average energy of the 12C ion beam at the surface of the PMMA phantom 
determined to be 280 ± 0.2 MeV/U. The measurement of 278.9 ± 2.1 MeV using the sDMG over 
various thickness of PMMA agrees with the simulated energy of 280 ± 0.2 MeV/U at the PMMA 
phantom surface, within the statistical uncertainty quoted for the measurement of the energy of the 
incident 12C ion beam using the sDMG. Disagreement between the measured and expected values 
for the 12C ion beam incident at the surface of the PMMA phantom is attributed to potential 
uncertainties present in the thicknesses of absorber materials placed in front of the sDMG detector 
as well as uncertainties related to the degradation of the energy of the beam prior to incidence upon 
the phantom. 
The sDMG detector was irradiated in a research bunker with a fixed horizontal beamline using a 
mono-energetic 12C ion beam with energy 290 MeV/U. The deposition of the pristine Bragg peak is 
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evident in the sDMG detector for each depth of PMMA investigated, shown in Figure 6.4. 
Visualised in depth in silicon, Figure 6.3(a), it is also evident that individual smaller peaks occur in 
regions of the detector previously irradiated by the 12C pristine Bragg peak. These smaller peaks, 
occurring at depths of 21 and 27 mm, are attributed to radiation damage defects generated by the 
previous measurement at depth in PMMA, measured with the same sDMG detector.  
Additionally, the smaller peaks are evident because the equalisation correction factors applied to the 
results acquired by the sDMG detector are generated by uniform MV photon irradiation, thus are 
not accounting for the non-linear localised variations in individual sensitivity of the detectors 
channels caused by the defects generated by the high LET 12C radiation at the distal end of the 
pristine Bragg peak.  
Prolonged exposure of the silicon detector sDMG to the 12C ion beam in edge-on acquisition mode 
was found to yield visible radiation damage defects in the form of non-linear localised variations in 
individual sensitivity of the detectors channels. The presence of these effects does not influence the 
accuracy of the energy reconstruction method described as the defects are highly localised within 
the detector. 
Deposition of energy beyond the distal edge of the pristine Bragg peak, measured by the sDMG, is 
attributed to the lateral scattering of 12C ions into the detector which have a comparatively extended 
range in the surrounding scattering materials of the PCB relative to the silicon detector. 
6.5 Conclusion 
A method of calculating the energy of the incident 12C ion beam from the measurement of the Bragg 
peak in silicon was developed utilising the calculated projected range in matter of 12C ions from the 
SRIM-2013 software package. The residual energy (E1) of 12C ions at the entrance to silicon is 
determined from the measurement of the pristine Bragg peak location in silicon, the projected range 
of 12C ions in PMMA without silicon present is then calculated and the energy of 12C ions (E0) at 
the PMMA phantom surface is determined based on the known thicknesses of PMMA from 
calculation of the pristine Bragg peak location in PMMA without silicon present. Based on the 
results of the experiment, the energy determined for the 12C ion beam incident upon the sDMG 
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detector was calculated to be 278.9 ± 2.1 MeV (this uncertainty is quoted with a coverage factor of 
k = 2). The results of this experimental work demonstrate the feasibility of the sDMG detector for 








The Serial Dose Magnifying Glass (sDMG), is a multi-strip silicon detector comprised of two linear 
arrays of 128 diodes with pitch 0.2 mm. The radiation damage study illustrates the sDMG detectors’ 
increase in response and stabilisation of the charge collection efficiency across all pixels within the 
array to within +/-5% after 40 kGy of accumulated uniform dose. The linearity of the detector’s 
accumulated charge response to delivered dose from a 6 MV linac photon beam was examined 
within the range 50 cGy to 500 cGy. The R2 of the linear fitting function was determined to be 
0.99999 and the conversion factor found to be 105 pC/cGy/pixel. The sDMG exhibits a maximum 
dose per pulse dependence of approximately 40% across the range of 2.1 x 10-5 Gy pulse-1 to 2.78 x 
10-4 Gy pulse-1 investigated. The response of the sDMG detector was normalised to the response of 
the CC13 ionisation chamber irradiated under identical conditions. These results were used to 
generate a series of correction factors to account for the dose per pulse dependence within the sDMG 
detector. PDD measurements for the sDMG were compared to a Markus ionisation chamber over 
the range 0.5 cm to 25 cm depth in Solid Water. Initially the exhibited agreement between the 
Markus IC and sDMG is within +/-8% for depths less than 5 cm in Solid Water, at greater depths 
the percentage difference between the sDMG and Markus chamber increases to a maximum of 20%. 
The discrepancy between the response of sDMG and the Markus IC is attributed to the intrinsic dose 
per pulse dependence of the sDMG. Utilising the calculated correction factors the observed 
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maximum difference is reduced from ±20% to ±4% with the sDMG response maintaining agreement 
within ±1.27% for depths greater than 1.5cm in Solid Water. A series of output factors for the sDMG 
were measured and compared to EBT3 film for field sizes ranging from 0.5 x 0.5 cm2 up to 10 x 10 
cm2. For field sizes less than 1.5 x 1.5 cm2 the sDMG is observed to under-respond up to a maximum 
of 3.3%, for the field size of 0.5 x 0.5 cm2, relative to EBT3 film. For field sizes greater than 1.5 x 
1.5 cm2 the sDMG detector is observed to over-respond relative to EBT3 film with the agreement 
remaining within ± 2%. The disagreement between the EBT3 film and sDMG without dose rate 
dependence correction is within 8%, with dose rate dependence correction agreement is within 
3.1%. Normalised beam profile measurements were conducted for field sizes between 0.5 x 0.5 cm2 
and 4 x 4 cm2 and compared between the sDMG and EBT3 film.  The sDMG detector exhibited 
agreement to within 0.90 % for the determination of the FWHM of the radiation field sizes when 
compared with EBT3 film measurements. The disagreement in penumbral width measurements 
between sDMG and EBT3 film was found to be at most 60 μm difference for static 6 MV photon 
beam delivery. This disagreement between the detectors is restricted to the submillimeter scale and 
is at most 0.45 mm in the case of FWHM comparison.  
From these measurements of dose linearity, dose per pulse dependence, PDD, beam profiling and 
output factor the sDMG was demonstrated to perform accurately and effectively as a QA tool for 
small radiation beam deliveries. 
The use of the sDMG and DUO detectors for high spatial resolution beam profiling in motion 
adaptive radiotherapy lung treatments with MLC tracking has been investigated. The quantitative 
agreement between the sDMG and EBT3 film was established through measurement and 
comparison of the FWHM and penumbra widths for each beam profile. The agreement between the 
sDMG and EBT3 film for measurements of the FWHM of the static and dynamic radiation field 
deliveries was within 1.31%. DUO is shown to reconstruct the FWHM of the delivered beam in a 
low-density medium with equivalent accuracy to EBT3 film, with at most an absolute difference of 
0.015 mm between the two detectors. For the LHS PW the greatest difference between DUO and 
EBT3 film was 0.065 mm, demonstrating the agreement between the detectors. In all scattering 
condition cases, and both 3DCRT and IMRT delivery techniques, the introduction of MLC tracking 
compensates for the effects of motion upon the dose distribution delivered, reducing the discrepancy 
135 
 
for a motion scenario. MLC Tracking is shown to effectively mitigate the penumbral smearing and 
recover the characteristics of the beam profiles and doses delivered without motion.  
The DUO and sDMG detectors have proven to be effective tools for pre-treatment verification of 
real-time adaptive stereotactic deliveries with high spatial resolution for dose profiling. 
With the advent of proton pencil beam scanning systems, accurate beam data commissioning and 
beam modelling measurements are vital for the treatment delivery commissioning process. The 
sDMG and DUO detector systems were investigated for capabilities to provide rapid, accurate and 
high spatial resolution measurements of a proton pencil beam spot and their results are compared to 
the measured results of the MatriXX ionisation chamber array. Using the sDMG and DUO detectors 
the FWHM and penumbral width (80%-20%) were quantitatively measured for a proton pencil beam 
spot at water equivalent depths of 13.8, 54.5, 105.1 and 125.9 mm, with each depth repeated for 
measurement using the sDMG, DUO and MatriXX detector systems for comparison. The sDMG 
and DUO calculated sharper FWHM and penumbral widths, respectively than the MatriXX 
ionization chamber array.  
The sDMG detector was irradiated by the proton pencil beam spot in an edge-on acquisition mode 
to investigate a means of fast and independent proton beam energy verification. The reconstructed 
entrance energy at the phantom surface was calculated to be 129.5 ± 0.2 MeV, 129.4 ± 0.2 MeV, 
129.1 ± 0.2 MeV and 128.9 ± 0.2 MeV for the thickness of 60, 70, 80 and 90 mm of polystyrene 
phantom material respectively. This results in a mean energy determination of 129.2 ± 0.49 MeV, 
which compares accurately with the delivered proton beam energy of 129.46 MeV at the treatment 
isocentre. The sDMG detector was also irradiated using a mono-energetic 12C ion beam with energy 
290 MeV/U in edge-on acquisition mode. Based on the results of this experiment, the energy 
determined for the 12C ion beam incident upon the sDMG detector was calculated to be 278.9 ± 2.1 
MeV (this uncertainty is quoted with a coverage factor of k = 2). The measurement of 278.9 ± 2.1 
MeV using the sDMG over various thickness of PMMA agrees with the expected energy of 280 ± 
0.2 MeV/U at the PMMA phantom surface, within the statistical uncertainty quoted for the 
measurement of the energy of the incident 12C ion beam using the sDMG. 
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The sDMG detector is shown to provide a fast, accurate and independent means of range and energy 
verification in both proton pencil beams and carbon-ion beams. 
Despite the limitations relating to dose per pulse dependence and physical size for both DUO and 
sDMG, the detectors have demonstrated uniquely valuable performance in providing high spatial 
resolution measurements of small radiation fields in homogenous and heterogeneous scattering 
conditions for accurate validation of static and dynamic delivery techniques. Furthermore, an 
efficient and practical methodology is presented utilising the sDMG for independent energy 
verification in proton and carbon-ion radiation beams. 
7.2 Impact & Future Directions 
The detailed investigation conducted in this work into the first version of the high spatial resolution 
silicon detectors sDMG and DUO, developed at CMRP, and fabricated on bulk silicon substrates, 
allowed for a clear demonstration of their advantages and initial shortcomings. These initial 
shortcomings and limitations included; discontinuities in measurement axis (sDMG), limiting 
overall physical dimensions and dose per pulse dependence. However these limitations were 
determined in combination with highly valuable accuracy and performance characteristics with high 
spatial resolution. These detectors merit further investigation in both small field photon dosimetry 
as well as independent energy verification for proton and heavy-ion therapies.  
The importance of this work is that it pioneered firstly the use of the high spatial resolution pixelated 
Si dosimeters for QA in EBRT MART and has directly led to the production of the second (low 
resistivity bulk) and third generation (epitaxial) silicon 1D and 2D family of CMRP dosimeters 
(DMG 256 , DUO, Octa and M512).  
Biasi et al. (Biasi, 2018) investigated a 2D monolithic silicon array, fabricated on a high resistivity 
p-type epitaxial layer, with 512 detectors across four linear arrays arranged with a shared central 
detector and the linear arrays at 45° relative to each other. Output factors, dose profiles, dose per 
pulse dependence and PDDs were investigated across flattening filter free and flattened photon 
beams of energy 6MV and 10MV. 
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Stansook et al. (Stansook, 2019) described and investigated the changes in performance 
characteristics of the family of 2D monolithic silicon detector arrays, consisting of M512, DUO and 
Octa, which were initially fabricated on bulk p-type substrates and are now subsequently fabricated 
on epitaxial p-type substrates. The output factors, off-axis ratios and PDDs in square 6MV and 
10MV flattened photon radiation fields were presented. 
Causer et al. (Causer, 2019) conducted a preliminary investigation into a monolithic silicon strip 
detector (sDMG-256) which consists of 256 detectors in a single continuous linear array, with 0.2 
mm pitch on a bulk p-type silicon substrate, for use in a static magnetic field of 1.2 T under exposure 
to small photon beams with energy 6MV and 10MV.  
Causer et al. (Causer, 2020) reported on an investigation using DUO for Bragg peak detection in a 
therapeutic quality proton beam with a 0.95 T transverse magnetic field.  
Alnaghy et al. (Alnaghy, 2020) utilised a 512 channel monolithic silicon detector array (M512) 
arranged in a 22 x 22 grid, fabricated on an epitaxial p-type silicon substrate, to investigate the 
feasibility of dose measurement in a 1.0 T inline MRI-linac during MR imaging. 
The initial findings and characterisations conducted in this work, for these detectors in MART and 
charged particle radiation therapy, has resulted in advanced performance of CMRP detectors which 
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A. MATLAB scripts 
The following scripts were generated in MATLAB for data analysis of decoded detector acquisition 
files. 
A.1. FindGamma.m 
function [ Gamma ] = FindGamma( Measurement, Comparison ) 
% 20/05/2016 
 
%Find Gamma value between two matrices 
 
% Measurement - LOW Resolution Detector i.e. MagicPlate 
% Comparison - HIGH Resolution Film 
 
% The GAMMA answer will possess same dimensions as the measurement 
matrix. 
 
%This function/methodology does not work in the other direction, in 
terms 
%of matrix dimensions... 
 
% Author: Matthew Newall 
% Date: 6/10/12 
 
%% 
pitchMeasurment = 2.54/75;  %define in cm. 
pitchComparison = 0.1;  %define in cm. 
 
displacement = 0; 
 
DistanceToAgreement = 0.2;  %Distance to Agreement criterion (cm) 
DoseDifference = 0.02;      %Percentage dose difference criterion % 
(decimal) 
 




sizeMeasurement = size(Measurement); 
sizeComparison = size(Comparison); 
 
TempGamma = zeros(sizeComparison(1),sizeComparison(2)); 
Gamma = zeros(sizeMeasurement(1),sizeMeasurement(2)); 
 
%% 
%if sizeMeasurement == sizeComparison 
    for My = 1:sizeMeasurement(1)   
        for Mx = 1:sizeMeasurement(2)   
            for Cy = 1:sizeComparison(1) 
                for Cx = 1:sizeComparison(2) 
                    dr = ((((Mx*pitchMeasurment)-
(Cx*pitchComparison))^2)+(((My*pitchMeasurment)-
(Cy*pitchComparison))^2))/(DistanceToAgreement^2);                     
                    dD = ((Measurement(My,Mx) - 
Comparison(Cy,Cx))^2)/((DoseDifference.*maxMeasurment)^2);                     
                    TempGamma(Cy,Cx) = dr + dD; 
                end 
            end 
            Gamma(My,Mx) = min(min(TempGamma)); 
        end 
    end 
    Gamma = sqrt(Gamma); 
%else 





T = size(Gamma,1)*size(Gamma,2); 
u = reshape(Gamma, T, 1); 
a=0; 
for i=1:T 
    if u(i,:)>1 
        a = a+1; 
    end 
end 
 
A = (1-(a/T))*100; 
 
fprintf('\n\tThe number of channels failing is %d out of %d', a, T); 






function [X] = findX(InputArray, Yvalue, isSDMG, showPlots) 
% findX - this function determines the x-axis location of a single y-
axis 
% normalised value along a gaussian distribution (i.e. beam profile) 
via 
% interpolation; using the 'piecewise cubic hermite interpolation 
% polynomial ('pchipinterp'). 
% 
%   A is a two column array; the first column consists of the x-axis 





%   Yvalue is the y-axis value (whose location is of interest) as a 
%   percentage of the maximum value in the profile, expressed as a 
decimal 
%   e.g. 0.5 to find the "exact" location of the Half Maximums. 
% 
%   Returns an array, X, containing the x-axis locations of the y-axis 
%   values for the Left Hand Side (LHS) and Right Hand Side (RHS) of 
the 
%   distribution (about the central maximum). 
% 
%   Nb: The columns MUST be of equal lengths and contain ONLY real 
numbers. 
%% DETERMINE ACTIONS BASED UPON NUMBER OF INPUTS. 
 
if nargin == 2 
    isSDMG = 0; 
    showPlots = false; 
elseif nargin == 3 
    showPlots = false; 
end 
 
%% HIDDEN PARAMETERS. 
 
% InputArray(:,1) = XinputVector; 
% InputArray(:,2) = YinputVector; 
 
useMaximumOfProfile = 0; % 0 -> No, 1-> Yes. 
 
%% sDMG ONLY - Interpolate across gap between DMG's to find 'true' 
maximum. 
if isSDMG == 1 
    %% COMPLETE THE ARRAY. 
    ArrayToFit = InputArray; 
     
    % Identify outliers (dead channels) to remove based upon 'n' and 
'sigma' values. 
    n = 8; 
    sigma = 1.5; 
    [~,I] = hampel(ArrayToFit(:,2),n,sigma); 
    ArrayToFit(I,:) = []; 
     
    % Plot outlier identification. 
    if showPlots == true 
        figure; 
        subplot(1,2,1); 
        title('Determine Outliers in Data'); 
        scatter(InputArray(:,1),... 
            InputArray(:,2),... 
            40,... 
            'MarkerFaceColor',[0 0 .8]); 
        box on 
        xlabel('Distance (cm)'); 
        ylabel('Response (counts)'); 
        hold on 
        plot(InputArray(I,1),InputArray(I,2),'sk','MarkerSize',10); 
        hold off 
        legend('Input Data','Identified Outliers'); 
        axis([0 InputArray(end,1) 0 max(ArrayToFit(:,2))*1.2]); 
    end 
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    % Cut away known dead channels (unnecessary if filtering with 
hampel). 
    % ArrayToFit(130:134,:) = []; % Cut dead channels for better 
fitting. 
     
    % Spline or Pchip fitting: pchip fitting provides 'flatter'/lower 
maximum -> broader FWHM. 
    %     FitOfProfile = 
fit(ArrayToFit(:,1),ArrayToFit(:,2),'smoothingspline','SmoothingParam'
, 0.999); 
    FitOfProfile = fit(ArrayToFit(:,1),ArrayToFit(:,2),'pchip'); 
     
    % Determine resolution of provided profile. 
    SamplingResolution = InputArray(2,1) - InputArray(1,1); 
     
    % Find spatial coordinates across missing interval with identical 
    % sampling resolution and coordinates of removed dead channels. 
    IntervalX = [transpose(InputArray(128,1)+SamplingResolution : 
SamplingResolution : InputArray(129,1)-SamplingResolution)  ; 
InputArray(I,1)]; 
     
    % Determine magnitude of profile from fit at the 'X' spatial 
coordinates. 
    IntervalY = feval(FitOfProfile,IntervalX); 
     
    % Concatenate vectors together. 
    CatArray = [ArrayToFit ; [IntervalX IntervalY]]; 
     
    % Sort spatial vector into descending order,and then sort the 
response vector based 
    % upon the corresponding swaps. 
    [CompleteArray,I] = sort(CatArray(:,1),1); 
    CompleteArray(:,2) = CatArray(I,2); 
     
    CentreArray = CompleteArray; 
     
    %% PLOT THE FIT, INPUT sDMG DATA AND INTERPOLATED DATA. 
    if showPlots == true 
        subplot(1,2,2); 
        scatter(InputArray(:,1),... 
            InputArray(:,2),... 
            40,... 
            'MarkerFaceColor',[0 0 .8]); 
        hold on 
        plot(FitOfProfile); 
        scatter(IntervalX(:,1),... 
            IntervalY(:,1),... 
            40,... 
            'MarkerFaceColor',[1 0 0]); 
        hold off 
        box on 
        xlabel('Distance (cm)'); 
        ylabel('Response (counts)'); 
        legend('Original Data','Fit','Interpolated Data'); 
        axis([0 InputArray(end,1) 0 max(ArrayToFit(:,2))*1.2]); 
    end 
     
elseif isSDMG == 2 
    %% FILTER ANY INPUT ARRAY FOR OUTLIERS ('DEAD' CHANNELS). 
    ArrayToFit = InputArray; 
    n = 9; 
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    sigma = 0.7; 
    [~,I] = hampel(ArrayToFit(:,2),n,sigma); 
    ArrayToFit(I,:) = []; 
     
    if showPlots == true 
        figure; 
        title('Determine Outliers in Data'); 
        scatter(InputArray(:,1),... 
            InputArray(:,2),... 
            40,... 
            'MarkerFaceColor',[0 0 .8]); 
        box on 
        xlabel('Distance (cm)'); 
        ylabel('Response (counts)'); 
        hold on 
        plot(InputArray(I,1),InputArray(I,2),'sk','MarkerSize',10); 
        hold off 
        legend('Input Data','Identified Outliers'); 
        axis([0 InputArray(end,1) 0 max(ArrayToFit(:,2))*1.2]); 
    end 
     
    %FitOfProfile = 
fit(ArrayToFit(:,1),ArrayToFit(:,2),'smoothingspline','SmoothingParam'
, 0.999); 
    FitOfProfile = fit(ArrayToFit(:,1),ArrayToFit(:,2),'pchip'); 
     
    IntervalX = InputArray(I,1); 
    IntervalY = feval(FitOfProfile,IntervalX); 
    CatArray = [ArrayToFit ; [IntervalX IntervalY]]; 
    [CompleteArray,I] = sort(CatArray(:,1),1); 
    CompleteArray(:,2) = CatArray(I,2); 
    CentreArray = CompleteArray; 
else 
    CentreArray = InputArray; 
end 
 
if useMaximumOfProfile == 0; 
    %% FINDING CENTRE OF ARRAY. 
    % Downsample data. 
    DownSampledInputArray = downsample(CentreArray,3); 
    % Filter out noise in downsampled data. 
    FilteredDSIA = medfilt1(DownSampledInputArray(:,2),5); 
    % Calculate the discrete forward derivative of the filtered data. 
    ForwardDerivative = 
diff(FilteredDSIA)./diff(DownSampledInputArray(:,1)); 
     
    % Determine the spatial coordinates of the max and min peaks. 
    LHS = DownSampledInputArray(ForwardDerivative == 
max(ForwardDerivative),1); 
    RHS = DownSampledInputArray(ForwardDerivative == 
min(ForwardDerivative),1); 
     
    % Calculate FWHM and estimate centre of profile. 
    FWHM = (RHS - LHS); 
    CentreEstimate = LHS + (FWHM/2); 
    % Find true centre of complete data from downsampled centre. 
    FindingCentre = (CentreArray(:,1) - CentreEstimate).^2; 
     
    % Determine Index of centre value and true centre value. 
    CentreIndex = find(FindingCentre == min(FindingCentre)); 
    CentreValue = CentreArray(CentreIndex(1),1); 
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    %% DETERMINE MAXIMUM. 
    % Empirically determined formula to determine size of ROI to 
average over 
    % for normalisation of profile and accurate percentage 
calculation. 
    AreaOfProfile = (-0.0037602032*(FWHM^3)) + (0.0768540576*(FWHM^2)) 
+ (0.1020720234*(FWHM)) + (0.0532649909); 
     
    % Determine resolution of profile. 
    SamplingResolution = InputArray(2,1) - InputArray(1,1); 
     
    % Calculate number of elements to determine the 'average of', 
about the centre. 
    NumberOfElements = AreaOfProfile/SamplingResolution; 
     
    % Round to nearest even integer. 
    NumberOfElements = 2*round(NumberOfElements/2); 
     
    Maximum = mean(CentreArray((CentreIndex(1) - NumberOfElements/2) : 
(CentreIndex(1) + NumberOfElements/2) , 2)); 
     
    %% FIT AND INTERPOLATE LOCATIONS. 
    FitModelOfInput = fit(CentreArray(:,1),CentreArray(:,2),'pchip'); 
     
    if showPlots == true 
        figure; 
        scatter(InputArray(:,1),... 
            InputArray(:,2),... 
            40,... 
            'MarkerFaceColor',[0 0 .8]); 
        box on 
        axis tight; 
        hold on 
        plot(FitModelOfInput); 
        hold off 
        legend('Input Data','Fit'); 
        xlabel('Distance (cm)'); 
        ylabel('Response (counts)'); 
        axis([0 InputArray(end,1) 0 max(CentreArray(:,2))*1.2]); 
    end 
     
    objective = @(i) FitModelOfInput(i) - (Yvalue*Maximum); 
    X(1,1) = fzero(objective,[CentreArray(1,1) CentreValue]);                    
%LHS 
    X(1,2) = fzero(objective,[CentreValue CentreArray(end,1)]);                  
%RHS 
     
    clearvars pitch y profile_temporary distance_temporary profile_max 
profile_fit 
     
    %% PLOTTING. 
    if showPlots == true 
        figure; 
        subplot(1,2,1); 
        scatter(DownSampledInputArray(1:end-1,1),... 
            ForwardDerivative(:,1),... 
            40,... 
            'MarkerFaceColor',[0 0 .8]); 
        box on 
        xlabel('Distance (cm)'); 
153 
 
        ylabel('First Derivative'); 
        hold on 
        plot(DownSampledInputArray(ForwardDerivative == 
max(ForwardDerivative),1),ForwardDerivative(ForwardDerivative == 
max(ForwardDerivative),1),'sk','MarkerSize',10); 
        plot(DownSampledInputArray(ForwardDerivative == 
min(ForwardDerivative),1),ForwardDerivative(ForwardDerivative == 
min(ForwardDerivative),1),'sk','MarkerSize',10); 
        hold off 
        legend('Forward Derivative','Identified Max/Min'); 
         
        subplot(1,2,2); 
        scatter(InputArray(:,1),... 
            InputArray(:,2),... 
            40,... 
            'MarkerFaceColor',[0 0 .8]); 
        box on 
        axis tight; 
        hold on 
        plot(FitModelOfInput); 
        
line([InputArray(1,1),InputArray(end,1)],[Maximum,Maximum],'Color','g'
,'LineWidth',1,'LineStyle','--'); % Maximum 
        line([CentreArray((CentreIndex(1)-
NumberOfElements/2),1),CentreArray((CentreIndex(1)-
NumberOfElements/2),1)],[0,max(InputArray(:,2))*1.2],'Color','m','Line
Width',1,'LineStyle','--'); %LHS line of maximum area. 
        
line([CentreArray((CentreIndex(1)+NumberOfElements/2),1),CentreArray((
CentreIndex(1)+NumberOfElements/2),1)],[0,max(InputArray(:,2))*1.2],'C
olor','m','LineWidth',1,'LineStyle','--'); %RHS line of maximum area. 
        
line([X(1,1),X(1,1)],[0,max(InputArray(:,2))*1.2],'Color','k','LineWid
th',1,'LineStyle','--'); %LHS occurence of POI. 
        
line([X(1,2),X(1,2)],[0,max(InputArray(:,2))*1.2],'Color','k','LineWid
th',1,'LineStyle','--'); %RHS occurence of POI. 
        hold off 
        legend('Input Data','Fit'); 
        xlabel('Distance (cm)'); 
        ylabel('Response (counts)'); 
        axis([0 InputArray(end,1) 0 max(CentreArray(:,2))*1.2]); 
    end 
else 
    %% USE THE MAXIMUM IN PROFILE. 
    FitModelOfInput = fit(InputArray(:,1),InputArray(:,2),'pchip'); 
     
    MaximumOfInput = max(InputArray(:,2)); 
    CentreOfProfile = InputArray(InputArray(:,2) == MaximumOfInput,1); 
     
    objective = @(i) FitModelOfInput(i) - (Yvalue*MaximumOfInput); 
    X(1,1) = fzero(objective,[InputArray(1,1) CentreOfProfile]);              
%LHS 
    X(1,2) = fzero(objective,[CentreOfProfile InputArray(end,1)]);            
%RHS 
     









function [ EqualisationFactors , EqualisationVector ] = 
calculateEqualisation( Path , ... 




%% Select File: 
 
fprintf('DETECTOR RESPONSE - EQUALISATION:\n'); 
fprintf('\tSelect the file/s to produce equalisation factors.\n'); 
[FileNames, FilePath] = uigetfile('*.txt', 'Select Decoded Files to 
produce Equalisation Array:', Path); 
 
if ischar(FilePath) == 0 && ischar(FileNames) == 0 
    % If cancel is pressed in pop-up window, function exits returning 
0. 
    fprintf('\tCancel.\n'); 
    EqualisationFactors = 0; 
    EqualisationVector  = 0; 
    return 
else 
    File = fullfile(FilePath, FileNames); 
    fprintf('\t\tFile selected: %s.\n',FileNames); 
end 
 
%% 0. HIDDEN PARAMETERS. 
fprintf('\t2. Generating the equalisation factors...\n'); 
 
plotProfile = true; 
 
plotTimeResponse = true; 
ChannelNumber = 200; 
 
baselineSubtractionOption = 0; % 0 = Manual, 1 = Automatic, 2 = off. 
useForLoop = false; 
 
LowerThreshold = 0.01; 
UpperThreshold = 3; 
 
LogicalStr = {'False', 'True'}; 
fprintf('\t\tPlot Time Response of channel %d: %s\n',ChannelNumber, 
LogicalStr{plotTimeResponse + 1}); 
 
if baselineSubtractionOption == 0 
    fprintf('\t\tBaseline Subtraction: Manual\n'); 
elseif baselineSubtractionOption == 1 
    fprintf('\t\tBaseline Subtraction: Automatic\n'); 
elseif baselineSubtractionOption == 2 
    fprintf('\t\tBaseline Subtraction: Off\n'); 
end 
 
fprintf('\t\tPlot the result: %s\n', LogicalStr{plotProfile + 1}); 
 
fprintf('\t\tRestrict Equalisation Factors below: %0.2f\n', 
LowerThreshold); 





%% 1. IMPORT DATA. 
 
Data = importdata(File, '\t'); 
 
%% 2. SETUP TIME PARAMETERS. 
 
samplingFrequency = 360;                            % Sampling 
frequency 
period = 1/samplingFrequency;                       % Sampling period 
numberOfSamples = size(Data,1);                     % Length of signal 
time = (0:numberOfSamples-1)*period;                % Time vector 
time = time';                                       % Swap to column 
vector 
 
%% 3. PLOT DETECTOR RESPONSE AS FUNCTION OF TIME. 
 
if plotTimeResponse == true 
    figure; 
    plot(time,(Data(:,ChannelNumber))./65535*100,'LineWidth',1); 
    axis tight; 
    box on; 
    title('Channel Response'); 
    ylabel('Response (%)'); 
    xlabel('Time (s)'); 
end 
 
%% 4. BASELINE SUBTRACTION OPTIONS. 
 
baselineSubtractionTime = 1;    % Time (in seconds) from end of file 
to consider noise over i.e. determines noise ROI. 
 
if baselineSubtractionOption == 0 
    defaultAns = {num2str(period*(size(Data,1))-
baselineSubtractionTime),num2str(period*(size(Data,1)))}; 
    answer = inputdlg({'Enter time 1 (s):','Enter time 2 
(s):'},'Input',1,defaultAns); 
    RegionOfInterestLeft = 
floor((str2double(answer{1}))*samplingFrequency); 
    RegionOfInterestRight = 
floor((str2double(answer{2}))*samplingFrequency); 
else 
    RegionOfInterestLeft = floor((period*(size(Data,1))-
baselineSubtractionTime)*samplingFrequency); 




% Calculate Noise. 
MeanNoise = (mean(Data( RegionOfInterestLeft : RegionOfInterestRight , 
:))).*size(Data,1); 
 
if baselineSubtractionOption == 2 % 2 - off. 
    IntegralData = sum(Data); 
else 
    IntegralData = (sum(Data)) - MeanNoise; 
end 
 
%% 6. ZERO-OUT NEGATIVE VALUES. 
 
if useForLoop == true 
    for i = 1 : size(IntegralData,2) 
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        if(IntegralData(1,i)<0) 
            IntegralData(1,i) = 0; 
        end 
    end 
else 
    [~ , col] = find( IntegralData < 0); 
    IntegralData(col) = 0; 





IntegralMean = mean(IntegralData); 
 
EqualisationVector = IntegralData./IntegralMean; 
 
%% 8. THRESHOLD EQUALISATION FACTORS TO ELIMINATE HIGHS/LOWS. 
 
if useForLoop == true 
    for i = 1 : size(EqualisationVector,2) 
        if(EqualisationVector(1,i)<LowerThreshold) 
            EqualisationVector(1,i) = 1; 
        end 
        if(EqualisationVector(1,i)>UpperThreshold) 
            EqualisationVector(1,i) = 1; 
        end 
    end 
else 
    [~, col] = find( EqualisationVector < LowerThreshold); 
    EqualisationVector(col) = 1; 
    clearvars row col 
     
    [~, col] = find( EqualisationVector > UpperThreshold); 





EqualisationFactors = rearrange(EqualisationVector,Map); 
 
[row, col] = find(isnan(EqualisationFactors)); 
for i=1:size(row,1) 






if plotProfile == true 







function [ Output ] = integrateFile( Path , ... 
    Map , ... 
    EqualisationFactors, ... 






% Check if equalisation factors are supplied or not, if not supplied 
% calculate un-equalised profile. 
if nargin == 2 
    EqualisationFactors = false; 
    Mask = false; 
elseif nargin == 3 
    Mask = false; 
end 
 
%% Select File: 
 
fprintf('\nDETECTOR RESPONSE - INTEGRATION:\n'); 
fprintf('\t1. Select the file/s to integrate.\n'); 
[FileNames, FilePath] = uigetfile('*.txt', 'Select Decoded Files for 
Analysis:', Path); 
 
if ischar(FilePath) == 0 && ischar(FileNames) == 0 
    % If cancel is pressed in pop-up window, function exits returning 
0. 
    fprintf('\tCancel.\n'); 
    Output = false; 
    return 
else 
    File = fullfile(FilePath, FileNames); 
    fprintf('\t\tFile selected: %s.\n',FileNames); 
end 
 
if EqualisationFactors == false 
    fprintf('\t2. Generating the unequalised integral...\n'); 
else 
    fprintf('\t2. Generating the equalised integral...\n'); 
end 
 
%% 0. HIDDEN PARAMETERS. 
plotProfile = true; 
plotTimeResponse = true; 
ChannelNumber = 200; 
baselineSubtractionOption = 2; % 0 = Manual, 1 = Automatic, 2 = off. 
useForLoop = false; 
 
filterData = true; 
k = 50; % Number of adjacent samples on either side samples in data 
over which to compute Hampel Identifier. 
nsigma = 0.5; % Number of estimated standard deviations above which 
will be filtered. 
plotFilteredComparison = false; 
 
plotType = 'charge'; 
chargeQuanta = 4.8; % (pC) - range 5 
 
if strcmp(plotType,'raw') == true 
    modifier = 1; 
    labelY = 'Raw Response (counts)'; 
elseif strcmp(plotType,'response') == true 
    modifier = 65535/100; 
    labelY = 'Normalised Response (%)'; 
elseif strcmp(plotType,'charge') == true 
    modifier = 65535/chargeQuanta; 
158 
 
    labelY = 'Charge (pC)'; 
elseif strcmp(plotType,'dose') == true 
    %     modifier = 65535/(chargeQuanta*doseConversion); 
    %     labelY = 'Dose (cGy)'; 
end 
 
%% DISPLAY OUTPUTS: 
LogicalStr = {'False', 'True'}; 
fprintf('\t\tFilter data: %s\n', LogicalStr{filterData + 1}); 
if filterData == true 
    fprintf('\t\t\tHampel Filter, k: %d\n', k); 
    fprintf('\t\t\tHampel Filter, nsigma: %0.2f\n', nsigma); 
end 
 
fprintf('\t\tPlot Time Response of channel %d: %s\n',ChannelNumber, 
LogicalStr{plotTimeResponse + 1}); 
 
if baselineSubtractionOption == 0 
    fprintf('\t\tBaseline Subtraction: Manual\n'); 
elseif baselineSubtractionOption == 1 
    fprintf('\t\tBaseline Subtraction: Automatic\n'); 
elseif baselineSubtractionOption == 2 
    fprintf('\t\tBaseline Subtraction: Off\n'); 
end 
 
fprintf('\t\tPlot the result: %s\n', LogicalStr{plotProfile + 1}); 
 
clearvars LogicalStr 
%% NESTED FUNCTIONS. 
 
    function [CorrectedIntegral , Integral] = baselineSubtract(file, 
data, option, frequency, period, isUnFilteredData) 
        subtractionTime = 1;    % Time (in seconds) from end of file 
to estimate average noise over. 
        if option == 0 
            defaultAns = {num2str(period*(size(data,1))-
subtractionTime),num2str(period*(size(data,1)))}; 
            answer = inputdlg({'Enter time 1 (s):','Enter time 2 
(s):'},'Input',1,defaultAns); 
            RegionOfInterestLeft = 
floor((str2double(answer{1}))*frequency); 
            RegionOfInterestRight = 
floor((str2double(answer{2}))*frequency); 
        else 
            RegionOfInterestLeft = floor((period*(size(data,1))-
subtractionTime)*frequency); 
            RegionOfInterestRight = 
floor(period*(size(data,1))*frequency); 
        end 
         
        MeanNoise = (mean(data(RegionOfInterestLeft : 
RegionOfInterestRight , :))).*size(data,1); 
         
        if option == 2   % If baseline subtraction is selected off. 
            [CorrectedIntegral , Integral] = sumData(file, data, 
frequency, isUnFilteredData); 
        else 
            [CorrectedIntegral , Integral] = sumData(file, data, 
frequency, isUnFilteredData); 
            if islogical(CorrectedIntegral) == false 
                CorrectedIntegral = CorrectedIntegral - MeanNoise; 
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            end 
            Integral = Integral - MeanNoise; 
        end 
    end 
 
    function [ CorrectedIntegral , Integral ] = sumData(file, data, 
frequency, isUnFilteredData) 
        AngleFile = strcat(file(1:end-11),'angles.aux'); 
        if exist(AngleFile,'file') == 2 
            AngleImport = importdata(AngleFile, '\t'); 
             
            load('C:\Users\Matt\Google 
Drive\MATLAB\Detector\DUO_angularCorrection'); 
            pp = 
pchip(DUO_angularCorrection(:,1),DUO_angularCorrection(:,2)); 
            cf = zeros(size(AngleImport,1),1); 
            for j = 1:size(AngleImport,1) 
                cf(j,1) = ppval(pp,AngleImport(j,1)); 
            end 
             
            correctedData = zeros(size(data,1),size(data,2)); 
            for row = 1:size(data,1) 
                for col = 1:size(data,2) 
                    correctedData(row,col) = data(row,col)/cf(row,1); 
                end 
            end 
             
            if isUnFilteredData == false 
                fprintf('\t\tAngular Correction Applied.\n'); 
                figure; 
                subplot(1,2,1); 
                t = 
linspace(1,size(AngleImport,1),size(AngleImport,1)); 
                t = t*1/frequency; 
                scatter(t,AngleImport); 
                axis square; box on; 
                xlabel('Time (s)');ylabel('Angle (degrees)'); 
                axis([0 t(end,end) -270 270]); 
                subplot(1,2,2); 
                scatter(t,cf); 
                axis square; box on; 
                xlabel('Time (s)');ylabel('Correction Factor'); 
                axis([0 t(end,end) 0 2]); 
            end 
             
            CorrectedIntegral = (sum(correctedData)); 
            Integral = (sum(data)); 
        else 
            if isUnFilteredData == false 
                fprintf('\t\tNo Angular Correction.\n'); 
            end 
             
            CorrectedIntegral = false; 
            Integral = (sum(data)); 
        end 
    end 
 
    function [ I ] = zeroOut(inputIntegral, useLoop) 
        if useLoop == true 
            for j = 1 : size(inputIntegral,2) 
                if(inputIntegral(1,j)<0) 
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                    inputIntegral(1,j) = 0; 
                end 
            end 
        else 
            [~ , c] = find( inputIntegral < 0); 
            inputIntegral(c) = 0; 
        end 
        I = inputIntegral; 
    end 
 
    function [UnequalisedIntegral, EqualisedIntegral] = 
adjustIntegral(inputVector, inputMap, inputEQFactors) 
        Array = rearrange(inputVector,inputMap); 
        if inputEQFactors == false 
            UnequalisedIntegral = Array; 
            EqualisedIntegral = false; 
        else 
            UnequalisedIntegral = Array; 
            EqualisedIntegral = Array ./ inputEQFactors; 
        end 
        [r, c] = find(isnan(UnequalisedIntegral)); 
        UnequalisedIntegral(r,c) = 0; 
        clearvars r c 
        [r, c] = find(isnan(EqualisedIntegral)); 
        EqualisedIntegral(r,c) = 0; 
    end 
 
 
%% 1. IMPORT DATA. 
 
DataImport = importdata(File, '\t'); 
 
%% 2. SETUP TIME PARAMETERS. 
 
samplingFrequency = 360;                            % Sampling 
frequency 
period = 1/samplingFrequency;                       % Sampling period 
numberOfSamples = size(DataImport,1);               % Length of signal 
time = (0:numberOfSamples-1)*period;                % Time vector 
time = time';                                       % Swap to column 
vector 
 
%% 2.b) Filter Data 
 
if filterData == true 
    Data = hampel(DataImport,k,nsigma); 
else 
    Data = DataImport; 
end 
 
%% 3. PLOT DETECTOR RESPONSE AS FUNCTION OF TIME. 
 
    function resize1(source,event) 
        fig1Pos = fig1.Position; 
        ax1.Position = [0.1*fig1Pos(3) 0.15*fig1Pos(4) 0.8*fig1Pos(3) 
0.75*fig1Pos(4)]; 
    end 
 
if plotTimeResponse == true 
    fig1 = figure; 
    fig1.SizeChangedFcn = @resize1; 
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    ax1 = axes(fig1); 
    ax1.Units = 'pixels'; 
    ax1.Position = [0.1*fig1.Position(3) 0.15*fig1.Position(4) 
0.8*fig1.Position(3) 0.8*fig1.Position(4)]; 
    ax1.Box = 'on'; 
    if filterData == true 
        
plot(ax1,time,(DataImport(:,ChannelNumber))./modifier,'LineWidth',1); 
        hold(ax1,'on'); 
        
plot(ax1,time,(Data(:,ChannelNumber))./modifier,'LineWidth',1); 
        legend('Unfiltered Data','Hampel Filtered Data'); 
        hold(ax1,'off'); 
    else 
        
plot(ax1,time,(Data(:,ChannelNumber))./modifier,'LineWidth',1); 
    end  
    ax1.Title.String ='Channel Response'; 
    ax1.XLabel.String ='Distance (cm)'; 




%% 4. BASELINE SUBTRACTION OPTIONS. 
 
[AngCorIntegral, Integral] = baselineSubtract(File, Data, 
baselineSubtractionOption, samplingFrequency, period, false); 
 
if filterData == true 
    [UnfiltAngCorIntegral, UnfiltIntegral] = baselineSubtract(File, 
DataImport, baselineSubtractionOption, samplingFrequency, period, 
true); 
else 
    UnfiltAngCorIntegral = false; 
    UnfiltIntegral = false; 
end 
%% 5. ZERO-OUT NEGATIVE INTEGRAL VALUES. 
 
Integral = zeroOut(Integral, useForLoop); 
 
if islogical(AngCorIntegral) == false 
    AngCorIntegral = zeroOut(AngCorIntegral, useForLoop); 
end 
 
if filterData == true 
    UnfiltIntegral = zeroOut(UnfiltIntegral, useForLoop); 
    if islogical(UnfiltAngCorIntegral) == false 
        UnfiltAngCorIntegral = zeroOut(UnfiltAngCorIntegral, 
useForLoop); 
    end 
end 
%% 6. MAP THE VECTOR INTO THE OUTPUT ARRAY. 
 
[UnEqIntegral, EqIntegral] = adjustIntegral(Integral, Map, 
EqualisationFactors); 
 
if islogical(AngCorIntegral) == false 
    [UnEqAngCorIntegral, EqAngCorIntegral] = 
adjustIntegral(AngCorIntegral, Map, EqualisationFactors); 
else 
    UnEqAngCorIntegral = false; 
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    EqAngCorIntegral = false; 
end 
 
if filterData == true 
    [UnEqUnfiltIntegral, EqUnfiltIntegral] = 
adjustIntegral(UnfiltIntegral, Map, EqualisationFactors); 
    if islogical(UnfiltAngCorIntegral) == false 
        [UnEqUnfiltAngCorIntegral, EqUnfiltAngCorIntegral] = 
adjustIntegral(UnfiltAngCorIntegral, Map, EqualisationFactors); 
    else 
        UnEqUnfiltAngCorIntegral = false; 
        EqUnfiltAngCorIntegral = false; 
    end 
end 
%% 7. SELECT CORRECT INTEGRAL. 
 
if islogical(EqualisationFactors) == false 
    if islogical(EqAngCorIntegral) == false 
        integral = EqAngCorIntegral; 
    else 
        integral = EqIntegral; 
    end 
else 
    if islogical(UnEqAngCorIntegral) == false 
        integral = UnEqAngCorIntegral; 
    else 
        integral = UnEqIntegral; 
    end 
end 
 
if plotFilteredComparison == true 
    if islogical(EqualisationFactors) == false 
        if islogical(EqUnfiltAngCorIntegral) == false 
            unfiltintegral = EqUnfiltAngCorIntegral; 
        else 
            unfiltintegral = EqUnfiltIntegral; 
        end 
    else 
        if islogical(UnEqUnfiltAngCorIntegral) == false 
            unfiltintegral = UnEqUnfiltAngCorIntegral; 
        else 
            unfiltintegral = UnEqUnfiltIntegral; 
        end 
    end 
end 
%% 
if size(Mask) > 1 
    channels = transpose(1:(size(integral,1)-1)); 
     
    Horiz(:,1) = channels; 
    Vert(:,1) = channels; 
    Horiz(:,2) = integral(1:end-1,1); 
    Vert(:,2) = integral(1:end-1,2); 
     
    MaskH = Mask(:,1); 
    MaskV = Mask(:,2); 
    Horiz(MaskH,:) = []; 
    Vert(MaskV,:) = []; 
     




    FinalIntegral(:,2) = 
interp1(Vert(:,1),Vert(:,2),channels,'pchip'); 
    FinalIntegral(end+1,:) = 0; 
     
    integral = FinalIntegral; 
    EqIntegral = FinalIntegral; 
end 
%% 8. PLOT. 
pitch = 0.02; 
 
    function resize2(source,event) 
        ax2.Position = [0.1*fig2.Position(3) 0.15*fig2.Position(4) 
0.8*fig2.Position(3)/2 0.8*fig2.Position(4)]; 
        ax3.Position = [0.55*fig2.Position(3) 0.15*fig2.Position(4) 
0.8*fig2.Position(3)/2 0.8*fig2.Position(4)]; 
    end 
 
fig2 = figure; 
orig2Position = fig2.Position; 
fig2.Position = [orig2Position(1) orig2Position(2) 2*orig2Position(3) 
orig2Position(4)]; 
fig2.SizeChangedFcn = @resize2; 
 
ax2 = axes(fig2); 
ax2.Units = 'pixels'; 
ax2.Position = [0.1*fig2.Position(3) 0.15*fig2.Position(4) 
0.75*fig2.Position(3)/2 0.8*fig2.Position(4)]; 
 
ax3 = axes(fig2); 
ax3.Units = 'pixels'; 
ax3.Position = [0.55*fig2.Position(3) 0.15*fig2.Position(4) 
0.75*fig2.Position(3)/2 0.8*fig2.Position(4)]; 
 
% distance = transpose(((0:(size(Map,1)-1))*pitch)); 
distance = transpose(1:(size(Map,1))); 
 
if plotProfile == true 
    if plotFilteredComparison == true 
        scatter(ax2,distance,integral(:,1),'filled'); 
        hold(ax2,'on'); 
        scatter(ax2,distance,unfiltintegral(:,1),'filled'); 
        hold(ax2,'off'); 
         
        scatter(ax3,distance,integral(:,2),'filled'); 
        hold(ax3,'on'); 
        scatter(ax3,distance,unfiltintegral(:,2),'filled'); 
        hold(ax3,'off'); 
    else 
        scatter(ax2,distance,integral(:,1),'filled'); 
        scatter(ax3,distance,integral(:,2),'filled'); 
    end 
end 
 
ax2.Box = 'on'; 
ax2.Title.String ='Horizontal'; 
ax2.XLabel.String ='Distance (cm)'; 
ax2.YLabel.String = labelY; 
ax2.XLim = [0 max(distance)]; 
 




ax3.XLabel.String ='Distance (cm)'; 
ax3.YLabel.String = labelY; 
ax3.XLim = [0 max(distance)]; 
 
%% 9. ASSEMBLE OUTPUT. 
 
Output.Equalised.Integral = EqIntegral; 
Output.Equalised.AngularCorrectedIntegral = EqAngCorIntegral; 




Output.Unequalised.Integral = UnEqIntegral; 
Output.Unequalised.AngularCorrectedIntegral = UnEqAngCorIntegral; 




Output.EqualisationFactors = EqualisationFactors; 
Output.Map = Map; 
 
Output.File = File; 
%% Find Channels responsible for penumbra: 20, 50 & 80% 
 
HorizontalOrVertical = 2; % 1 - Horizontal or 2 - Vertical. 
 
    function [out] = findChannels(inputdata, R, inputIntegral, 
inputMap, HorV) 
        % Y 
        in(:,2) = inputIntegral(:,HorV); 
        % X 
        pitch = 0.02; 
        profileSize = size(in,1)-1; 
        distance = transpose((0:profileSize)*pitch); 
        in(:,1) = distance; 
         
        channel = findX(in,R,2,false); 
        channel = round(channel./pitch); 
         
        if size(Mask) > 1 
            while Mask(channel(1),HorV) == 1 
                channel(1) = channel(1)+1; 
            end 
            while Mask(channel(2),HorV) == 1 
                channel(2) = channel(2)+1; 
            end 
        end 
         
        channel = inputMap(channel,HorV); 
         
        out(:,1) = inputdata(:,channel(1)); 
        out(:,2) = inputdata(:,channel(2)); 
    end 
 






























B. Co-author works 
 
The following pages detail the first page of manuscripts where I am co-author with a significant 
contribution to the study, the experimental data of which relates directly to: 
 
 Chapter 6 – “Feasibility study of a novel multi-strip silicon detector for use in proton 
therapy range verification quality assurance”, published in Radiation Measurements 
 Chapter 7 – “A silicon strip detector array for energy verification and quality assurance in 
heavy ion therapy” (Debrot, 2018), published in Medical Physics 
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